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INTRODUCTION 
In work performed in the Toxicology Section, Iowa 
Veterinary Diagnostic Laboratory and the Department of 
Veterinary Microbiology and Preventive Medicine, Iowa State 
University, Hemphill (1973) found that mice orally exposed to 
low levels of lead nitrate experienced significantly higher 
mortality rates than non-lead-exposed controls when challenged 
with virulent Salmonella typhimurium organisms. These studies 
also revealed that lead nitrate-exposed mice which were 
inoculated with a bacterin of S. typhimurium developed 
significantly lower agglutinating antibody titers and had 
significantly lower serum alpha^ and gamma globulin 
concentrations than did non-lead-exposed mice. 
In light of the ubiquitous natural nisr/rihntion of lead 
(Chisolm, 1971) and the resultant exposure of all animals, 
including man, to this metal, the finding of both lead-induced 
reduction of resistance to infection and alteration of certain 
immunologic parameters has important biological implications. 
The effect of lead exposure on immunity and/or resistance 
should, therefore, be studied in another mammalian species 
more closely related to man. The pig is physiologically 
similar to man (Earl et al., 1964; Bustad and McClellan, 1966) 
and should be a useful test animal. 
The purpose of this investigation was to determine the 
effect of subclinical levels of lead exposure on the 
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resistance of swine to bacterial infection. It was proposed 
that such an effect might be detected by observing relative 
mortality rates in lead- and non-lead-exposed pigs subse­
quently challenged with a gram-negative, endotoxin-
synthesizing bacteria. Furthermore, it was felt that 
measurement of physiologic parameters such as serum antibody 
titers against bacterial antigens, serum protein electro-
phoretic patterns (with special attention to relative 
globulin concentrations), total leukocyte counts, and 
leukocyte differential counts could give valuable information 
on the response of the animals to such a challenge. 
It was also hoped that such studies would reveal any 
other physiopathologic alterations caused by lead exposure 
in swine. 
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LITERATURE REVIEW 
Excellent reviews concerning sources and extent of 
environmental lead contamination (Patterson, 1965), metabolism 
of lead in the animal body (Kehoe, 1961) , and possible adverse 
effects of lead on health (Chisolm, 1971; De Bruin, 1971) have 
previously been compiled. 
Chisolm (1971) stated that "Among the natural substances 
that man concentrates in his immediate environment, lead is 
one of the most ubiquitous," and Patterson (1965) contended 
that "the average resident of the United States is being 
subjected to severe chronic lead insult." It is evident that 
lead wastes have been accumulating during the last century 
and that lead concentrations in organs of individuals from 
highly industrialized societies are higher than those of most 
individuals from primitive populations (Chisolm, 1971). 
The best known adverse effect of lead on the living 
organism is inhibition of the activities of enzymes which 
are dependent on the presence of free sulfhydryl groups for 
their activities (Chisolm, 1971). The classic example of 
such en effect is lead-induced inhibition of activities of 
enzymes in the heme synthetic pathway. 
Lead is thought to inhibit energy metabolism of certain 
cells of the kidney and, after long-term exposure, to cause 
chronic kidney failure (Chisolm, 1371; De Bruin, 1971). 
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Lead adversely affects the central nervous system 
through upset of energy metabolism and/or direct injury to 
neurons, and also injures the peripheral nervous system by 
causing nerve sheath demyelination (Chisolm, 1971). 
It has been theorized that lead reduces thyroid gland 
activity, efficiency of the clotting mechanism, and 
immunologic responsiveness (De Bruin, 1971). 
The concept of immunosuppression caused by environmental 
contaminants (such as lead) is not new. A number of workers 
have investigated the potential immunosuppressive properties 
of such contaminants as polychlorinated biphenyls (PCBs), 
particulate carbon, sulfur dioxide, cobalt, arsenicals, 
cadmium, mercury, and lead. 
Friend and Trainer (1970) noted that mallard ducklings 
orally exposed to PCBs and then challenged with duck hepatitis 
virus suffered more rapid onset of mortality as well as higher 
mortality rates than did non-PCB-treated controls. Guinea 
pigs fed low levels of PCBs had significantly decreased 
a H u Z u O X i n  L . Î L . 0 i r S  â S  C O ï u p 5 . 2 r c u  L . O  S x .  u c j T  C I I 3 . X W i u n  
tetanus toxoid (Vos and De Roij, 1972; Vos and Van Driel-
Grootenhuis, 1972). Such guinea pigs also had decreased 
numbers of gamma globulin-producing cells in popliteal lymph 
nodes, decreased serum gamma globulin concentrations, and 
decreased cell-mediated immune responses as measured by the 
intradermal tuberculin test (Vos and Van Driel-Grootenhuis, 
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1972). Roller and Thigpen (1973) found that rabbits fed three 
different formulations of PCBs developed significantly lower 
serum-neutralizing antibody titers to pseudorabies virus than 
did rabbits not fed PCBs. In this same study, serum gamma 
globulin concentrations were lowered in rabbits receiving one 
of the PCB formulations but were elevated in rabbits receiving 
the other two PCB formulations. 
Zarkower (1972) observed significant decreases in 
agglutinin titers in mice exposed to carbon or to a 
combination of carbon and sulfur dioxide by the aerosol route 
and then challenged by this same route with Escherichia coli 
bacterin. Such mice also had decreased numbers of splenic 
antibody-producing cells. In similar studies using sulfur 
dioxide without carbon, it was found that there was an 
increase in agglutinin titers and in numbers of splenic 
antibody-producing cells after 135 days of exposure but that 
both decreased after 192 days of sulfur dioxide inhalation. 
Mice consuming "non-growth-depressing" concentrations of 
cobalt sulfate had significantly higher mortality rates and 
virus titers in brain, heart, and spleen than did controls 
after exposure to encephalomyocarditis virus (Gainer, 1972b). 
These studies also revealed that cobalt sulfate inhibited the 
action of interferon in cell cultures. 
Berry and Mitchell (1953) reported increased mortality 
rates in mice parenterally exposed to sodium arsenite and 
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inoculated with Salmonella typhimurium organisms. These 
workers explained that the increased susceptibility resulted 
from inhibition of the Krebs cycle and subsequent metabolic 
upset. Mice treated with sodium arsenite and sodium arsenate 
suffered significantly higher mortality rates as compared to 
controls when challenged with pseudorabies virus, encephalo-
myocarditis virus, or St. Louis encephalitis virus (Gainer and 
Pry, 1972). These findings were attributed to arsenical-
induced inhibition of interferon. In further studies, Gainer 
(1972a) noted that high levels of exposure to sodium arsenite 
and roxarsone inhibited both the synthesis and action of 
interferon vivo and ^  vitro. 
Jones et al. (1971) reported that rats receiving intra­
venous (i.v.) injections of cadmium chloride two weeks prior 
to initial inoculation with human gamma globulin (HGG) exper­
ienced enhanced primary and secondary antibody responses, but 
that rats receiving similar cadmium injections one week prior 
to HGG inoculation had delayed primary and depressed secondary 
antibody responses. Roller (1973) found that rabbits receiving 
oral cadmium for a 70-day period and then inoculated with 
formalinized pseudorabies virus developed significantly lower 
serum-neutralizing antibody titers than did non-cadmium-
exposed controls. 
Roller (1973) also detected decreased serum-neutralizing 
antibody titers in mercury-exposed rabbits inoculated with 
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formalinized pseudorabies virus; however, this decrease was 
not as marked as that noted in cadmium- or lead-exposed 
rabbits. 
Hemphill (1973) demonstrated that mice orally exposed 
to lead nitrate and subsequently challenged with virulent 
S. typhimurium organisms experienced significantly higher 
mortality rates than did non-lead-exposed controls. In these 
same studies, mice orally exposed to lead nitrate and then 
inoculated with a S. typhimurium bacterin developed 
significantly lower agglutinating antibody titers and had 
significantly lower serum alpha^ and gamma globulin 
concentrations as compared to controls. Such mice also had 
marked decreases in serum properdin activity. Hemphill 
suggested that this study gave evidence for lead inactivation 
of antibodies. 
Hamsters exposed to different levels of lead for variable 
periods of time were no more susceptible to S. typhimurium 
than were non-lead-exposed controls, and no significant 
alterations in serum protein clectrcphoretic patterns were 
detected (Mankus, 1975). 
In lead-exposed workers, Soliman et al. (1970) noted 
decreased serum alpha^ and alphag globulin levels, but no 
decreases in serum gamma globulin concentrations were found. 
The decreased concentrations of these serum protein fractions 
were theorized to be related to urinary protein loss. 
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Rabbits exposed to lead orally for 70 days developed 
lower serum-neutralizing antibody titers (lOX) when challenged 
with formalinized pseudorabies virus as compared to rabbits 
not consuming lead (Roller, 1973). 
In studying mice inoculated intraperitoneally (i.p.) with 
sheep red blood cells, Roller and Kovacic (1974) found that 
those exposed to lead acetate orally had lower numbers of 
splenic cells producing either IgG or IgM antibodies. These 
workers felt that chronic lead exposure caused a significant 
decrease of antibody synthesis and that this probably involved 
memory cells. 
Lead-exposure produced no difference in passive 
hemagglutination titers in lambs inoculated with Serratia 
marcescens (Hoffman, 1974). In this same series of studies, 
lead-exposed lambs had significantly lower serum alphag 
globulin concentrations than did controls, but lead exposure 
caused no difference in serum IgG or IgM levels. 
Vengris and Mare (1974) reported that long-term 
subclinical lead intake did not suppress either interferon 
or antibody production in chickens; however, higher levels of 
lead exposure markedly decreased interferon concentrations 
and duration of interferon in serum. 
Trejo and Di Luzio (1971) found that a single i.v. 
injection of lead acetate in rats did not modify the primary 
or secondary immune response to an injection of sheep red 
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blood cells as measured by the hemagglutination test. 
Hoffman et al. (1972) suggested that rather than 
effecting humoral immunity, lead might act to increase 
susceptibility to infections by causing impaired phagocytosis 
or impairment of protein synthesis by phagocytic cells. 
There has been extensive study of the relationship of 
bacterial endotoxin and lead acetate in living organisms. 
Selye et al. (1356) discovered that rats which received 
simultaneous i.v. injections of lead acetate and E. coli 
endotoxin were approximately 100,000 times more sensitive to 
endotoxin than were rats receiving endotoxin alone. These 
workers noted that the minimum i.v. dosage of lead acetate 
needed to induce increased sensitivity to endotoxin was 
10 mg/kg body weight. 
Other workers have confirmed the endotoxin-sensitizing 
quality of lead in rats (Filkins, 1970; Filkins and Buchanan, 
1973), chicks (Truscott, 1970), mice (Rippe and Berry, 1972; 
Seyberth et al., 1972) and baboons (Holper et al., 1973). 
ïrejo and ûi Luzio (1971) observed highest îfiori.ality 
rates and most severe tissue damage when rats received 
simultaneous injections of lead acetate and E. coli endotoxin 
but noted increased mortalities as compared to rats not 
exposed to lead acetate when endotoxin was administered from 
one hour before to seven hours after lead acetate injection. 
Bertok (1968a) reported that rats rendered endotoxin-tolerant 
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by a previous small dose of endotoxin experienced a decrease 
in this tolerance when exposed to a mixture of lead acetate 
and endotoxin. 
In studying the fate of intravenously injected, radio­
labeled endotoxin in rabbits, Braude et al. (1955) found that 
endotoxin was first concentrated in the plasma and then in 
the buffy coat (especially during leukopenic periods) and the 
liver. It was felt that the endotoxin accumulation in the 
liver was probably in phagocytic (Kupffer) cells. These 
authors also suggested that endotoxin accumulation in 
neutrophils might cause damage to these cells and subsequent 
release of pyrogens and other substances mediating 
endotoxic shock. 
Di Luzio and Crafton (1969) demonstrated that i.v.-
injected, Cr^^-labeled S. enteritidis endotoxin was localized 
in the liver and suggested that this accumulation was mainly 
in Kupffer cells. Filkins (1970) contended that most 
detoxification of endotoxin occurred in the liver and spleen. 
This contention was strengthened by Trejo and Di Luzio (1371) 
who demonstrated that mice receiving endotoxin which had been 
previously incubated with homogenates of rat liver and spleen 
suffered lower mortality rates than did mice receiving 
endotoxin not previously incubated with such homogenates. 
These workers did not detect significant endotoxin detoxifying 
ability in homogenates of lung, kidney, heart, or brain. 
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Rutenberg et al. (1950) found macrophages to have potent 
endotoxin detoxifying activity vitro. Hoffman et al. 
(1972) felt that Kupffer cells played an important part in 
uptake and detoxification of endotoxin while hepatocytes were 
important sites for adjustments of fat, carbohydrate, and 
protein metabolism necessary for tolerance of endotoxin 
exposure. 
In studies with rabbits previously rendered tolerant to 
endotoxin, Greisman et al. (1953) found that tolerance could 
be transferred to other rabbits via plasma and concluded that 
a humoral factor might play a role in defense against 
endotoxin. It was suggested that this factor could be an 
opsonin. Rutenberg et al. (1960) reported that serum from 
animals which were immune to an endotoxin-producing bacteria 
had some detoxifying effect on endotoxin from this bacteria. 
It was also noted that a mixture of macrophages and immune 
serum detoxified endotoxin more potently than a mixture of 
macrophages and normal serum. 
A single i.v. injection of lead acetate impaired 
intravascular phagocytosis of colloidal carbon in rats 
(Trejo et al., 1972; Cook et al., 1974), These workers also 
demonstrated decreased vascular clearance and decreased 
hepatic uptake of an R-E test-lipid emulsion following i.v. 
injection of lead acetate, but no alterations in splenic 
localization were detected. Trejo et al. (1972) found that 
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prior opsonization of the R-E test-lipid emulsion did not 
reverse lead-induced impairment of phagocytosis and concluded 
that a lack of opsonin was not the mediating factor in such 
dysfunction. Grafton and Di Luzio (1969) agreed that no 
stable, circulating plasma factor was involved in altered 
sensitivity to endotoxin. Selye et al. (1966) compared the 
endotoxin-sensitizing ability of lead acetate to a variety 
of reticuloendothelial (R-E) blocking agents and suggested 
that if lead acetate is an R-E blocking agent, it is more 
potent than any known. 
After an i. injection of lead acetate, Hoffman et al. 
(1972) observed ultrastructural alteration of the mito­
chondria, endoplasmic reticulum, and lysosomes of Kupffer 
cells. These cells contained a finely granular, electron-
dense material which may have been protein-bound lead. This 
same material was observed in lysosomes of splenic macro­
phages. Since these changes occurred later than the period 
of increased sensitivity to endotoxin, it was felt that they 
were a sign of earlier functional iirpairmcnt. 
Many workers have cast doubt on the importance of 
hypophagocytosis as a mechanism causing increased endotoxin 
sensitivity. Trejo et al. (1972) reported that maximum 
phagocytic impairment in rats occurred 24 hours after lead 
acetate injection and that such rats were no more sensitive 
to endotoxin than control rats at this time. While treatment 
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with methylprednisolone or cysteine reduced mortality in lead-
acetate-sensitized rats exposed to endotoxin, it did not 
reverse hypophagocytosis of an R-E test-lipid emulsion (Cook 
and Di Luzio, 1973). Intravascular removal of an i.v. dose 
of S. enteritidis endotoxin was not altered by lead acetate 
injection (Filkins and Buchanan, 1973). Trejo and Di Luzio 
(1971) reported that colloidal carbon clearance by the R-E 
system was actually increased in lead-treated mice. 
Treatment of rats with various sulfhydryl-containing 
compounds (cysteine, glutathione, methionine, and ethionine) 
reduced lead-induced sensitization to endotoxin (Bertok, 
1968b). It was suggested that lead inactivation of 
sulfhydryl-containing enzymes or other compounds which play 
a part in endotoxin detoxification might be the mechanism of 
lead-induced sensitivity to endotoxin. Liver and spleen 
homogenates from rats which received i.v. injections of lead 
acetate had significantly lowered endotoxin detoxifying 
capacities (Trejo and Di Luzio, 1971; Trejo et al., 1972). 
Filkins and Buchanan (1973), however, found that liver 
homogenates from rats treated with lead acetate had no 
decreases in endotoxin-detoxifying potency and that the 
in vitro addition of lead to such homogenates did not alter 
detoxification. 
Several workers have contended that altered hepatocyte 
function plays a more important role than does reduced 
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endotoxin detoxification in lead-induced endotoxin hyper­
sensitivity (Cook and Di Luzio, 1973; Holper et al., 1973; 
Cook et al., 1974). A single i.v. injection of lead acetate 
caused ultrastructural alteration of both mitochondria and 
endoplasmic reticulum and accumulation of finely granular, 
electron-dense material in vesicles in hepatocytes of rats 
(Hoffman et al., 1972). Cook et al. (1973) observed more 
severe and diffuse ultrastructural changes in hepatocytes of 
rats exposed to lead acetate and endotoxin simultaneously 
than in rats receiving either of these individually. 
Lead acetate-exposed rats had decreased bromsulfothalein 
(BSP) clearance, increased plasma concentrations of 
unconjugated bilirubin, and increased serum activities of 
alkaline phosphatase (SAP) and glutamic oxaloacetic 
transaminase (SCOT) (Trejo et al., 1972). Rats receiving lead 
acetate and endotoxin simultaneously had decreased BSP 
clearance, increased blood lactate and pyruvate concentrations, 
decreased plasma glucose concentrations, and increased serum 
glutamic pyruvic transaminase (SGPT) , SGO'T, and SAP 
activities (Cook and Di Luzio, 1973; Cook et al., 1973; Cook 
et al., 1974). These changes were partially prevented by 
methylprednisolone treatment. 
Filkins (1973) observed that rats which received lead 
acetate and endotoxin experienced decreased gluconeogenesis 
from lactate, pyruvate, and alanine and had drastic depletion 
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of liver glycogen. It war; felt that these findings indicated 
that lead-induced endotoxin hypersensitivity probably occurred 
due to a failure by the liver to make necessary metabolic 
adjustments to endotoxin and that one or more of the following 
alterations may have caused this lack of adjustment: 
1. Decreased mitochondrial function. 
2. Increased sensitivity of hepatocytes to insulin. 
3. Decreased activity of an enzyme of the 
gluconeogenic pathway. 
Rippe and Berry (1972) have noted that phosphoenolpyruvate 
carboxykinase, the rate limiting enzyme in gluconeogenesis, 
is inhibited in lead-treated mice. 
The lipid soluble anti-oxidant, N,N'-diphenyl-p-
phenylenediamine (DPPD) protects against lead-induced 
endotoxin hypersensitivity, and it is possible that an 
oxidizing action of lead plays a part in hepatocyte injury 
and increased endotoxin susceptibility (Trejo et al., 1972). 
Trejo and Di Luzio (1971) suggested that lead 
absorption might lead to lysosomal instability with subsequent 
leakage of lysosomal enzymes and damage to Kupffer cells and 
hepatocytes. Increased serum activities of the lysosomal 
enzymes, beta-glucuronidase and acid phosphatase, have been 
detected in animals exposed to lead and endotoxin; however, 
since methylprednisolone treatment did not decrease serum 
activities of these enzymes, it is doubtful that lysosomal 
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instability is an important locus of lead-induced 
hypersensitivity to endotoxin (Cook and Di Luzio, 1973). 
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MATERIALS AND METHODS 
Experimental Design 
Experiment 1_ 
Thirty crossbred six-week-old pigs obtained from the 
Swine Nutrition Farm, Iowa State University and weighing 
17-24 kilograms (kg) were randomly divided into 10 groups of 3 
pigs per group. The pigs were housed in 10 pens in a heated 
barrî. Pens had cement floors and bedding was not used. 
All pigs were fed a balanced 16% protein ration which 
was replaced by a 14% protein ration as their weights 
increased. Feed consumption was limited in order to keep 
weight gains under 1 pound per day. 
Each group was assigned 1 of 10 different treatments as 
shown in Table 1. The 3 pigs in group 5 received 3 different 
dosages of sodium acetate orally corresponding in acetate 
dosages to those received by groups 2, 3, and 4, respectively; 
and the 3 pigs in group 10 received 3 different dosages of 
sodium acetate intraperitoneally (i.p.) corresponding in 
acetate dosages to those received by groups 7, 8, and 9, 
respectively. Treatments were administered 6 days per week 
for 13 weeks (90 days). 
Lead and sodium acetate were dissolved in distilled 
water in order to facilitate both oral and i.p. administration. 
Four different solutions of lead acetate were administered to 
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orally-exposed pigs. During the first 28 days of exposure, 
groups 1 and 2 received a solution containing 3.65 g/dl lead 
acetate and groups 3 and 4 received a solution containing 
Table 1. Group treatments for experiment 1. 
Group Compound Route Dosage Pb Dosage 
1 Pb Acetate Oral 8 mg/kg 4.4 mg/kg 
2 Pb Acetate Oral 16 mg/kg 8.8 mg/kg 
3 Pb Acetate Oral 32 mg/kg 17.6 mg/kg 
4 Pb Acetate Oral 64 mg/kg 35.2 mg/kg 
5 Na Acetate Oral 
a 
— 
6 Pb Acetate i.p.^ 2 mg/kg 1.1 mg/kg 
7 Pb Acetate i.p. 4 mg/kg 2.2 mg/kg 
8 Pb Acetate i.p. 8 mg/kg 4.4 mg/kg 
9 Pb Acetate i.p. 16 mg/kg 8.8 mg/kg 
10 Na Acetate i.p. a 
^Variable dosages—see text. 
^Intraperitoneal. 
14.50 g/dl lead acetate. After 28 days, the concentrations 
of the solutions were increased in order to maintain a 
reasonable volume for administration, and groups 1 and 2 
received a solution containing 5.45 g/dl lead acetate while 
groups 3 and 4 received a solution containing 21.80 g/dl lead 
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acetate. Oral sodium acetate solutions were also adjusted at 
28 days in order to match the increased acetate dosages 
received by groups 2, 3, and 4. Sucrose was added to all 
oral solutions at a concentration of 2 g/dl in an attempt to 
increase palatibility. 
Two different solutions were administered to i.p.-exposed 
pigs. During the first 28 days of exposure, groups 6 and 7 
received a solution containing 1.82 g/dl lead acetate while 
groups 8 and 9 received a solution containing 7.30 g/dl lead 
acetate. Because of severe irritation of injection sites in 
pigs from groups 8 and 9, the pigs in these groups were given 
a solution identical to that administered to groups 5 and 7 
after the 28th day of lead exposure. 
Oral solutions were administered via disposable 12 
milliliter (ml) polypropylene syringes with hubs inserted 
into 5 inch lengths of flexible plastic tubing.^ As the pigs 
were held in an upright position, the tubing was thrust into 
the ventral-caudal oral cavity, and the solution was expelled. 
It was found that slow administration of the liquid stimu­
lated the pig to swallow, and most of the solution was 
consumed. 
Intraperitoneal solutions were administered via 12 ml 
polypropylene syringes with attached disposable 1 inch 20 
gauge needles. Initially all injections were made through 
^Tygon tubing. The Norton Company, Akron, Ohio. 
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the ventral abdominal wall at a site caudal to the umbilicus 
and on either side of the midline. Later in the experiment, 
injections were made in the paralumbar fossa. 
All pigs were weighed at weekly intervals. All groups 
were observed several times per day, and clinical signs were 
recorded. Body temperatures were measured when warranted by 
clinical signs. Blood samples were collected from all pigs 
via the orbital sinus (Kuhn et al., 1969) prior to the 
beginning of lead or sodium acetate exposure and at weekly 
intervals thereafter. Blood was collected into tubes 
containing potassium ethylenediaminetetraacetate (K^ EDTA), 
sodium heparin, or no anticoagulant. 
Analyses on blood anticoagulated with Kg EDTA were: 
1. Hematocrit 
2. Hemoglobin concentration 
3. Total red blood cell count 
4. Red blood cell morphology 
5. Total leukocyte count 
6. Leukocyte differential 
7. Plasma protein concentration 
8. Plasma fibrinogen concentration 
Mean corpuscular volumes (MCVs), mean corpuscular hemoglobin 
concentrations (MCHCs), mean corpuscular hemoglobins (MCHs), 
absolute differential leukocyte counts, and plasma protein: 
fibrinogen ratios were calculated from these results. 
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Blood anticoagulated with sodium heparin was used in 
measuring lead concentration and delta-aminolevulinic acid 
dehydratase (ALAD) activity. 
Serum was used in performing protein electrophoresis. 
An erythrocyte osmotic fragility test was carried out 
during the 13th week of the experiment. Blood samples from 
6 lead acetate-exposed and 6 sodium acetate-exposed pigs were 
tested. Potassium EDTA was the anticoagulant used in this 
trial. 
Pigs which did not die during the 13 week lead or sodium 
acetate-exposure period were stunned by electric shock and 
exsanguinated. With the exception of groups 8 and 9, 1 of 
the 3 pigs from each group was euthanatized 1 day, 30 days, 
and 60 days,- respectively, after the cessation of lead 
exposure. The 2 surviving pigs from groups 8 and 9 were 
euthanatized 1 day and 60 days, respectively, after the 
cessation of lead exposure. 
Necropsy examinations were performed on all pigs, and 
all major organs were examined for macroscopic lesions. The 
following tissues were fixed in 10% formaldehyde solution in 
preparation for histologic examination; 
1. Kidney 
2. Liver 
3. Cerebrum 
4. Cerebellum 
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5. Spinal cord 
6. Ischiatic nerve 
7. Lymph node 
8. Spleen 
9. Lung 
10. Other tissues with macroscopic lesions 
Tissues collected, frozen, and later used for measurement 
of tissue lead concentrations were; 
1. Kidney 6. Lung 
2. Liver 7. Skeletal muscle 
3. Brain 8. Rib 
4. Lymph node 9. Bone marrow 
5. Spleen 
IL Ape J. xmcix u c 
Thirty-six eight- to nine-week-old crossbred pigs 
weighing 15-24 kg were obtained from the Swine Nutrition 
Farm, Iowa State University. The pigs were randomly divided 
into 2 groups (A and B) of 18 pigs per group and were housed 
in adjacent pens in a heated barn. The pens had cement 
floors, and no bedding was used. 
All pigs were fed a balanced 16% protein ration. The 
ration received by group A also contained 500 parts per 
million (ppm) lead as lead acetate while that received by 
group B contained sodium acetate at a level such that the 
23 
acetate concentration was equivalent to that received by 
group A. It was estimated that lead-exposed pigs received 
a dosage of about 40 mg lead per kg body weight. This dosage 
was comparable to the highest oral lead exposure level in 
experiment 1. Rations were fed ^  libitum. 
At the beginning of the second week of lead or sodium 
acetate exposure and at weekly intervals thereafter, 6 pigs 
from each group were randomly selected, moved to an isolation 
building, and challenged with a live, virulent culture of 
Salmonella choleraesuis var. Kunzendorf^ by i.p. injection. 
This resulted in the 1st replicate (1) being exposed to lead 
or sodium acetate for 1 week prior to challenge; the second 
replicate (2) being exposed for 2 weeks prior to challenge; 
and the 3rd replicate (3) being exposed for 3 weeks prior to 
challenge. Administration of lead or sodium acetate in the 
feed stopped following challenge. 
Replicate 1 was challenged with 2 different dosages of a 
previously lyophilized and subsequently reconstituted culture 
of S. choleraesuis var. Kunzendorf which was incubated at 
37°C for 2.5 hours after reconstitution. Three lead-exposed 
and 3 non-lead-exposed pigs received 2.5 ml (approximately 
g 
1.9 X 10 cells) while 3 lead-exposed and 3 non-lead-exposed 
"Courtesy of Dr. Billie 0. Blackburn, Leader, Enteric 
Bacteriology, VSDL, APHIS, Ames, Iowa, 50010, 
NADC Type Culture #70-13679. 
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g 
pigs received 0.5 ml (approximately 3.7 x 10 cells) of the 
culture. 
9 
Groups 2 and 3 were challenged with 5.0 ml ( >1.9 x 10 
cells) of the same type of culture which had been incubated 
for 4 hours after reconstitution. 
During lead or sodium acetate exposure and following 
Salmonella challenge, all pigs were observed 3-4 times per 
day, and clinical signs and mortalities were recorded. Body 
temperatures were measured 3 times per week during the lead 
or sodium acetate-exposure period, at 8 hours following 
Salmonella challenge, and at daily intervals thereafter. 
Blood samples were collected from all pigs at various 
intervals via the orbital sinus (Huhn et al., 1969). Blood 
was collectsd into tubes containing sodium heparin.- K- EDTA. 
or no anticoagulant. 
Blood anticoagulated with sodium heparin was used for 
measuring lead concentration and ALAD activity. 
Analyses on blood anticoagulated with Kg EDTA were: 
1. Hematocrit 
2. Red blood cell morphology 
3. Total leukocyte count 
4. Leukocyte differential 
5. Plasma protein concentration 
6. Plasma fibrinogen concentration 
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Absolute differential leukocyte counts and plasma protein: 
fibrinogen ratios were calculated from these results. 
Serum was used in performing protein electrophoresis, 
measuring complement titers, and determining S. choleraesuis 
var. Kunzendorf agglutinin titers. 
A schedule of analyses is given in Table 2. 
Pigs which did not die during the experiment were 
stunned by electric shock and exsanguinated 10 days after 
challenge. Necropsy examinations were performed on all pigs, 
and all major organs were examined for macroscopic lesions. 
The following tissues were fixed in 10% formaldehyde solution 
in preparation for histologic examination; 
1. Liver 5. Lung 
2. Kidney 6. Ileum 
3. Mesenteric lymph node 7. Colon 
4. Spleen 8. Cecum 
Mesenteric lymph node, mandibular lymph node, liver, 
kidney, spleen, and ileum were collected and cultured 
immediately. 
Portions of kidney, liver, lymph node, and brain were 
frozen and later analyzed for lead concentrations. 
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Table 2. Schedule of analyses on blood samples collected 
during experiment 2. 
Day Analyses^ Replicates Tested 
Exposure Period^ 
0 Pb, ALAD, 
Elect, C 
CBC, 1 ,2 ,3  
2 Pb, ALAD, Elect, C' 1 ,2 ,3  
4 Pb, ALAD, Elect, C' 1 ,2 ,3  
8 Pb, ALAD, 
Elect, C' 
CBC, 1,2,3 
15 Pb, ALAD, 
Elect, C 
CBC, 2,3 
21 Pb, ALAD, 
Elect, C 
CBC, 3 
Post-challenge 
2 Pb, ALAD, 
Elect, C 
CBC, 
, Agglut 
1,2,3 
4 CBC, Elect, C, 
Agglut 
1,2,3 
7 Elect, C , Agglut 1,2,3 
9 Pb, ALAD, 
Elect, C 
CBC, 
, Agglut 
1 ,2 ,3  
Pb = Blood lead concentration; ALAD = Blood delta-
aminolevulinic acid dehydratase activity; CBC = Hemato­
crit, total leukocyte count, leukocyte differential, 
plasma protein and fibrinogen concentrations; Elect = 
Serum protein electrophoresis; C = Serum complement 
titration; Agglut = Serum S. choleraesuis var. 
Kunzendorf agglutinin titers. 
'^Period of lead or sodium acetate exposure prior to 
Salmonella challenge. 
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Experiment 2 
Twenty-four four- to five-week-old crossbred pigs 
derived from breeding stock at the Swine Nutrition Farm, Iowa 
State University, and weighing 5-9 kg were randomly 
divided into 3 groups (A, B, and C) of 8 pigs each. Each 
group was divided into 2 replicates of 4 pigs each. The 
animals were housed in an isolation building with each 
replicate in a separate pen. Pens had cement floors, and no 
bedding was used. Because the pigs were young and the 
weather was cold, a heat lamp was provided for each pen. 
Lead-exposed pigs were fed a balanced 16% protein 
ration containing 3,000 ppm lead as lead chloride. This 
resulted in an estimated lead exposure of 250 mg lead per kg 
body weight. Control pigs were fed the 16% protein ration 
containing sodium chloride rather than lead chloride. The 
chloride concentrations of both the lead chloride- and sodium 
chloride-containing rations were equivalent. All pigs were 
fed ^  libitum. The groups were designated as follows: 
Group A—not exposed to lead; Group D—exposed to lead for 
2 weeks prior to challenge with S. choleraesuis var. 
Kunzendorf; and Group C—exposed to lead for 1 week prior to 
challenge with S. choleraesuis var. Kunzendorf. 
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All pigs were challenged simultaneously with a virulent 
strain of S. choleraesuis var. Kunzendorf.^ Twelve ml of a 
bacterial suspension (see laboratory procedures) was 
administered intragastrically via a flexible plastic stomach 
tube to each of the 24 pigs. After the tube was inserted 
into the stomach, a 20 ml polypropylene syringe containing 
the bacterial suspension was attached to the free end, and 
the suspension was expelled» The tube was flushed with 20 ml 
of sterile saline to insure complete administration of the 
suspension. At the time of challenge, lead and sodium 
chloride exposure was terminated. 
Rectal swabs and serum samples were collected from all 
pigs prior to their assignment to isolation pens. Swabs were 
cultured (see laboratory procedures), and serum samples were 
tested for 3. choleraesuis var. Kunzendorf agglutinin titers. 
Throughout the trial, all pigs were observed at least 4 
times per day, and clinical signs and mortalities were 
recorded. In an attempt to quantitate the clinical signs 
observed, a numerical rating system v;as used (Table 3) 
following Salmonella challenge. Body temperatures of all 
pigs were measured and recorded daily beginning 1 week prior 
to lead or sodium chloride exposure. 
^Courtesy of R. D. Clock, DVM, Department of Veterinary 
Pathogy, Iowa State University, Ames, Iowa. 
2 
Tygon tubing. The Norton Company, Akron, Ohio. 
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Table 3. Numerical rating system for clinical signs— 
Experiment 3. 
Rating General 
condition 
Fecal 
consistency 
Appetite Hydration 
1 Normal 
2 Rises readily 
but depressed. 
Slightly 
gaunt. 
3 Rises 
reluctantly. 
Very gaunt. 
Moribund 
(cannot 
rise). 
Normal 
Soft(pasty) 
Normal 
Slightly 
anorectic. 
Normal 
Skin 
slightly 
less 
pliable. 
Loose(liquid) Interested Skin not 
in feed, pliable, 
but eats 
little. 
Eyes 
slightly 
sunken. 
Watery Completely Skin not 
anorectic, pliable. 
Eyes 
markedly 
sunken. 
Immediately preceding initiation of lead or sodium 
chloride exposure and at pre-determined intervals throughout 
the experiment, blood was collected from the anterior vena 
cava (Hoerlein et al., 1951) into tubes containing sodium 
heparin, EDTA, or no anticoagulant. 
Blood anticoagulated with sodium heparin was used in 
measuring lead concentration and ALAD activity. 
Blood anticoagulated with EDTA was used in the 
following determinations: 
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1. Hematocrit 
2. Hemoglobin concentration 
3. Total red blood cell count 
4. Red blood cell morphology 
5. Total leukocyte count 
6. Leukocyte differential 
7. Plasma protein concentration 
8. Plasma fibrinogen concentration 
Mean corpuscle volumes, MCHCs, MCHs, absolute leukocyte 
differentials, and plasma protein;fibrinogen ratios were 
calculated from these results. 
Serum was used in performing protein electrophoresis and 
in determining S. choleraesuis var. Kunzendorf agglutinin 
titers. 
A schedule of analyses on blood samples is given in 
Table 4. 
All pigs which had not died by 14 days after challenge 
were stunned by electric shock and exsanguinated. Necropsy 
examinations were performed, and all major organs were 
examined for macroscopic lesions. The following tissues were 
fixed in 10% formaldehyde solution in preparation for 
histologic examination; 
1. Liver 
2. Kidney 
3. Spleen 
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Table 4. Schedule of analyses on blood samples collected 
during experiment 3. 
. a 
Day Analysis 
1 Pb^, ALAD^, CBC 
6 Pb, ALAD, CBC, Elect 
8 Pb, ALAD, CBC 
13 Pb, ALAD, CBC, Elect, Agglut 
15^ Pb, ALAD, CBC 
17 CBC, Elect, Agglut 
18 CBC 
20 CBC, Elect, Agglut 
21 Pb, ALAD 
22 CBC, Elect, Agglut 
24 CBC, Agglut 
Pb = Blood lead concentration; ALAD = Blood delta-
aminolevulinic acid dehydratase activity; CBC = Hemato­
crit, blood hemoglobin concentration, total red blood 
cell count, total leukocyte count, leukocyte differen­
tial, plasma protein and fibrinogen concentrations; 
Elect = Serum protein electrophoresis; Agglut = 
S. choleraesuis var. Kunzendorf agglutinin titers. 
^No blood lead concentrations or ALAD activities 
measured in group C on this day. 
Day of challenge. 
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4. Mesenteric lymph node 
5. Lung 
6. Duodenum 
7. Jejunum 
8. Ileum 
9. Colon 
10. Cecum 
Mesenteric lymph node, liver, and ileum were collected 
and cultured immediately. 
Portions of liver and kidney were frozen and later 
analyzed for lead concentrations. 
Laboratory Procedures 
Preparation of inocula 
Experiment 2 Salmonella choleraesuis var. Kunzendorf 
organisms were transferred from an agar slant to 4 ml of 
trypticase soy broth and incubated at 37°C for 8 hours. The 
4 ml culture was then added to 100 ml of trypticase soy 
broth and incubated at 37°C for 5 hours. At the end of this 
time, 12.5 ml of the culture was transferred into 250 ml of 
trypticase soy broth and incubated at 37°C for 4 hours. Ten 
ml aliquots of the final culture were pipetted into 15 ml 
serum bottles and lyophilized in a Universal Sub-Mobile-15 
lyophilizer.^ The bottles were then capped with rubber 
^The Virtis Company, Gardiner, New York. 
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stoppers and aluminum seals. Prior to challenge, the 
lyophilized cultures were reconstituted with 10 ml of 
distilled water and incubated in a 37°C waterbath. 
Experiment 2 Standard 0.1 ml aliquots from a frozen 
culture of S. choleraesuis var. Kunzendorf were placed in 
4 ml of trypticase soy broth and incubated for 24 hours at 
37°C. After incubation, the 4 ml quantities were transferred 
into 250 ml of fresh trypticase soy broth in 500 ml bottles. 
These were incubated for 5 hours at 37°C with continuous 
shaking on a variable speed rotator. The cultures were then 
transferred to 50 ml sterile, screw-capped centrifuge bottles, 
and the bacterial cells were sedimented by centrifugation at 
1400 X g for 30 minutes. The packed cells were washed 3 
times by alternate resuspension and centrifugation in saline. 
After washing, the bacterial cells were diluted in saline to 
a density equal to tube 7 of a McFarland nephalometer 
9 (approximately 2 x 10 bacteria/ml). 
Blood lead concentrations 
Blood lead concentrations were measured on an atomic 
absorption spectrophotometer.^ The method of extraction and 
measurement was that described by Hessel (1968). 
^Perkin-Elmer Model 303 Atomic Absorption Spectrophoto­
meter. Perkin-Elmer, Inc., Maywood, Illinois. 
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Blood ALAD activities 
The method of Burch and Siegel (1971) was used to assay 
blood ALAD activities. Erythrocytes in whole blood were lysed 
by the addition of a 0.2% solution of Triton X-100^, and 
delta-aminolevulinic acid (ALA) hydrochloride^ was added to 
the hemolysate. During a 1 hour incubation period at 38°C, 
ALAD from hemolyzed erythrocytes catalyzed the condensation 
of ALA to form porphobilinogen. The addition of 
trichloroacetic acid to the hemolysate-enzyme mixture 
precipitated proteins and stopped the reaction. The mixture 
was centrifuged, and the supernatant fluid was decanted into 
other tubes. Addition of a modified Erhlich's reagent to the 
supernatant fluid caused a color to develop. The absorbance 
of the solution was measured on a Coleman Junior II 
2 Spectrophotometer at 555 nanometers (nm). A unit of enzyme 
activity was expressed as an increase in absorbance of 0.100 
with a 1.0 cm light path per ml of erythrocytes per hour at 
38°C. 
Hematologic measurements 
Hematocrits were measured by the microhematocrit method. 
3 
The cyanmethemoglobin method was used in determining blood 
^Sigma Chemical Company, St. Louis, Missouri. 
2 
Perkin-Elmer, Inc., Haywood, Illinois. 
^Hycel, Inc., Houston, Texas. 
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hemoglobin concentrations. Total red blood cell and 
leukocyte counts were performed on a Coulter Counter Model 
electronic cell counter. Mean corpuscular volumes, MCHCs, 
and MCHs were calculated via the standard Wintrobe formulas 
(Schalm et al., 1975). Blood smears were made within 3 hours 
of collection, fixed with absolute methanol, and stained with 
Wright's stain (Schalm et al., 1975). The cross-sectional 
method (Schalm et al., 1975) was used in performing 
differential leukocyte counts. Red blood cell morphology was 
observed during differential counting. Plasma and serum 
2 
protein concentrations were measured by refractometry. 
Plasma fibrinogen concentrations were determined via the heat 
precipitation method (Schalm et al., 1975). 
Erythrocyte fragility test 
The method used in measuring erythrocyte fragility was 
that of Hepler (1966). One drop of whole blood was added to 
each of 20 tubes containing dilutions of sodium chloride 
ranging from 0.28%-0.66%. Each tube contained a dilution 
0.02% more concentrated than the previous tube. The mixtures 
were incubated at room temperature for 2 hours. Dilutions at 
which initial hemolysis (faint yellow color in supernatant 
fluid) and complete hemolysis (red color in supernatant 
^Coulter Electronics, Inc., Hialeah, Florida. 
2 
American Optical TS Meter. American Optical Instruments 
Company, Buffalo, New York. 
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fluid and no erythrocytes on bottom of tube) occurred were 
recorded. 
Serum agglutinin titrations 
Production of antigens for serum agglutinin titrations 
was carried out by propagating cultures of S. choleraesuis 
var. Kunzendorf in Kolle flasks containing tryptose agar. 
After incubation for 24 hours, the organisms were suspended 
in sterile saline, diluted with 3 parts 95% ethyl alcohol, 
and incubated at 37°C for 2 hours. Following centrifugation 
and elimination of the supernatant fluid, the bacterial cells 
were diluted in phenolized saline (0.3%) to a concentration 
equal to tube 3 of a McFarland nephalometer. The resulting 
antigen suspension was somatic in type. 
Flagellar antigens were produced in a similar manner 
except for the elimination of ethyl alcohol dilution and 
incubation, and the replacement of phenolized saline with 
formalinized saline (0.5%). 
Preliminary agglutinin titers were determined by diluting 
serum samples 1:5, 1:25, 1:50, 1:100, and 1:200 in phosphate-
buffered saline and adding a preparation of flagellar 
antigen. Test results were determined after 2 hours 
incubation at 37°C and after 18 hours incubation at 55^C. 
Proper negative controls were used. 
Post-challenge agglutinin titrations were performed by 
making two-fold dilutions of test sera in saline. Dilutions 
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ranged from 1:10 to 1:2560. Saline was used as a negative 
control. After addition of somatic or flagellar antigen 
preparations (resulted in dilutions becoming 1:20 through 
1:5120) , the tubes were incubated at 52°C. Flagellar 
agglutinin titers were read after 4 hours of 52°C and 18 hours 
of room temperature incubation. 
Positive flagellar agglutination tests were indicated 
by a cottony, flocculent mass of bacteria floating in the 
mixture. A mat or button of bacteria which was not readily 
dispersed by shaking represented a positive somatic 
agglutination reaction. 
Serum protein electrophoresis 
Experiment 1 Serum protein electrophoresis was 
performed in a Mikrophor electrophoresis chamber" using 
2 
cellulose acetate membranes and barbital-sodium barbital-
3 
sodium acetate buffer (pK 8.6 and molarity of 0.05). Serums 
were electrophoresed for 50 minutes at a constant voltage of 
250 volts. After electrophorectic migration, protein bands 
4 
were stained with Ponceau S. 
^Brinkman-Sartorius, Brinkman Instruments, Westbury, 
New York. 
2 
'Brinkman Instruments, Westbury, New York. 
^Kallestad Labs, Inc., Minneapolis, Minnesota. 
4 Gelman Instrument Company, Ann Arbor, Michigan. 
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Experiments 2 and 2 Serum protein electrophoresis 
was performed in an ACI Agarose Universal Electrophoresis 
Cell^ using ACI Agarose Universal Electrophoresis Film^ and 
Universal Barbital Buffer^ (pH 8.6, molarity of 0.05, 
containing 0.035% EDTA). Serums were electrophoresed for 35 
minutes at a constant voltage of 110 volts. After electro-
phoretic migration, protein bands were stained with Amido 
Black lOB.^ 
Relative serum protein concentrations were quantitated 
3 
with a scanning photoelectric densitometer. Optimal density 
was measured at 600 nm (experiment 1) or 580 nm (experiments 
2 and 3), and an integrated density curve was plotted. 
Individual peaks were separated by drawing vertical lines at 
their lowest points, and the number of integrated pulse 
strokes falling under each peak were counted and used in 
calculating relative percentages of each fraction. Relative 
percentages were converted to absolute concentrations by 
multiplying serum protein concentrations by the percentage 
of each protein fraction. 
^Analytical Chemists, Inc., Palo Alto, California. 
2 Gelman Instrument Company, Ann Arbor, Michigan. 
^Model RIIV, Beckman Instruments, Pullerton, California. 
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Serum complement titration 
Equal volumes of a sheep red blood cell suspension 
q 
(4 X 10 cells/ml) which had previously been sensitized by 
incubation with 8 AbH^^ units (1 AbH^g unit represents a 
quantity of hemolysin which will lyse 50% of the erythrocytes 
in the presence of adequate complement) of hemolytic antiserum 
were added to serial dilutions of test serum in a barbital 
buffer. Cell suspensions were also added to control tubes 
containing diluent but no serum. After incubation for 1 hour 
at 37°C, the mixtures were centrifuged in the cold at 1000 x 
g for 5 minutes (in order to sediment unlysed erythrocytes). 
Supernatant fluid was decanted into spectrophotometer cells 
and optical density (O.D.) was read at 530 nm. Transmission 
was considered to be 100% in a diluent blank, and the O.D. 
of a completely hemolyzed sample which contained the same 
concentration of erythrocytes as test mixtures was also 
measured. Percent lysis was calculated via the formula; 
% ivqic! = O'D" test serum - O.P. control 
y O.D. 100% hemolyzed - O.D. control 
The complement titer was the dilution at which 50% lysis took 
place. 
Salmonella isolation 
Tissues and swabs to be cultured for Salmonella were 
placed in tetrathionate broth and incubated for 18 hours at 
37°C. Streakings were made from tetrathionate broth to 
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brilliant green agar, incubated at 37°C for 24 hours, and 
examined for the presence of lactose negative (red) Salmonella 
colonies. Selected isolates were transferred to tryptose 
broth, incubated at 37°C for 24 hours, and serotyped.^ 
Tissue lead concentrations 
Tissues were dried in an oven overnight, and then ashed 
in a muffle furnace at 450°C. Lead was extracted from the 
ash into 2N hydrochloric acid and aspirated into an atomic 
2 
absorption spectrophotometer. The tissue concentration of 
lead was calculated using a standard curve. 
Tissue preparation for histologic examination 
Formalin-fixed tissues were trimmed and prepared for 
sectioning by standard ethanol dehydration and paraffin 
embedding techniques. Sections cut 6 microns thick were 
stained with Harris hematoxylin and eosin Y. In addition, 
sections of liver and kidney were stained with Ziehl-Neelsen 
acid-fast stain (Mallory, 1942). 
^Courtesy of Dr. Billie 0. Blackburn, Leader, Enteric 
Bacteriology, VSDL, APHIS, Ames, Iowa, 
2 
Perkin-Elmer Model 303 Atomic Absorption Spectrophoto­
meter, Perkin-Elmer, Inc., Maywood, Illinois. 
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Statistical Procedures 
Experiment 1 
Since lead or sodium acetate solutions were administered 
to pigs on an individual basis, each pig within a group was 
considered an experimental unit. This resulted in 5 orally-
and 5 i.p.-exposed groups with 3 replicates per group. 
An unpaired group comparison was used to analyze for 
group differences (lead-treated versus control) in 
erythrocyte fragility. The standard error of the difference 
between group means was calculated via standard formulas 
(Steel and Torrie, 1960). A Student's t test was applied 
to evaluate the significance of this difference. 
In evaluating other results, orally- and i.p.-exposed 
groups were analyzed separately. The experimental design 
was considered to be a split-plot. An analysis of variance 
was performed with group and replicate within group 
considered the whole-plot portion and week, group by week 
interaction, and residual error constituting the split-plot 
portion. The group means for each parameter were calculated 
by averaging the 13 values obtained following initiation of 
lead or sodium acetate exposure. Standard errors of these 
means and least significant differences were calculated using 
appropriate formulas (Cochran and Cox, 1957). For any given 
parameter, means of groups exposed to lead orally were 
42 
compared to that of the orally sodium acetate-exposed group, 
and means of groups exposed to lead i.p. were compared to 
that of the i.p. sodium acetate-exposed group. 
Experiment 2  
Each of the replicates challenged after 1 week, 2 weeks, 
or 3 weeks of lead or sodium acetate exposure was considered 
an experimental unit. Thus, there were 2 groups, lead 
acetate-exposed and sodium acetate-control, and 3 replicates 
within each of these groups. 
The experimental design was considered to be a split-
plot. In analyzing blood lead concentrations and ALAD 
activities, group and replicate within group were considered 
the whole-plot portion, and day, group by day interaction, 
and residual error constituted the split-plot portion of the 
analysis. 
For analysis of all parameters other than blood lead 
concentrations, blood ALAD activities and serum agglutinin 
titers, group and replicate within group were considered the 
whole-plot portion and period (period 1 = pre-challenge and 
period 2 = post-challenge), day within period, group by period 
interaction, group by day within period interaction, and 
residual error constituted the split-plot portion of the 
analysis. 
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Standard errors of means and least significant 
differences were calculated by standard formulas (Cochran 
and Cox, 1957). 
In testing for significant differences in blood lead 
concentrations and ALAD activities, group means were 
calculated by averaging values obtained from the 3 replicates 
for the entire experiment. Two means resulted, 1 for the 
lead acetate-exposed group and 1 for the sodium acetate-
exposed control group. 
In testing for significant differences of parameters 
other than blood lead concentrations, blood ALAD activities, 
and serum agglutinin titers, means were calculated for the 
lead acetate-exposed group and the sodium acetate-exposed 
control group within each period, i.e. 4 means were obtained; 
lead acetate-exposed prior to challenge, lead acetate-exposed 
following challenge, sodium acetate-control prior to 
challenge, and sodium acetate-control following challenge. 
The 2 means prior to challenge were compared, and the 2 means 
following challenge were compared. 
Serum agglutinin titers were compared on a daily basis. 
An unpaired group comparison was performed using standard 
formulas (Steel and Torrie, 1960) to calculate the standard 
error of the difference between means of lead acetate-exposed 
and sodium acetate-control groups,- and a Student's t test was 
used to evaluate significance. 
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Experiment 2 
There were 3 groups and 2 replicates within each group. 
Each replicate was considered an experimental unit. Results 
were analyzed as in experiment 2 with the exception that means 
from 3 groups rather than 2 groups were analyzed. Period 1 
was again considered to be pre-challenge, and period 2 was 
considered to be post-challenge. 
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RESULTS 
Experiment 1 
Clinical signs and mortalities 
None of the pigs exposed to lead acetate orally died 
during the experiment. Clinical abnormalities were observed 
in only 2 of these pigs; both were from group 4 (54 mg/kg 
lead acetate orally). One pig had a cough after 5 days of 
lead exposure, and this persisted for the remainder of the 
experiment. After 8 days of lead exposure, both pigs were 
gaunt, had rough coats, and had body temperatures of 40°C. 
These abnormalities lasted for 5 to 6 days. 
One pig from group 5 (oral sodium acetate-control) began 
coughing sporadically after 5 days cf sodium acetate exposure 
and continued to do so for the remainder of the experiment. 
No other clinical signs were seen in the oral-control group. 
Four of the pigs exposed to lead acetate i.p. died during 
the experiment, and clinical signs were observed in all i.p. 
lead acetate-exposed groups. Signs ranged from gauntness and 
rough coats in those most mildly affected to depression, 
apparent abdominal discomfort, pale mucous membranes and skin, 
variable degrees of inappetance, and vomiting in pigs more 
severely ill. Initial signs appeared from 3 to 49 days after 
the beginning of lead exposure. Many of the pigs developed 
masses in the abdominal wall at injection sites. Such masses 
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were first noticed after 16 days of lead exposure. Pigs from 
groups 8 (8 mg/kg lead acetate i.p.) and 9 (16 mg/kg lead 
acetate i.p.) were more severely affected than those from 
groups 6 (2 mg/kg lead acetate i.p.) and 7 (4 mg/kg lead 
acetate i.p.). 
Two pigs from group 8 died after 25 and 35 days of lead 
exposure, respectively; and 2 pigs from group 9 died after 
23 and 38 days of lead exposure, respectively. Pigs became 
incoordinated and reluctant to move several days before death. 
One pig had diarrhea and another had lateral nystagmus and 
rhythmic jerking of the head and forelimbs prior to death. 
Pigs exposed to sodium acetate i.p. remained clinically 
normal throughout the experiment. 
Blood lead concentrations 
Highly significant (P <.01) elevations of mean blood 
lead concentrations for the entire experiment occurred in all 
lead acetate-exposed groups. 
Prior to lead or sodium acetate exposure, blood lead 
concentrations were at background levels (mean = 6 ug/dl). 
Blood lead concentrations rose gradually throughout the 
experiment in all groups exposed to lead acetate orally and 
in i.p. lead acetate-exposed groups 6, 7, and 8. Blood lead 
concentrations rose much more rapidly in group 9 (16 mg/kg 
lead acetate i.p.), and the surviving pig in this group had 
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a blood lead concentration of 14,300 ug/dl by the end of the 
13th week of lead exposure. The highest blood lead concentra­
tion detected in orally lead acetate-exposed pigs was 
290 ug/dl at the end of the 13th week in a pig from group 4 
(64 rag/kg lead acetate orally). 
Highest blood lead concentrations in the 4 pigs which 
died before the end of the experiment were 60, 69, 93, and 
122 ug/dl. Several other pigs had blood lead concentrations 
exceeding these levels during the experiment. 
Blood lead concentrations of control pigs remained at 
background levels throughout the trial. 
Mean blood lead concentrations and results of 
statistical analyses are given in Tables 5 and 6. Weekly 
group means are given in the Appendix (Tables 36 and 37) . 
Blood ALAD activities 
Highly significant (P <.01) reductions of mean blood ALAD 
activities for the entire experiment were detected in all lead 
acetate-exposed groups. 
Mean blood ALAD activity prior to initiation of lead 
exposure was 214.4 units. After 1 week of lead exposure, 
activities of lead acetate-exposed groups had decreased 
sharply to 20.2-30.8% of their original levels. These 
activities continued to fall for the first 8 weeks of the 
experiment and then became stable at very low levels. 
Table 5. Experiment 1—Orally lead or sodium acetate-exposed groups. Means^ for 
the entire experiment. 
Groups 
Measurement 1 2 3 4 5 
(control) 
L.S.D. 
. 05 
L. S . iJ. 
. 01 
Blood lead concen­
tration (ug/dl) 
38** 38** 54** 78** 10 14 20 
Blood ALAD activity 15.2** 10.3** 11.0** 8.2** 130.8 15.3 21. 8 
Blood hemoglobin 
concentration (g/dl) 
12. 2 12.5 12.3 11. 7 12. 5 0.9 1.3 
Hematocrit (%) 38.0 38.8 38.2 37.1 37.1 2.8 4.0 
Total red blood 
cell count (x lO^jC 
5. 90 7.03 6.70 6.96 7.00 0.62 0.89 
MCV (fl) 56.0 56.4 57.8 54.1 56.8 5.8 8.3 
MCHC (g/dl) 32. 2 32.2 32. 2 31.6 32.2 0.9 1.3 
MCH (pg) 18.1 18 .1 18.6 17.2 18.2 2.0 2.9 
^Bleeding prior t:o lead or sodiuia acetate exposure not used in calculating 
means. 
bCroups 1, 2, 3, and 4 received 3 ,  1 6 ,  32, and 64 mg/kg lead acetate, 
respectively. 
^Count in cells/cubic mm., 
**Highly significant difference (P <.01) as compared to group 5. 
Table 6. Experiment 1—Intraperitoneally lead or sodium acetate-exposed groups. 
Means^ for the entire experiment. 
Groupé 
Measurement 6 7 8 9 10 
(control) 
XJ . S . D. 
.05 
L.S.D. 
.01 
Blood lead concen­
tration (ug/dl) 
64* 82* 89* 1,940** 12 50 81 
Blood ALAD activity 12.8** 13.5** 12.4** 11.1** 80.6 29.2 42.3 
Blood hemoglobin 
concentration (g/dl) 
11.2 11. 4 10.1* 9.0** 12.5 2.3 3.2 
Hematocrit (%) 35-8 37. 0 32. 5* 30.1* 35.5 2.8 4. 0 
Total red blood , 
cell count (x lO^jC 
6-49 6.59 6.26 5.48 6.66 2.26 3.24 
MCV (fl) 56.2 56. 9 52. 3* 55.2 58.5 4.1 6.0 
MCHC (g/dl) 31.2** 30.8** 31.2** 29.9** 32.6 0.5 0.8 
MCH (pg) 17.5** 17.5** 16.2** 16.4** 19.0 1.3 2.0 
^Bleeding prior to lead or sodium acetate exposure not used in calculating 
means. 
^Groups 6, 7, 8, and 9 received 2 ,  4, 8, and 16 mg/kg lead acetate, 
respectively. 
^Count in cells/cubic mm. 
^Significant difference (P <.05) as compared to group 10-
**Highly significant difference (P <.01) as compared to group 10. 
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Blood ALAD activities of sodium acetate-control groups 
declined gradually throughout the trial. By the end of the 
experiment, mean activities were 39 and 15% of their original 
levels in oral- and i.p.-control groups, respectively. 
Mean blood ALAD activities and results of statistical 
analyses are given on Tables 5 and 6. Weekly group means are 
given in the Appendix (Tables 38 and 39) . 
Hematologic observations 
There were significant (P <•05) and highly significant 
(P <.01) decreases in both mean blood hemoglobin concentra­
tions and hematocrit percentages for the entire experiment in 
groups 8 (8 mg/kg lead acetate i.p.) and 9 (16 mg/kg lead 
acetate i.p.), respectively. Weekly mean blood hemoglobin 
concentrations were below normal (10-15 g/dl) in groups d and 
9 on most sampling dates after 5 weeks of lead exposure, and 
weekly mean hematocrit percentages were below normal (32-50%) 
in these same groups on most bleeding dates after 3 weeks of 
lead exposure. Hemoglobin concentrations and hematocrit 
percentages remained within normal limits in all other groups. 
No significant group differences in mean total red blood 
cell counts for the entire trial were detected. The red 
blood cell count of the surviving pig from group 9 (15 mg/kg 
lead acetate i.p.) was below normal (5-8 x 10^/cubic ram) on 
several bleeding dates after 7 weeks of lead exposure. 
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A significant (P <.05) decrease in mean MCV for the 
entire experiment occurred only in group 8 (8 mg/kg lead 
acetate i.p.). Although weekly mean MCVs were occasionally 
below normal (50-68 fl) in all groups, low values were more 
consistently found in group 8. 
Highly significant (P <.01) decreases in mean MCHCs and 
MCHs for the whole experiment were found in all i.p. lead 
acetate-exposed groups. Weekly mean MCHCs fell below normal 
(30-34 g/dl) only in i.p. lead acetate-exposed groups, and 
such low values occurred as early as 1 week after initiation 
of lead exposure. Weekly mean MCHs were below normal 
(17-21 pg) in all groups (both orally and i.p. lead and 
sodium acetate-exposed) on various sampling dates. 
Mean blood hemoglobin concentrations, hematocrit 
percentages, total red blood cell counts, MCVs, MCHCs, and 
MCHs and results of statistical analyses are summarized in 
Tables 5 and 6. Weekly groups means are given in the Appendix 
(Tables 40-51). 
Variable degrees of anisocytosis and polychromasia plus 
small numbers of nucleated red blood cells were evident in 
smears from both lead acetate-exposed and sodium acetate-
control pigs during the trial. These changes were most marked 
in the surviving pigs from groups 8 (8 mg/kg lead acetate 
i.p.) and 9 (16 mg/kg lead acetate i.p,). Basophilic 
stippling was occasionally observed in erythrocytes of both 
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orally and i.p. lead acetate-exposed pigs but not in those of 
sodium acetate-controls. 
A highly significant (P <.01) increase in mean total 
leukocyte count for the whole trial occurred in group 9 
(16 mg/kg lead acetate i.p.). Although weekly mean total 
leukocyte counts were occasionally above normal (11,000-
22,000/cubic mm) in all groups, they were most consistently 
elevated in group 9 (on 10 of 14 bleedings). 
A highly significant (P <.01) increase in mean total 
segmented neutrophil count for the entire trial was also 
detected in group 9, but a significant (P <.05) decrease in 
this same value occurred in group 3 (32 mg/kg lead acetate 
orally). Weekly mean total segmented neutrophil counts were 
above or below normal (3,200-10,000/cubic mm) in most groups 
at various times, but were most consistently and markedly 
elevated in group 9. 
Highly significant (P <.01) increases in mean total band 
neutrophil counts for the entire experiment were noted in 
groups 2 (16 mg/kg lead acetate orally) and 9 (16 mg/kg lead 
acetate i.p.). Weekly mean total band neutrophil counts were 
above normal (0-800/cubic mm) on several bleeding dates in all 
groups. These counts were most consistently elevated in i.p. 
lead and sodium acetate-exposed groups, and highest counts 
occurred in group 5. 
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The mean total lymphocyte count for the entire trial was 
significantly (P <.05) decreased in group 8 (8 mg/kg lead 
acetate i.p.). Mean total lymphocyte counts were above 
normal (4,500-13,000/cubic mm) on certain sampling dates in 
groups 1 (8 mg/kg lead acetate orally), 4 (64 mg/kg lead 
acetate orally), 5 (oral-control), and 10 (i.p.-control) and 
below normal on the final bleeding of group 9 (15 mg/kg lead 
acetate i.p.). 
The mean total eosinophil count for the whole trial was 
significantly (P <.05) elevated in group 7 (4 mg/kg lead 
acetate i.p.). Weekly mean total eosinophil counts were 
never above normal (50-2,000/cubic mm) in any group and were 
below normal in all groups on 1 or more bleeding dates. 
Meekly counts tended to be highest in group 7 and lowest in 
group 9 (16 mg/kg lead acetate i.p.). 
There were no significant group differences in mean total 
monocyte or basophil counts for the entire experiment. While 
weekly mean total monocyte counts were below normal 
(50-2,000/cubic ram) on 1 or more bleeding dates in several 
orally and i.p. lead acetate-exposed groups, they were most 
consistently low in group 9 (16 mg/kg lead acetate i.p.). 
Weekly mean total basophil counts were within normal limits 
(0-400/cubic mm) except for a low value detected on the last 
sampling date in group 6 (2 mg/kg lead acetate i.p.). 
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The mean plasma protein;fibrinogen ratio for the entire 
trial was significantly (P <.05) decreased in group 9 
(16 mg/kg lead acetate i.p.). Although weekly mean plasma 
protein:fibrinogen ratios fluctuated in all groups, they were 
most consistently low in group 9. 
Mean total leukocyte, segmented neutrophil, band 
neutrophil, lymphocyte, eosinophil, monocyte, and basophil 
counts and mean plasma protein:fibrinogen ratios are 
summarized in Tables 7 and 8. Results of statistical analyses 
are also presented in these tables. Weekly group means are 
given in the Appendix (Tables 52-67) . 
Erythrocyte osmotic fragility 
Initial hemolysis occurred at mean sodium chloride 
concentrations of 0.47% and 0.50% and complete hemolysis was 
observed at mean sodium chloride concentrations of 0.39% and 
0.41% in lead acetate-exposed and sodium acetate-control pigs, 
respectively. In comparing lead acetate-exposed and sodium 
acetate-control pigs, differences in concentrations at which 
initial or complete hemolysis took place were not 
statistically significant. 
Cellulose acetate electrophoresis 
A significant (P <.05) decrease of mean serum protein 
concentration for the whole trial was found only in group 3 
(32 mg/kg lead acetate orally). Weekly mean total serum 
Table 7. Experiment 1—Orally lead or sodium acetate-exposed groups. Means^ for 
the entire experiment. 
Groupé 
Z>Ie a sûrement 1 2 3 4 5 
(control) 
L.S.D. 
. 05 
L.S.D. 
.01 
Total counts^ 
Leukocyte 19, 684 17,931 18, 231 20 ,762 18,315 4,048 5,758 
Segmented 
neutrophil 
5,203 5,6 33 4, 397* 5 ,922 6,548 1,916 2,726 
Band neutrophil 693 1,906** 748 864 932 674 957 
Lymphocyte 12,. 919 9,093 11/ 945 12 ,607 10,003 3,859 5,489 
Eosinophil 455 616 660 723 390 417 593 
Monocyte 343 432 379 540 390 243 346 
Basophil 95 81 80 86 52 51 73 
Plasma protein: 
fibrinogen ratio 
34 36 30 36 31 8 11 
^Bleeding prior to lead or sodium acetate exposure not used in calculating 
means. 
^Groups 1, 2, 3, and 4 received 8, 16, 32, and 64 mg/kg lead acetate, 
respectively. 
^Cells/cubic mm of blood. 
*Significant difference (P <.05) as compared to group 5. 
**Highly significant difference (P <.01) as compared to group 5. 
Table 8. Experiment ].—Intraperiton€;ally lead or sodium acetate-exposed groups. 
Meansa for the entire experiment. 
Groupé 
Measurement 6 7 8 9 10 
(control) 
L.S.D. 
.05 
L.S.D. 
. 01 
Total counts^ 
Leukocyte 19,109 20,969 18,501 25,733** 20,231 3,002 4,414 
Segmented 
neutrophil 
5,287 7,013* 6,529 10,189** 5,634 1,358 2,006 
Band neutrophil 1,057 1,554 1,672 4,892** 1,897 924 1,364 
Lymphocyte 11,480 10,722 9,205* 9,889 11,838 2,219 3,252 
Eosinophil 725 1,059* 440 292 616 364 534 
Monocyte 391 481 542 369 412 339 501 
Basophil 145 135 63 38 104 54 81 
Plasma protein: 30 37 42 24* 36 10 15 
fibrinogen ratio 
^Bleeding prior to lead or sodium acetate exposure not used in calculating 
means. 
^Groups 6, 7, 8, and 9 received 2, 4, 8, and 16 mg/kg lead acetate, 
respectively. 
"^Cells/cubic mm of blood. 
* 
Significant difference (P<. 0 5 )  as compared to group 10. 
* * 
Highly significant difference (P < .01) as compared to group 10. 
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protein concentrations of group 3 were lower than those of 
other orally lead or sodium acetate-exposed groups on most 
sampling dates. 
Highly significant (P <.01) decreases of mean serum 
albumin concentrations for the entire experiment were detected 
in groups 3 (32 mg/kg lead acetate orally), 4 (64 mg/kg lead 
acetate orally) and all i.p. lead acetate-exposed groups. 
After 2 weeks of lead exposure, weekly mean serum albumin 
concentrations in these orally or i.p. lead acetate-exposed 
groups were lower than those of oral- or i.p.-controls on most 
bleeding dates. Lowest serum albumin concentrations occurred 
in the surviving pig of group 9 (16 mg/kg lead acetate i.p.). 
A significant (P <.05) increase of the mean serum albumin 
concentration for the entire trial was found in group 2 
(16 mg/kg lead acetate orally), and weekly mean serum albumin 
concentrations of this group were higher than those of the 
oral-control group on most sampling days. 
No significant group differences in mean serum alpha^ 
globulin concentrations for the whole experiment were noted= 
Significant (P <.05) and highly significant (P <.01) 
elevations of mean serum alphag globulin concentrations for 
the entire experiment were found in groups 6 (2 mg/kg lead 
acetate i.p.) and 9 (16 mg/kg lead acetate i.p.), respectively; 
but a significant (P <.05) reduction of this same value was 
detected in group 3 (32 mg/kg lead acetate orally). Weekly 
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mean serum alphag globulin concentrations fluctuated in all 
groups during the experiment but highest values were found in 
group 9 and lowest values were noted in group 3. 
Mean serum beta^ globulin concentrations for the whole 
trial were significantly (P<.05) elevated in groups 3 
(32 mg/kg lead acetate orally) and 8 (8 mg/kg lead acetate 
i.p.). Highest weekly mean serum beta^ globulin concentra­
tions in orally-exposed groups occurred in group 3 while those 
in i.p.-exposed groups occurred in group 8. 
Significantly (P <.05) decreased mean serum betag 
globulin concentrations for the whole experiment were found 
in groups 3 (32 mg/kg lead acetate orally) and 4 (64 mg/kg 
lead acetate orally). 
Significant (P <.05) increases in mean serum gamma 
globulin concentrations and albumin;globulin ratios for the 
entire experiment occurred in group 4 (64 mg/kg lead acetate 
orally), and highly significant (P <.01) increases of these 
same values occurred in groups 7 (4 mg/kg lead acetate i.p.), 
R ffl ma/ka lead acetate i.o.ï . and 9 flS ma/ka lead acetate 
i.p.). Weekly mean serum gamma globulin concentrations of 
group 4 were higher than those of other orally lead or sodium 
acetate-exposed groups on most bleeding dates. After the 
fifth week of lead acetate exposure, weekly serum gamma 
globulin concentrations of groups 7, 8, and 9 were higher than 
those of i.p.-controls on most bleeding dates. 
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Mean total serum protein, albumin, alpha^ globulin, 
alphag globulin, beta^ globulin, betag globulin, and gamma 
globulin concentrations and albumin:globulin ratios are 
presented in Tables 9 and 10. Results of statistical analyses 
are also summarized in these tables. Weekly group means are 
given in the Appendix (Tables 68-83). 
Tissue lead concentrations 
Tissue lead concentrations in orally lead acetate-exposed 
pigs were consistently greatest in the rib. Bone marrow, 
kidney, liver, spleen, and lung all had high lead concentra­
tions in relation to other organs in various groups. Lymph 
node, skeletal muscle, and brain had consistently lower lead 
concentrations. 
In i.p. lead acetate-exposed piqs, greatest tissue lead 
concentrations were consistently found in the rib with lymph 
node, lung, liver, spleen, and bone marrow also having very 
high concentrations. Kidney lead concentrations were markedly 
elevated but were lower than concentrations in the previously 
mentioned organs. Lead concentrations in skeletal muscle and 
brain were very low. 
Mean tissue lead concentrations tended to fall in lead 
acetate-exposed pigs during the 60 day period after cessation 
of lead acetate exposure. This fall was not noted in tissues 
which had accumulated only small amounts of lead such as 
Table 9. Experiment 1—Orally lead or sodium acetate-exposed groups. Means^ for 
the entire experiment. 
Groupé 
Measurement 1 2 3 4 5 
(control) 
L.S.D. 
.05 
L.S.D. 
.01 
Serura concentrations*^ 
Total protein 6. 3 6.7 5. 9* 6. 2 6.4 0.4 0.6 
Albumin 2. 65 2.91* 2. 35** 2. 30** 2.68 0.18 0. 26 
Globulins 
Alpha]_ 0. 26 0.23 0. 21 0. 24 0.25 0. 05 0.07 
Alpha2 0. 97 1.08 0. 86* 1. 02 1. 04 0.13 0.18 
Betai 0. 35 0.32 0. 40* 0. 30 0.31 o
 
o
 
0.10 
Beta2 0. 93 0.96 0. 87* 0. 88* 1. 02 0.13 0.18 
Gamma 1. 16 1.15 1. 24 1. 45* 1.11 0.33 0.46 
Albumin : globulin ratio 0. 73 0.78 0. 66 0. 60* 0.72 0.09 0.12 
^Bleeding prior to lead or sodivji acetate exposure not used in calculating 
means. 
^Groups 1, 2 ,  3, and 4 received 8, 16, 32, and 64 mg/kg lead acetate, 
respectively. 
^Concentrations d.n g/dl. 
*Significant difference (P<.05) as compared to group 5. 
#c 'k 
Highly significant difference (P<.01) as compared to group 5. 
Table 10- Experiment 1—Intraperitoneally lead or sodium acetate-exposed groups. 
Means^ for i;he entire expeiriment. 
Groupé 
Measurement 6 7 8 9 10 
(control) 
L.S.D. 
.05 
L.S.D. 
.01 
Serum concentrations^ 
Total protein 6. 3 6. 5 6. 8 6. 2 6.6 0.5 0.8 
Albumin 2. 42** 2. 22** 2. 15** 1. 84** 2.65 0.20 0.30 
Globulins 
Alpha 2^ 0. 22 0. 25 0. 27 0. 22 0.24 0.05 0.07 
Alpha2 1. 10* 1. 06 1. 04 1. 27** 1. 02 0.07 0.11 
Beta^ 0. 38 0. 39 0. 51* 0. 44 0.35 0.12 0.17 
Betag 0. 89 0. 89 1. 00 0. 87 0.98 0.14 0.20 
Garoma 1. 27 1. 7 3** 1. 75** 1. 57* 1.28 0.23 0. 34 
Albumin 1 globulin ratio 0. 64 0. 5 2 * *  0. 47** 0. 42** 0.68 0. 07 0.11 
^Bleeding prior to lead or sodium acetate exposure not used in calculating 
means. 
^Groups 6, 7, 8, and 9 received 2 ,  4, 8, and 16 mg/kg lead acetate, 
respectively. 
•^Concentrations in g/dl. 
*Significant difference (P < .05) as compared to group 10. 
* * 
Highly significant difference (P< .01) as compared to group 10. 
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brain and skeletal muscle. Lead concentrations of lung 
actually rose during the 60 day post-lead-exposure period in 
pigs which had been exposed to lead acetate orally. It is 
also notable that highest lead concentrations in rib and bone 
marrow occurred in both orally and i.p. lead acetate-exposed 
pigs euthanatized 30 days after lead exposure had ceased. 
Mean lead concentrations in tissues from orally and i.p. 
lead and sodium acetate-exposed groups are given in Tables 
11 and 12. Mean tissue lead concentrations of orally lead 
acetate-exposed, i.p. lead acetate-exposed, and sodium 
acetate-control pigs euthanatized at 1, 30, or 60 days after 
cessation of lead or sodium acetate exposure are given in 
Table 13. 
Few significant macroscopic lesions were observed in 
pigs which received lead or sodium acetate orally. Adhesions 
were present in the pleural and pericardial cavities of 2 pigs 
from group 4 (64 mg/kg lead acetate orally). 
Adhesions, which were centered at injection sites, were 
observed in abdominal cavities of all but 1 i.p. lead 
acetate-exposed pig. Only small portions of intestine were 
involved in groups 6 (2 mg/kg lead acetate i.p.) and 7 
(4 mg/kg lead acetate i.p.). In groups 8 (8 mg/kg lead 
acetate i.p.) and 9 (16 mg/kg lead acetate i.p.) larger 
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Table 11. Experiment 1—Orally lead or sodium acetate-exposed 
groups. Mean^ tissue lead concentrations (ppm). 
Groupé 
Tissue 12 3 4 5 
(control) 
Kidney 4. 85 5. 92 4. ,74 9. 00 1. ,34 
Liver 5. ,42 3. 18 3. ,84 4. ,77 2. ,25 
Spleen 5. ,52 4. 83 3. ,21 1. ,40 2. ,00 
Lymph node 2. ,50 3. 25 1. 
o
 
in 
1. 
o
 
CO 
0. . 6 3  
Lung 4. ,77 15. 35 3. ,48 113. ,75 0. 67 
Brain 1. ,77 1. 52 1, .54 0. 97 0, .79 
Skeletal muscle 1. ,05 1. 60 0. 95 0. ,87 0, .59 
Rib 44, .09 63. 09 336, .74 356, .33 15, .03 
Bone marrow 5, .25 8. 18 4, .67 2. 55 0, .58 
^Means of 3 pigs euthanatized at 1, 30, and 60 days 
after cessation of lead or sodium acetate exposure. 
^Groups 1, 2, 3, and 4 received 8, 16, 32, and 64 mg/kg 
lead acetate, respectively. 
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Table 12. Experiment 1—Intraperitoneally lead or sodium 
acetate-exposed pigs. Mean tissue lead 
concentrations (ppm). 
Groupé 
Tissue 6^ 7^ 8 9 10^ 
(control) 
Kidney 6. ,67 8. ,67 7. O
 
o
 o
 
9. 14° 3. ,00 
Liver 6. ,00 10. ,17 40. 75° 30. 33° 2. 25 
Spleen 3. ,60 4. ,43 18. 
no 
o
 
00 
89. 00
 
w
 o
 
3. ,75 
Lymph node 25. 30 13. 75 385. 
o
 
o
 — 
e 
3. ,38 
Lung 9, .30 19. 75 31, ,00^ 15, .25^ 2. ,00 
Brain 2, .18 2. 04 1. 20° 3, 
o
 o
 1. ,50 
Skeletal muscle 1, .27 1. 04 0, 90° 0, .75° 2, 07 
Rib 191, .85 497, .64 641, ,90^ 941, .80^ 17, .41 
Bone marrow 8, .77 22, .63 18, 
O
 
o
 27, .50^ 2, .00 
^Groups 6, 7, 8, and 9 received 2, 4,- 8,- and 16 mg/kg 
lead acetate, respectively. 
^Mean of 3 pigs euthanatized at 1, 30, and 60 days after 
cessation of lead or sodium acetate exposure. 
°Mean concentrations from 2 pigs dying during the 
experiment and 1 pig which survived to the end of the 
experiment. 
^Mean from the pig in this group which survived to the 
end of the experiment. 
^Three different lymph nodes examined; 
Mesenteric = 31.80 ppm 
Cervical = 2.00 ppm 
Prefemoral = 1050.00 ppm 
Table 13. Experiment 1—Mean lead concentrations of selected tissues on 1, 30, and 
5 0 days after cessation of lead or sodium acetate exposure. 
^ ._ , , .a Intraperitoneally Oral- and intraperi-
Orally lead-exposed lead-exposed^ toneal-control^ 
Days 
Tissue 1 30 60 1 30 60 1 30 60 
Kidney 10.12 3.58 3.69 10.25 8.12 4.62 3.00 0.75 1.62 
Liver 7.02 3.63 2.25 9. 25 H
 
O
 
o
 
o
 
5. 00 1.38 2.25 1.75 
Spleen 5.48 2.40 3.60 6.40 3.52 2.12 2.50 w
 
o
 
o
 
2.75 
Lymph 2.73 1.00 4.75 47.00 9.90 1.68 1.44 0.50 2.62 
node 
Lung 13.32 16.25 49.06 27.00 7.82 9.50 0.69 0.88 1.88 
Brain 1.30 1-25 1.80 1.69 2.20 2.44 0.69 0.50 1.75 
Skeletal 0.93 1.40 1.01 0.50 1.15 1.82 1.13 0.50 1.56 
muscle 
Rib 187.68 255.06 97.69 229.60 388.17 282.45 13.28 21.92 16.40 
Bone 5.80 6.09 4.49 4.20 24.05 9.62 1.38 1.00 1.00 
marrow 
^Mean of 4 orally lead-exposed pigs euthanatized on each of these days. 
^Mean of 2 pigs, 1 each from groups 6 and 7, euthanatized on each of these 
days. 
^Mean of 1 oral control and 1 i.p. control pig euthanatized on each of these 
days. 
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sections of intestine and other abdominal organs were adhered 
to each other and to the parietal peritoneum. 
During the experiment, 4 pigs exposed to lead acetate 
i.p. died. Partial to complete intestinal obstruction, gas-
and fluid-filled intestines cranial to these obstructions, 
and 1 intussuception were observed in these pigs. 
No macroscopic lesions were found in oral or i.p. sodium 
acetate-control pigs. 
Microscopic lesions 
Slight to moderate extramedullary hematopoiesis was 
evident in livers and kidneys of many orally lead or sodium 
acetate-exposed pigs, and interstitial foci of lymphocytes 
were present in kidneys of a few of these pigs. 
Lymphoid hyperplasia adjacent to bronchioles and slight 
thickening of alveolar walls with fibrous connective tissue 
were observed in lungs of orally lead acetate-exposed pigs, 
but not in those of oral sodium acetate-controls. A chronic 
diffuse pleuritis characterized by fibrin, macrophages, and 
villous proliferation of the visceral pleura was evident in 
2 pigs from group 4 (64 mg/kg lead acetate orally). 
A chronic diffuse epicarditis characterized by 
proliferation of fibrous connective tissue was detected in 
2 pigs from group 4 (64 mg/kg lead acetate orally). 
No attempt was made to isolate bacterial or mycoplasmal 
organisms. 
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Large, eosinophilic, acid-fast, intranuclear inclusion 
bodies were visualized in hepatocytes and epithelial cells 
of proximal renal tubules in 1 pig from group 4 (64 mg/kg 
lead acetate orally) but not in tissues of oral sodium 
acetate-control pigs. 
Foci of extramedullary hematopoiesis and/or mononuclear 
inflammatory cells were found in livers and kidneys of both 
i.p. lead and sodium acetate-exposed pigs. 
Lymphoid hyperplasia adjacent to bronchioles was 
evident in lungs of both i.p. lead and sodium acetate-exposed 
pigs. 
Numerous large, eosinophilic, acid-fast, intranuclear 
inclusion bodies were present in hepatocytes of surviving 
pigs froru groups 8 (8 mg/kg lead acetate i.p.) and 9 (16 
mg/kg lead acetate i.p.). A few small, eosinophilic, acid-
fast, intranuclear inclusion bodies were observed in 
epithelial cells of proximal renal tubules of the surviving 
pig from group 8. Inclusions were not observed in tissues 
of i.p. sodium acetate-control pigs. 
Chronic granulomatous lymphadenitis characterized by R-E 
hyperplasia and a few foreign-body giant cells was evident in 
lymph nodes of 2 pigs from group 9 (16 mg/kg lead acetate 
i.p.). The granulomatous reaction was most intense adjacent 
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to the hilus of the nodes. An amorphous, yellow-brown biré­
fringent material was present both within R-E cells and 
extracellularly. This material was most dense near the hilus 
and was mineralized in this area. 
Chronic focal granulomatous peritonitis characterized by 
well encapsulated masses containing lymphocytes, macrophages, 
and foreign-body giant cells and/or subacute focal to diffuse, 
fibrinous peritonitis characterized by accumulations of 
fibrin, macrophages, and neutrophils were observed in i.p. 
lead acetate-exposed pigs. An amorphous, yellow-brown, 
birefringent material was present both within phagocytic cells 
and extracellularly in the granulomatous masses. This 
material was partially mineralized. In a few pigs, 
organization of fibrin on serosal surfaces and/or mesothelial 
proliferation were visualized. 
No microscopic lesions were observed in spleen, cerebrum, 
cerebellum, spinal cord, or ischiatic nerve of pigs exposed 
to lead or sodium acetate either orally or i.p. 
Experiment 2 
Clinical signs and mortalities 
No clinical abnormalities were observed in lead or 
sodium acetate-exposed pigs during the pre-challenge period. 
Following i.p. challenge with Salmonella, clinical signs 
were evident in 12 of the 18 pigs previously exposed to lead. 
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Onset of illness was consistently on the second day after 
challenge. Signs varied from slight inappetence and 
depression to complete anorexia, weakness, gauntness, 
shivering, cyanosis of extremities, increased respiratory 
rates, and yellow, watery diarrhea. Duration of clinical 
signs was 1-9 days. Four of the 18 pigs were judged to be 
severely ill. One pig developed cyanosis of extremities, and 
4 pigs had periods of diarrhea. No mortalities occurred in 
lead acetate-exposed replicates. 
Clinical signs were observed in 11 of 18 sodium acetate-
exposed pigs following challenge. Signs were similar to 
those observed in lead acetate-exposed pigs. Time of onset 
was again 2 days, and duration of illness varied from 1-9 
days. Seven of the 18 pigs were severely ill. Five pigs 
developed cyanosis of extremities, and 6 had diarrhea. One 
pig from the sodium acetate-exposed group died. This pig had 
severe cyanosis but did not develop diarrhea. 
Body temperatures 
Mean body temperatures of lead or sodium acetate-exposed 
groups were not significantly different during either the pre-
or post-challenge period. Prior to Salmonella challenge, mean 
body temperatures of all replicates remained within normal 
limits (38.6°-40.0°C) but were above normal by the third day 
after challenge and remained elevated for 4-6 days. 
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Mean body temperatures prior to and following challenge 
and results of statistical analysis are presented in Table 
14. Daily group means are given in the Appendix (Tables 84 
and 85). 
Table 14. Experiment 2—Group raeans^ from 3 replicates. 
Group 
Measurement A B L.S.D. L.S.D. 
(lead-exposed) (control) .05 .01 
Body temperature(°C) 
Pre-challenge^ 39.6 39.5 0.4 0.6 
Post-challenge*^ 40.2 40.3 0.4 0.6 
Blood lead concen­ 33** 4 2 4 
tration (ug/dl) 
Blood ALAD activity 42.7** 200.3 41.7 70.7 
Hematocrit (%) 
Pre-challenge^ 33 32 2 3 
Post-challenge 31 30 2 3 
^Bleedings prior to lead or sodium acetate exposure not 
used in calculating means. 
^Period of lead or sodium acetate exposure prior to 
Salmonella challenge. 
*^Following Salmonella challenge. 
* * 
Highly significant difference (P <.01) as compared to 
group B. 
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Blood lead concentrations 
A highly significant (P<.01) increase in mean blood 
lead concentration for the entire trial occurred in group A 
(lead acetate-exposed) as compared to group B (sodium acetate-
exposed) . 
Prior to initiation of lead or sodium acetate exposure, 
the mean blood lead concentration was 6 ug/dl. Mean blood 
lead concentrations of the 3 lead acetate-exposed replicates 
at the time of challenge were 42, 42, and 48 ug/dl. In the 
3 sodium acetate-exposed replicates, mean blood lead 
concentrations at the time challenge were 1, 5, and 2 ug/dl. 
Mean blood lead concentrations and results of 
statistical analysis are given in Table 14. Daily group 
means are summarized in the Appendix (Table 86). 
Blood ALAD activities 
A highly significant (P <.01) decrease in mean blood 
ALAD activity for the whole experiment was detected in group 
A (lead acetate-exposed) as compared to group B (sodium 
acetate-exposed). 
Mean blood ALAD activity prior to the beginning of lead 
or sodium acetate exposure was 219.3 units. Blood ALAD 
activities decreased rapidly during the first 7 days in lead-
exposed pigs. Activities of ALAD remained high in sodium 
acetate-exposed pigs during the first 2 weeks of such 
exposure but fell slightly during the third week. 
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Mean blood ALAD activities and results of statistical 
analysis are summarized in Table 14. Daily group means are 
presented in the Appendix (Table 87). 
Hematologic observations 
No significant group differences in mean hematocrit 
percentages were detected during either the pre- or post-
challenge period. Hematocrit percentages prior to challenge 
were normal (32-50%) except in replicate 1 of group B (sodium 
acetate-exposed) where this value was slightly low (31%). 
Hematocrit percentages had fallen below normal in all 
replicates by the end of the post-challenge period. 
Mean hematocrit percentages, prior to and following 
challenge, and results of statistical analysis are given in 
•Table 14. Daily yroup meaus are presented in the Appendix 
(Table 88) . 
The erythrocyte morphology of lead and sodium acetate-
exposed pigs was not significantly different. Variable 
anisocytosis and polychromasia of erythrocytes were observed 
during the trial. Occasional nucleated erythrocytes were 
also present in blood smears. Basophilic stippling was not 
observed. 
No significant group differences in mean total leukocyte 
counts for either the pre- or post-challenge period were 
noted. Prior to Salmonella challenge, mean total leukocyte 
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counts were normal (11,000-22,000/cubic mm) except in 
replicate 3 of group B (sodium acetate-exposed) where slight 
elevations occurred. By 2 days post-challenge, total 
leukocyte counts were above normal in all replicates except 
replicate 2 of group A (lead acetate-exposed). Mean total 
leukocyte counts had fallen by the fourth day after challenge 
and were normal in all replicates by the ninth day of the 
post-challenge period. 
The mean total segmented neutrophil count of group A 
(lead acetate-exposed) was significantly (P <.05) lower than 
that of group B (sodium acetate-exposed) during the pre-
challenge period, but no significant group differences were 
detected following Salmonella challenge. Total segmented 
neutrophil counts were above normal (3,200-10,000/cubic mm) 
in 1 lead and 2 sodium acetate-exposed replicates and below 
normal in 1 lead acetate-exposed replicate on the second day 
after challenge, but were within normal limits by 4 days 
after challenge. 
Significant group differences in total band neutrophil 
counts were not found during the pre-challenge period, but 
following Salmonella challenge, the mean total band 
neutrophil count in group A (lead acetate-exposed) was 
significantly (P < .05) lower than that of group B (sodium 
acetate-exposed). Prior to challenge, band neutrophil counts 
were above normal (0-800/cubic mm) in 1 lead and 2 sodium 
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acetate-exposed replicates. Band neutrophil counts had risen 
sharply by 2 days after challenge and, although they remained 
above normal, fell gradually in most replicates during the 
remainder of the post-challenge period. 
Mean total lymphocyte, eosinophil, and monocyte counts 
of group A (lead acetate-exposed) were not significantly 
different from those of group B (sodium acetate-exposed) 
during either the pre- or post-challenge period. 
On certain sampling dates during the pre-challenge 
period, total lymphocyte counts were above normal (4,500-
13,000/cubic mm) in 1 lead and 1 sodium acetate-exposed 
replicate. After Salmonella challenge, total lymphocytes 
counts of all replicates decreased, but counts fell below 
normal only in 1 sodium acetate-exposed replicate. 
Eosinophil counts were lowest on the second day after 
Salmonella challenge in most replicates, but counts fell 
below normal (50-2,000/cubic mm) in only 2 lead and 1 sodium 
acetate-exposed replicate. Eosinophil counts had risen by 
the fourth day after challenge. 
Mean plasma protein : fibrinogen ratios of groups A (lead 
acetate-exposed) and B (sodium acetate-exposed) were not 
significantly different during either the pre- or post-
challenge period. Ratios had decreased by the second day 
after Salmonella challenge and stayed low in most replicates 
throughout the post-challenge period. 
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Mean total leukocyte, segmented neutrophil, band 
neutrophil, lymphocyte, eosinophil, and monocyte counts and 
mean plasma protein:fibrinogen ratios, prior to and following 
challenge, are given in Tables 15 and 16. Results of 
statistical analyses are also summarized in these tables. 
Daily group means are presented in the Appendix (Tables 89-
95) . 
Agarose film electrophoresis 
Significant group differences in mean total serum 
protein concentrations were not found during either the pre-
or post-challenge periods. Mean total serum protein concen­
trations of all replicates rose after challenge and remained 
high during the post-challenge period. 
Meaa seruir. albuir.in ccncsr.trations of groups à (l ead 
acetate-exposed) and B (sodium acetate-exposed) were not 
significantly different during either the pre- or post-
challenge period. Concentrations decreased in all replicates 
following Salmonella challenge. 
There were no significant group differences in serum 
alpha^ globulin concentrations during either the pre- or post-
challenge period. In most replicates, concentrations 
decreased gradually after Salmonella challenge. 
Mean serum alphag globulin concentrations of groups A 
(lead acetate-exposed) and B (sodium acetate-exposed) were 
not significantly different during the period before 
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Table 15. Experiment 2—Group means^ from 3 replicates. 
Period of lead or sodium acetate exposure prior 
to Salmonella challenge. 
Group 
Measurement A 
(lead-exposed) 
B 
(control) 
L.S.D. 
.05 
L.S.D. 
.01 
Total counts^ 
Leukocyte 17,626 20,384 2,884 4,645 
Segmented 
neutrophil 
4,859* 7,428 2,300 3,625 
Band neutrophil 446 513 1,112 1,758 
Lymphocyte 11,842 12,024 1,090 1,648 
Eosinophil 382 331 182 297 
Monocyte 138 82 131 204 
Plasma protein: 
fibrinogen ratio 
25 21 7 11 
"Bleedings prior to lead or sodium acetate exposure not 
used in calculating means. 
^Cells/cubic mm of blood. 
* 
Significant difference (P <.05) as compared to group B. 
Salmonella challenge, but during the post-challenge period, 
the mean concentration of group A was significantly (P <.05) 
lower than that of group B. While mean alpha2 globulin 
concentrations of both groups rose following challenge, the 
rise was greater in group B (sodium acetate-exposed). 
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Table 16. Experiment 2—Group means from 3 replicates. 
Period following Salmonella challenge. 
Group 
Measurement A 
(lead-exposed) 
B 
(control) 
L.S.D. 
.05 
L.S.D. 
.01 
Total counts^ 
Leukocyte 21,733 22,580 2,884 4,645 
Segmented 
neutrophil 
6,619 6,187 2,300 3,625 
Band neutrophil 6,559* 8,159 1,112 1,758 
Lymphocyte 8,205 7,858 1,090 1,648 
Eosinophil 293 275 182 297 
Monocyte 89 96 131 204 
Plasma protein: 
fibrinogen ratio 
17 17 7 11 
^Cells/cubic mm of blood. 
^Significant difference (P <.05) as compared to group B. 
During the period prior to Salmonella challenge, the 
mean serum beta^ globulin concentration of group A (lead 
acetate-exposed) was significantly (P <.05) higher than that 
of group B (sodium acetate-exposed). Following challenge, no 
significant group difference in mean beta^ globulin concentra­
tion was noted. Serum beta^ globulin concentrations rose in 
all replicates following challenge. 
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No significant group differences in mean betag globulin 
concentrations were found during either the pre- or post-
challenge period. 
Significant group differences in mean serum gamma 
globulin concentrations were not detected during either the 
pre- or post-challenge period. Gamma globulin concentrations 
of all replicates rose gradually throughout the trial. 
The mean albumin:globulin (A/G) ratio of group A (lead 
acetate-exposed) was not significantly different from that 
of group B (sodium acetate-exposed) during the pre-challenge 
period. Following Salmonella challenge, the mean A/G ratio 
of group A was significantly (P <.05) higher than that of 
group B. Albumin:globulin ratios of all replicates decreased 
following challenge. 
Mean total serum protein, albumin, alpha^ globulin, 
alphag globulin, beta^ globulin, betag globulin, and gamma 
globulin concentrations and mean albumin:globulin ratios, 
prior to and following challenge, are presented in Tables 17 
and IB. Results of statistical analyses are also summarized 
in these tables. Daily group means are given in the Appendix 
(Tables 96-103). 
Serum agglutinin titrations 
The mean serum S. choleraesuis var. Kunzendorf somatic 
agglutinin titer of group A (lead acetate-exposed) was 
significantly (P <.05) higher than that of group B (sodium 
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Table 17. Experiment 2—Group means from 3 replicates. 
Period of lead or sodium acetate exposure prior 
to Salmonella challenge. 
Group 
Measurement A 
(lead-exposed) 
B 
(control) 
L.S.D. 
.05 
L.S.D. 
.01 
Serum concentrations^ 
Total protein 6.2 6.0 0.3 0.5 
Albumin 2.25 2.15 0.12 0.19 
Globulins 
Alpha^ 0.34 0.33 0.06 0.09 
Alphag 1.24 1.19 0.07 0.11 
Beta^ 0.48* 0.43 0.05 0.07 
Beta^ 0.91 0.83 0.09 0.13 
Gamma 1.01 1.04 0.18 0.29 
Albumin: globulin 
ratio 
0.56 0.57 0.02 0.03 
^Bleedings prior to lead or sodium acetate exposure not 
used in calculating means. 
^Concentrations in g/dl. 
*Significant difference (P <.05) as compared to group B. 
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Table 18= Experiment 2—Group means from 3 replicates. 
Period following Salmonella challenge. 
Group 
Measurement A 
(lead-exposed) 
B 
(control) 
L.S.D. 
.05 
L.S.D. 
.01 
Serum concentrations^ 
Total protein 6.8 6.8 0.3 0.5 
Albumin 2.03 2.03 0.12 0.19 
Globulins 
Alpha^ 0.33 0.34 0.06 0.09 
Alphag 1.61* 1.69 0.07 0.11 
Beta^ 0.63 0.67 0.05 0.07 
Betag 0.86 0.83 0.09 0.13 
Gamma 1.29 1.27 0.18 0.29 
Albumin ; globulin 
ratio 
0.43* 0.41 0.02 0.03 
^Concentrations in g/dl. 
Significant difference (P < .05) as compared to group B. 
acetate-exposed) on the ninth day after Salmonella challenge. 
No other significant group differences were noted on either 
the day prior to challenge or on days 2, 4, or 7 following 
challenge. 
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There were no significant group differences in mean 
serum S. choleraesuis var. Kunzendorf flagellar agglutinin 
titers on the day prior to Salmonella challenge or on days 
2, 4, 7, or 9 following challenge. 
Daily mean somatic and flagellar agglutinin titers on 
the day prior to and on several days following challenge are 
summarized in Tables 19 and 20. 
Serum complement titrations 
Mean serum complement titers for the pre-challenge 
period were 95.2 and 89.9 in groups A (lead acetate-exposed) 
and B (sodium acetate-exposed), respectively. Following 
Salmonella challenge, mean serum complement titers were 112.4 
and 101.1 in groups A and B, respectively. Group differences 
v;sre net found to be significant-
Daily mean serum complement titers for the pre- and 
post-challenge periods are summarized in Tables 21 and 22. 
Salmonella isolation from tissues 
Salmonella organisms were most frequently isolated from 
the mesenteric lymph node and ileum. While Salmonella 
organisms were isolated from 12 of 108 tissues from group A 
(lead acetate-exposed), they were isolated from 27 of 108 
from group B (sodium acetate-exposed). Organisms were 
isolated from 7 of 18 lead acetate-exposed pigs and from 10 
Table 19. Experiment 2--Geometric means of S. choleraesuis var. Kunzendorf somatic 
agglutinin titers on a dai.ly basis. 
Day 
Group A (lead-•exposed) Group B (control) 
Rep 1 Rep 2 Rep 3 Mean Rep 1 Rep 2 Rep 3 Mean 
0^ 0 0 0 0 0 0 0 0 
2 0 0 0 0 0 0 0 0 
4 7 0 4 4 0 1 3 1 
7 9 13 14 12 3 15 13 10 
9 28 2 0 28 25* 11 15 18 15 
^Day of Salmonella challenge. 
* 
Significantly different (P < . 0!) ) as compared to the mean of group B on this 
day. 
Table 20. Experiment 2—Geometric means of S^. choleraesuis var. Kunzendorf 
agglutin titers on a daily basis. 
Day 
Group A ( lead-exposed) Group B (control) 
Rep 1 Rep 2 Rep 3 Mean Rep 1 Rep 2 Rep 3 Mean 
0^ 0 0 0 0 0 0 0 0 
2 0 0 0 0 0 0 0 0 
4 20 35 80 45 25 40 160 75 
7 870 1,955 2,280 1,700 1,610 5,110 6,450 4 ,390 
9 2,030 6,450 4,560 4,350 2,880 13,500 14,500 10 ,295 
^Day of Salmonella challenge. 
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Table 21. Experiment 2—Mean serum complement (CH50) titers 
during the lead or sodium acetate-exposure period 
prior to Salmonella challenge. 
Group 
Day A B 
(lead-exposed) (control) 
0^ 75.9 75.9 
2 103.2 91.5 
4 95.6 93.9 
8 93.9 96.3 
15b 89.4 86.6 
21C 111.9 95.1 
^Prior to lead or sodium acetate exposure. 
^Means from replicates 2 and 3. 
^Means from replicate 3 only. 
Table 22. Experiment 2--Mean serum complement (CH50) titers 
following Salmonella challenge. 
Day 
Group 
A 
(lead-exposed) 
B 
(control) 
2 116.4 104.5 
4 126.3 113.1 
7 100.6 95.1 
9 105.9 91.8 
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of 18 sodium acetate-exposed pigs. All isolates were sero-
typed as S. choleraesuis var. Kunzendorf. 
Results of attempted Salmonella isolation from various 
tissues are given in Table 23. 
Tissue lead concentrations 
The mean lead concentrations of livers and kidneys from 
group A (lead acetate-exposed) were 100% and 75% higher, 
respectively, than mean concentrations of kidneys and livers 
from group B (sodium acetate-exposed). The mean lead 
concentration of lymph nodes from group B was 20% higher than 
that of lymph nodes from group A. Mean brain lead concentra­
tions of the 2 groups were very similar. 
Mean lead concentrations of various tissues are 
suiumarized in Table 24. 
Macroscopic lesions 
Focal areas of the mucosal surface of the cecum, colon, 
and/or small intestine were unusually red in about 50% of the 
pigs (9 of 18 lead acetate-exposed; 8 of 18 sodium acetate-
exposed) . Yellow raised nodules (button ulcers) were evident 
on the mucosal surface of the cecum of 1 sodium acetate-
exposed pig but were not observed in pigs exposed to lead 
acetate. 
Spleens of some pigs (4 of 18 lead acetate-exposed; and 
4 of 18 sodium acetate-exposed) were enlarged 2-4 times and 
Table 23. Experiment 2—Positive Salmonella isolates from selected tissues/number 
of pigs in replicate or group. 
Tissue 
Group Kidney Liver Spleen Mesenteric 
lymph node 
Mandibular 
lymph node 
Ileum 
( lec.d-exposed) 
Rep 1 0/6 0/6 1/6 2/6 1/6 0/6 
Rep 2 0/6 0/6 0/6 0/6 0/6 0/6 
Rep 3 0/6 0/6 0/6 2/6 2/6 4/6 
Total 0/18 0/18 1/18 4/18 3/18 4/18 
(control) 
Rep 1 1/6 2/6 2/6 4/6 3/6 3/6 
Rep 2 1/6 1/6 1/6 2/6 1/6 3/6 
Rep 3 0/6 0/6 0/6 1/6 0/6 2/6 
Total 2/18 3/18 3/18 7/18 4/18 8/18 
Table 24- Experiment 2—Mean tissue lead concentrations (ppm) of selected tissues. 
Tissue 
Group Kidney Liver Lymph node Brain 
( lead-exposed) 
Rep 1 3. 25 3.83 2.17 1.75 
Rep 2 3.50 3. 75 2.00 2.00 
Rep 3 3.75 4.50 2.00 1.58 
Total 3.50 4.03 2.06 1.78 
(control) 
Rep 1 1. 83 1.49 2.92 1.62 
Rep 2 2.67 2.17 2 . 0 8  2.04 
Rep 3 2. 00 2.50 2.28 1.38 
Total 2.17 2.05 2.43 1.68 
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dark red. Focal deposits of white, fibrinous material were 
present on serosal surfaces of abdominal organs in 50% of the 
pigs (10 of 18 lead acetate-exposed; 8 of 18 sodium acetate-
exposed) . 
Microscopic lesions 
Acute multifocal hepatitis characterized by coagulative 
necrosis with no definite lobular distribution surrounded by 
accumulations of lymphoreticular cells and neutrophils, 
moderate hyperplasia of Kupffer cells, and increased neutrophil 
numbers in sinusoids was evident in 17 of 36 pigs (8 of 18 
lead acetate-exposed; 9 of 18 sodium acetate-exposed). 
Splenitis characterized by multifocal to diffuse neutro­
phil accumulations and lymphoid depletion was detected in 
nearly all spleens from both lead and sodium acetate-exposed 
pigs. A small number of spleens were congested. 
Acute multifocal to diffuse interstitial pneumonia 
characterized by accumulations of neutrophils and macrophages 
in alveolar walls was found in nearly all lead or sodium 
acetate-exposed pigs. An acute fibrinous pneumonia charac­
terized by the presence of fibrin and macrophages in alveoli 
and bronchioles was evident in the 1 pig which died during the 
course of the experiment. 
Lymphoid depletion was observed in most lymph nodes. 
Lymphadenitis characterized by edema, microabscesses, and 
focal coagulative necrosis was found in mesenteric lymph nodes 
of a small number of pigs. 
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Increased numbers of mononuclear inflammatory cells were 
present in the lamina propria and submucosa, and increased 
mucin-producing cells were present in the mucosa of the ileum, 
colon, and cecum of most pigs. Coagulative necrosis involving 
the mucosa and submucosa of the cecum was evident in 1 sodium 
acetate-exposed pig. Macrophages, eosinophils, and 
neutrophils were present in tissues adjacent to the necrotic 
area. 
Chronic multifocal fibrinous peritonitis characterized 
by fibrin, macrophages, and neutrophils plus variable amounts 
of loose connective tissue and fibroblasts was detected in 
most lead and sodium acetate-exposed pigs. 
No microscopic lesions were observed in kidneys. 
/-s ^ TT»/-* 4- *5 
Clinical signs and mortalities 
No clinical signs of overt lead toxicosis were noted in 
either of the 2 lead chloride-exposed groups; however, 
appetites of pigs in group B appeared tc be somewhat decreased 
near the end of the 2 week lead chloride-exposure period. No 
other clinical abnormalities were detected in the 3 groups 
prior to challenge. 
During the first 24 hours after challenge, all pigs 
appeared to be normal. By 48 hours post-challenge, about 50% 
of the pigs were visibly depressed, a smaller number were 
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unusually gaunt, and a few were suffering from diarrhea and/or 
vomition. At 72 hours, their conditions varied from normal to 
extremely depressed and gaunt. All were anorectic, about 40% 
were suffering from diarrhea, and a few were visibly 
dehydrated. During the next 11 days, the conditions of all 
pigs deteriorated. Most continued to have diarrhea until 
death or until the termination of the experiment. Appetites, 
while quite variable,- seemed to return to normal in animals 
surviving after 8 days post-challenge. 
The severity of clinical signs was not judged to be 
visibly different between groups. No statistically signifi­
cant group differences were noted in the 4 numerically rated 
categories of clinical signs. Mean scores for each of these 
categories are summarized in Table 25. 
Table 25. Experiment 3—Group means for 4 categories of 
numerically-rated clinical signs following 
Salmonella challenge. 
Category 
Groupé General 
condition 
Hydration Appetite Fecal 
consistency 
A (control) 1.8 1.4 1.6 2.1 
B 1.6 1.4 1.7 1.8 
C 1.7 1.3 1.6 2.0 
^Groups B and C exposed to lead chloride for 2 and 1 
week; respectively. 
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The first death occurred in group C (1 week lead 
chloride) on the third day post-challenge. All pigs in group 
B (2 weeks lead chloride) were dead by 12 days after 
challenge. Seven pigs from group C and 4 pigs from group A 
(sodium chloride-control) had died by the time the trial was 
terminated at 14 days post-challenge. Daily and cumulative 
mortality rates are summarized in Figure 1. While 15 of 16 
(93.8%) lead chloride-exposed pigs died, 4 of 8 (50.0%) sodium 
chloride-control pigs died. The mortality rate in lead 
chloride-exposed pigs was significantly (P <.05) higher than 
in sodium chloride-controls. 
Body temperatures 
While mean body temperatures of lead chloride-exposed 
rfroiTni3 wor-p nof niffpT-pnr frorn r.har. of aroiiD A 
(sodium chloride-control) prior to Salmonella challenge, the 
mean body temperature of group B (2 weeks lead chloride) was 
significantly (P <.05) higher than that of group A during the 
post-challenge period. 
Prior to challenge, daily mean body temperatures of all 
groups remained normal (38.6°-40.0°C) with the exception of a 
0.2°C elevation noted in group A on day 14. 
Mean temperatures were above normal in all groups by the 
third day after Salmonella challenge but returned to normal and 
remained normal by 9, 11, and 9 days after challenge in groups 
A, B, and C (1 week lead chloride), respectively. 
Figure 1. Experiment 3—Daily and cumulative mortalities in groups A (sodium 
chloride-control), B (2 week lead chloride), and C (1 week lead 
chloride) following challenge with S^. choleraesuis var. Kunzendorf» 
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Mean body temperatures, prior to and following challenge, 
and results of statistical analysis are summarized in Table 
26. Daily group means are given in the Appendix (Tables 104 
and 105) . 
Blood lead concentrations 
Highly significant (P <.01) elevations of mean blood 
lead concentrations for the entire experiment were detected 
in both lead chloride-exposed groups as compared to group A 
(sodium chloride-control). 
The mean blood lead concentration prior to the 
beginning of lead or sodium acetate exposure was 4 ug/dl. At 
the time of challenge, concentrations were 1.0, 97.4, and 
85.6 ug/dl in groups A, B (2 weeks lead chloride), and C 
(1 week lead chloride), respectively. 
Mean blood lead concentrations and results of statistical 
analysis are given in Table 26. Daily group means are 
summarized in the Appendix (Table 105). 
Blood ALAD activities 
Highly significant (P< .01) decreases of mean blood ALAD 
activities for the whole trial were noted in both lead 
chloride-exposed groups as compared to group A (sodium 
chloride-control). 
Table 26. Experiment 3—Group means'^ from 2 replicates. 
Groupé 
Measurement A 
(control) 
B C L.S.D. 
.05 
L.S.D. 
.01 
Body temperature (°C) 
Pre-challenge^ 39.6 39.4 39.4 0.5 0.8 
Post-challenge^ 39.8 40.3* 39.9 0.5 0.8 
Blood lead 5 89** 67** 30 60 
concentration (ug/dl) 
Blood ALAD activity 124. 7 15.5** 21.3** 10. 7 19.6 
^Bleedings prior to lead or sodium chloride exposure not used in calculating 
means. 
^Groups B and C exposed to lead chloride for 2 and 1 week, respectively. 
^Period of lead or sodium chloride exposure prior to Salmonella challenge. 
'^Following Salmonella challenge. 
^Significant difference (P <.05) as compared to group A. 
**Highly significant difference (P <.01) as compared to group A. 
95 
Mean blood ALAD activity prior to lead or sodium acetate 
exposure was 116.5 units. Following lead chloride exposure, 
blood ALAD activities fell sharply to about 20% of pre­
exposure levels and remained at these levels at the time of 
challenge. Activities tended to rise in group A (sodium 
chloride-control) prior to challenge. 
Mean blood ALAD activities and results of statistical 
analysis are given in Table 26. Daily group means are 
summarized in the Appendix (Table 107). 
Hematologic observations 
No significant group differences in mean blood hemoglobin 
concentrations were found during the period prior to 
Salmonella challenge. Following challenge, the mean blood 
*-» r«cj,r\4-va+• i r>n rTvrMir> P f 1 nrooV lean 1 Of "Î ) 
was significantly lower than that of group A (sodium chloride-
control) . Mean blood hemoglobin concentrations of all groups 
were below normal (10-16 g/dl) throughout the pre- and post-
challenge periods. Concentrations fell throughout the pre-
challenge period, rose slightly by the second day after 
challenge and then decreased again in all groups. Decreases 
during the post-challenge period were most marked in lead 
chloride-exposed groups. 
Mean hematocrit percentages of lead and sodium chloride-
exposed groups were not significantly different during either 
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the pre- or post-challenge period and were below normal 
(32-50%) in all groups during both periods. 
No significant group differences in total red blood cell 
counts were found during either the pre- or post-challenge 
period. Total red blood cell counts fell below normal 
(5-8 X 10^/cubic nun) in all groups on various sampling dates 
during the trial. 
Mean MCVs of lead and sodium chloride-exposed groups 
were not significantly different during either the pre- or 
post-challenge period. Except for slight decreases in group 
C (1 week lead chloride) on 2 sampling dates, mean MCVs 
remained within normal limits (50-68 f1) throughout the 
experiment. 
Mean MCHCs of groups B (2 weeks lead chloride) and C 
(1 week lead chloride) were significantly (P <.05) lower than 
that of group A (sodium chloride-control) during the period 
prior to Salmonella challenge. Following challenge, the mean ' 
MCHC of group B remained significantly (P <.05) lower than 
that of group A, Gradual decreases of MCHCs were noted in 
all groups during the pre-challenge period, and values fell 
below normal (30-34 g/dl) in groups B and C during this time. 
Mean MCHCs rose by the second day after challenge but then 
fell below normal by the fourth day after challenge and 
continued to decrease in all groups during the remainder of 
the post-challenge period. 
97 
During the pre-challenge period, the mean MCH of group 
B (2 weeks lead chloride) was significantly (P <.05) lower 
than that of group A (sodium chloride-control). Following 
Salmonella challenge, mean MCHs of groups B and C (1 week lead 
chloride) were significantly (P<.05) lower than that of group 
A. Mean MCHs were below normal in all groups on most sampling 
dates throughout the experiment, but lowest values occurred 
in groups B and C. 
Mean blood hemoglobin concentrations, hematocrit 
percentages, total red blood cell counts, MCVs, MCHCs, and 
MCHs, prior to and following challenge, are given in Tables 
27 and 28. Results of statistical analyses are summarized in 
these tables. Daily group means are given in the Appendix 
(Tables 108-113). 
During the pre-challenge period, significant group 
differences in mean total leukocyte counts were not detected. 
After challenge, the total leukocyte count of group C (1 week 
lead chloride) was significantly (P<.05) lower than that of 
group A (sodium chloride-control). Mean total leukocyte 
counts of groups B (2 weeks lead chloride) and C were above 
normal (11,000-22,000/cubic mm) on some bleeding dates prior 
to challenge. Counts were above normal in all groups on the 
second and third days after Salmonella challenge and then fell 
to within normal limits on the fifth day after challenge. On 
Table 27. Experiment 3—Group means^ 
chloride exposure prior to 
from 2 replicates. 
Salmonella challenge 
Period of lead or sodium 
Groupé 
Measurement A 
(control) 
B C L.S.D. 
.05 
L.S.D. 
.01 
Blood hemoglobin 
concentration (g/dl) 
8.6 8.4 7.8 0 . 9 1.5 
Hematocrit (%) 28 28 26 3 5 
Red blood cell 
count (x 10°) c 
5.0 5.3 4.8 0 . 9 1.6 
MCV (fl) 56 . 6 54 . 5 55 . 0 3.6 4.5 
MCHC (g/dl) 31.0 29 . 4* 29.5* 1.1 1.8 
MCH (pg) 17.3 15. 9* 16 .2 1.3 2.1 
^Bleedings prior to lead or sodivm chloride exposure not used in calculating 
means. 
^Groups B and C exposed to lead chloride for 2 and 1 week, respectively. 
^Count in cells/cubic mm. 
*Significant difference (P<.05) as compared to group A. 
Table 28. Experiment 3--Group means from 2 replicates. Period following Salmonella 
challenge. 
Groupé 
Measurement A 
(control) 
B C L.S.D. 
. 05 
L.S.D. 
.01 
Blood hemoglobin 
concentration (g/dl) 
8. 3 7.5 7.2* 0.9 1.5 
Hematocrit (%) 28 27 26 3 5 
Red blood cell 
count (x loG)b 
5 .1 5.1 5 . 0 0.9 1.6 
MCV (fl) 55.6 53.5 52.1 3.6 4.5 
MCHC (g/dl) 29.2 28 . 1* 28 . 2 1.1 1.8 
MCH (pg) 16 .1 14. 7* 14.6* 1.3 2.1 
^Groups B and C exposed to lead chloride for 2 and 1 week, respectively. 
^Count in cells/cubic mm. 
*Significant difference (P<.05) as compared to group A. 
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the seventh and ninth days post-challenge, counts were very 
high in group A but remained normal to slightly above normal 
in groups B and C. 
No significant group differences in mean total segmented 
neutrophil counts were found during either the pre- or post-
challenge period. Prior to challenge, total segmented 
neutrophil counts were above normal (3,200-10,000/cubic mm) 
in all groups on several sampling dates. Counts were above 
normal in all groups by 2 days post-challenge, but then fell 
and reached their lowest points on the fifth day after 
Salmonella challenge. While mean segmented neutrophil counts 
of groups B (2 weeks lead chloride) and C (1 week lead 
chloride) remained very low on the seventh and ninth days 
after Salmonella challenge, the count had risen and was above 
normal by the ninth day post-challenge in group A (sodium 
chloride-control). 
Mean total band neutrophil counts of lead and sodium 
chloride-exposed groups were not significantly different 
during either the pre- ox post-challenge period. Prior to 
challenge, total band neutrophil counts were above normal 
(0-800/cubic mm) in all groups on certain bleeding dates. 
Counts were above normal in group A (sodium chloride-control) 
by 2 days after challenge and in groups B (2 weeks lead 
chloride) and C (1 week lead chloride) by 3 days after 
challenge. While total band neutrophil counts of group A 
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remained stable on the fifth, seventh, and ninth days after 
Salmonella challenge, counts continued to rise in groups B 
and C on these same days. 
Prior to Salmonella challenge, no significant group 
differences in mean total lymphocyte counts were detected, 
but mean counts of groups B (2 weeks lead chloride) and C 
(1 week lead chloride) were significantly (P <.05) lower than 
that of group A (sodium chloride-control) during the post-
challenge period. Total lymphocytes counts remained within 
normal limits (4,500-11,000/cubic mm) in all groups throughout 
the experiment. While total counts in groups B and C 
decreased after challenge, they remained stable in group A. 
Mean total eosinophil counts of lead and sodium chloride-
exposed groups were not significantly different during either 
the pre- or post-challenge period. During the pre-challenge 
period, total eosinophil counts remained normal (50-2,000/ 
cubic mm). Total counts fell below normal in groups B (2 
weeks lead chloride) and C (1 week lead chloride) by the third 
day after challenge= On moat sampling dates of the post-
challenge period, mean total eosinophil counts of groups B 
and C were much lower than that of group A (sodium chloride-
control) . 
No group differences in mean total monocyte counts were 
noted during either the pre- or post-challenge period. Total 
monocyte counts of all groups rose after challenge. 
102 
Mean plasma protein;fibrinogen ratios of lead and sodium 
chloride-exposed groups were not significantly different 
during either the pre- or post-challenge period. 
Mean total leukocyte, segmented neutrophil, band 
neutrophil, lymphocyte, eosinophil, and monocyte counts and 
mean plasma protein:fibrinogen ratios, prior to and following 
challenge, are summarized in Tables 29 and 30. Results of 
statistical analyses are also presented in these tables. 
Daily group means are given in the Appendix (Tables 114-120). 
Daily mean total leukocyte, segmented neutrophil, and 
band neutrophil counts are diagramed in Figures 2-4. 
Agarose film electrophoresis 
Electrophoretic separation of serum protein fractions was 
not complete enough to allcv; separation cf alpha^ and alpha^ 
or beta^ and beta2 globulin peaks. Therefore, the alpha and 
beta globulin fractions were each measured as 1 fraction. 
No significant group differences in mean total serum 
protein or albumin concentrations were found during either the 
pre- or post-challenge period. These concentrations were 
highest in all groups on the second day after challenge and 
then decreased during the rest of the post-challenge period. 
The mean serum alpha globulin concentration of group B 
(2 weeks lead chloride) was significantly (P <.05) lower than 
that of group A (sodium chloride-control) during the pre-
challenge period, and following Salmonella challenge, mean 
Table 29. Experiment 3—Group means^ from 2 replicates. Period of lead or sodium 
chloride exposure prior to Salmonella challenge. 
(îroup^ 
Measurement A 
(control) 
B C L.S.D. 
.05 
L.S.D. 
.01 
Total counts^ 
Leukocyte 19,634 21,659 19,128 7,534 13,008 
Segmented 
neutrophil 
10,882 11,212 10,374 7,033 11,848 
Band neutrophil 484 452 215 4,702 8,259 
Lymphocyte 8,118 9 ,448 8,280 2,639 4,436 
Eosinophil 234 438 208 441 786 
Monocyte 4 82 26 207 330 
Plasma protein: 
fibrinogen ratio 
25 34 28 10 17 
^Bleedings prior to lead or sodium chloride exposure not used in calculating 
means. 
^Groups B and C exposed to lead chloride for 2 and 1 week, respectively. 
^Cells/cubic mm of blood. 
Table 30. Experiment 3—Group means J:rom 2 replicates. Period following Salmonella 
challenge. 
Groupé 
Measurement A 
(control) 
B C L.S.D. 
.05 
L.S.D. 
.01 
Total counts^ 
Leukocyte 28,583 23,325 20,973* 7,534 13,008 
Segmented 
neutrophil 
9,616 5,909 5,607 7,033 11,848 
Band neutrophil 8,123 10,4 74 7,385 4,702 8,259 
Lymphocyte 10,372 6,601* 7,713* 2,639 4,436 
Eosinophil 281 98 175 441 786 
Monocyte 281 182 72 210 330 
Plasma protein: 
fibrinogen ratio 
21 26 24 10 17 
^Groups B and C e xposed to lead chloride for 2 and 1 week. respectively. 
^Cell/cubic mm of blood. 
Significant diff orence (P <.05) as compared to group A. 
Figure 2. Experiment 3——Mean total lêiukocyte (WBC) counts of groups A (sodium 
chloride-control), B (2 weeks lead chloride), and C (1 week lead 
chloride) prior to and folJ.owing challenge with S^. choleraesuis var. 
Kunzendorf. 
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serum alpha globulin concentrations of both lead chloride-
exposed groups were significantly (P<.05) lower than that of 
group A. Alpha globulin concentrations of all groups 
increased after challenge, but this increase was more marked 
in group A. 
Mean serum beta and gamma globulin concentrations of lead 
and sodium chloride-exposed groups were not significantly 
different during either the pre- or post-challenge period. 
Beta and gamma globulin concentrations of all groups rose 
after Salmonella challenge. 
The mean serum A/G ratio of group B (2 weeks lead 
chloride) was significantly (P<.05) higher than that of 
group A (sodium chloride-control) during the pre-challenge 
period. After Salmonella challenge, the mean serum A/G ratios 
of both lead chloride-exposed groups were significantly 
(P <.05) higher than that of group A. 
Mean total serum protein, albumin, alpha globulin, beta 
globulin, and gamma globulin concentrations and mean albumin: 
globulin ratios, prior to and following Salmonella challenge, 
are summarized in Tables 31 and 32. Results of statistical 
analyses are also given in these tables. Daily group means 
are presented in the Appendix (Tables 121-126). 
Table 31. Experiment 3—Group means^ from 3 replicates. Period of lead or sodium 
chloride exposure prior to Salmonella challenge. 
Measurement A 
(control) 
Groupé 
B C Xj . S . 0 . 
.05 
L. S .D 
.01 
Serum concentrations"^ 
Total protein 4.6 4.4 4.4 0.6 0.9 
Albumin 1.43 1.49 1.46 0.30 0.52 
Globulins 
Alpha 1.64 1.41* 1.53 0.20 0.32 
Beta 0.76 0.76 0.76 0.14 0.23 
Ganma 0.76 0 . 73 0.70 0.27 0. 48 
Albumin : globulin 0.46 0.51* 0.49 0.05 0. 08 
ratio 
^Bleedings prior to lead or sodium acetate exposure not used in calculating 
means. 
^Groups B and C exposed to lead chloride for 2 and 1 week, respectively. 
'^Concentrations in g/dl. 
* 
Significant difference (P <.05) as compared to group A. 
Table 3 2 .  Experiment 3—Group means from 2 replicates. Period following 
Salmonella challenge. 
Groupé 
Measurement A 
(control) 
B C L.S.D. 
.05 
L.S.D. 
.01 
Serum concentrations^ 
Total protein 5.3 4.9 4.7 0.6 0.9 
Albumin 1.44 1. 45 1.45 0.30 0.52 
Globulin 
Alpha 2.10 1.62** 1.60** 0.20 0.32 
Beta 0. 86 0.82 0.79 0.14 0.23 
Gamma 0.89 0.93 0. 84 0.27 0.48 
Albumin : globulin 
ratio 
0.37 0.43* 0.45** 0.05 0.08 
^Groups B and C exposed to lead chloride for 2 and 1 week, respectively. 
Concentrations in g/dl. 
* 
Significant difference (P <.05) as compared to group A. 
* 
Highly significant difference (P < .01) as compared to group A. 
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Serum agglutinin titrations 
Serum samples obtained prior to assignment of pigs to 
groups were negative for S. choleraesuis var. Kunzendorf 
agglutinins. 
Salmonella choleraesuis var. Kunzendorf somatic and 
flagellar agglutinin titers of lead and sodium acetate-
exposed groups following Salmonella challenge were not 
significantly different. 
Daily mean somatic and flagellar agglutinin titers on a 
day prior to and on several days following challenge are given 
in Tables 33 and 34. 
Salmonella isolation from tissues and rectal swabs 
Salmonella was not isolated from rectal swabs obtained 
prior to assignment of pigs to groups. 
Salmonella was isolated from 15 of 16 lead chloride-
exposed pigs and 6 of 8 sodium chloride-control pigs. Isolates 
which were serotyped were all determined to be S. choleraesuis 
var. Kunzendorf. 
Results of attempted Salmonella isolation from selected 
tissues are given in Table 35. 
Tissue lead concentrations 
Mean liver lead concentrations were 4.23, 10.78, and 
10.33 ppm and mean kidney lead concentrations were 2.80, 9.23, 
and 7.83 ppm in groups A, B, and C, respectively. 
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Table 33. Experiment 3—Geometric means of S. choleraesuis 
var. Kunzendorf somatic agglutinin titers on a 
daily basis. 
Dayb 
Groupé 
A 
(control) 
B C 
13 0 0 0 
17 0 0 0 
20 8 2 2 
22 52 40 40 
24 60 86 65 
^Groups B and C exposed to lead chloride for 2 and 1 
week, respectively. 
^Pigs were challenged with Salmonella on day 15. 
Table 34. Experiment 3—Geometric means of choleraesuis 
var. Kunzendorf flagellar agglutinin titers on a 
daily basis. 
Groupé 
Day^ A 
(control) 
B C 
13 0 0 0 
17 0 0 0 
20 0 0 0 
22 22 20 25 
24 60 120 70 
^Groups B and C exposed to 
week, respectively. 
lead chloride for 2 and 1 
^Pigs were challenged with Salmonella on day 15. 
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Table 35. Experiment 3—Positive Salmonella isolates from 
selected tissues/number of pigs in replicate or 
group. 
Tissue 
Groupé Liver Mesenteric Ileum 
lymph node 
A (control) 
Rep 1 3/4 3/4 3/4 
Rep 2 3/4 3/4 3/4 
Total 6/8 6/8 6/8 
B 
Rep 1 4/4 4/4 4/4 
Rep 2 4/4 4/4 3/4 
Total 8/8 8/8 7/8 
C 
Rep 1 3/4 3/4 3/4 
Rep 2 4/4 4/4 3/4 
Total 7/8 7/8 6/8 
^Groups B and C exposed to lead chloride for 2 and 1 
week, respectively. 
Macroscopic lesions 
Spleens of 50% of the pigs (10 of 16 lead chloride-
exposed; 2 of 8 sodium chloride-control) were enlarged 
2-4 times and dark red. 
Consolidated areas were found in lungs of 5 pigs (4 of 
16 lead chloride-exposed; 2 of 8 sodium chloride-control). 
In most pigs, scattered lobules were consolidated while in 
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1 pig a 4 X 2 X 2 cm area was involved. Anterior and middle 
lobes were most frequently altered; however, the diaphragmatic 
lobe was also involved in 2 pigs. 
A crusty to mucoid, yellow-white material covered the 
mucosal surface of portions of the intestinal tract in most 
pigs (14 of 16 lead chloride-exposed; 6 of 8 sodium chloride-
control) . This material was found most consistently in the 
cecum and colon but frequently also lined portions of the 
caudal ileum. In some pigs, the material was present in 
elevated foci on the mucosal surface (button ulcers). 
Intestinal lesions were numerically rated on the following 
basis ; 
1—Necrosis not grossly evident. 
2—Focal necrosis only. 
3—Diffuse necrosis of cecum and colon with slight 
involvement of ileum (i.e. 60 cm or less). 
4—Diffuse necrosis of cecum and colon with major 
involvement of ileum (i.e. greater than 60 cm). 
The average score of lead chloride-exposed pigs was 2.6 while 
that of sodium chloride-control pigs was 2.0. 
The mucosa of other portions of the gastrointestinal 
tract was reddened in many pigs. 
In 1-2 pigs from each group, the peritoneum was covered 
with a white, milky material, and abdominal organs tended to 
adhere to each other. 
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Microscopic lesions 
Acute, multifocal necrotic hepatitis characterized by 
coagulative necrosis with no definite lobular distribution, 
moderate hyperplasia of Kupffer cells, increased neutrophil 
numbers in sinusoids, and accumulations of mononuclear 
inflammatory cells in portal areas was detected in 9 pigs 
(4 of 16 lead chloride-exposed; 5 of 8 sodium chloride-
control) . Neutrophils, lymphoreticular cells, or large 
numbers of erythrocytes were present in various necrotic foci. 
Lymphoid depletion was evident in all spleens. Congestion 
and extramedullary hematopoiesis were also found in spleens 
of many lead or sodium chloride-exposed pigs. Splenitis 
characterized by focal to diffuse neutrophil accumulations 
was detected in a small number of pigs. 
An acute diffuse interstitial pneumonia characterized by 
accumulations of macrophages and neutrophils in alveolar walls 
was evident in most pigs. In a few pigs, alveoli and 
bronchioles contained; abundant fibrin, neutrophils, 
macrophages,- and necrotic debris. 
Lymphoid depletion was detected in all mesenteric 
lymph nodes examined. Lymphadenitis characterized by micro­
abscesses, edema, and multifocal coagulative necrosis was 
found in 1 lymph node. 
Acute to subacute colitis, typhlitis, and ileitis 
characterized by focal to diffuse coagulative necrosis, edema, 
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and accumulations of neutrophils, eosinophils, macrophages, 
and lymphocytes in the mucosa and/or submucosa were detected 
in pigs from all groups. Fibroplasia was evident in the 
submucosa of the pigs which died late in the experiment. 
Congestion and a slight increase in neutrophil numbers 
on the mucosal surface were the only lesions observed in the 
jejunum and duodenum. 
Focal collections of neutrophils and fibrin were 
present on serosal surfaces of various sections of intestine. 
No microscopic lesions were observed in kidneys. 
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DISCUSSION 
Experiment 1 
This experiment was performed to detect physiopathologic 
effects of lead in the pig, including levels of lead exposure 
which would and would not cause clinical toxicosis. Such a 
study was necessary before subclinical levels of lead 
exposure could be chosen for use in experiments 2 and 3. 
This research demonstrated that pigs are extremely 
tolerant of lead. Link and Pensinger (1966) reported mean 
blood lead concentrations of 120 ug/dl at the time of death 
in lead-poisoned pigs, but in the present research, several 
i.p. lead acetate-exposed pigs had blood lead concentrations 
exceeding 120 ug/dl at various times, and 1 pig from group 9 
(16 mg/kg lead acetate i.p.) had an extremely high blood lead 
concentration (up to 14,300 ug/dl), but these pigs did not 
die of lead toxicosis. 
The first report of lead toxicosis in swine was by 
Bywater (1937) who observed anorexia, incoordination, hindlimb 
paralysis, abortions, passing of black, bloody feces, purple-
blue discoloration of skin, and death (over 1 month after the 
suspected exposure date). Lead concentration in "ingesta and 
organs" was 114 ppm. The possible role of infectious disease 
was not thoroughly investigated in this report. 
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Link and Pensinger (1966) reported on experimentally-
induced lead toxicosis in swine. Oral lead acetate exposure 
rates of either 11 or 66 mg elemental lead per kg body weight 
did not cause acute lead toxicosis. Pigs developed mild 
diarrhea after 3 days of lead exposure but this subsided 
after 7 to 11 days. Other clinical signs observed during a 
16-week lead-exposure period were inappetance, listlessness, 
muscle tremors, incoordination, increased respiratory rates, 
enlarged carpal joints, and mild clonic seizures. Five of 8 
pigs died within 90 days after initiation of lead exposure. 
In the current research, the coughing observed in 1 
orally lead acetate-exposed and 1 orally sodium acetate-
exposed pig was probably due to either a transient respiratory 
infection or inhalation of the fluid which was administered. 
Gauntness and rough coats were noted in orally lead 
acetate-exposed pigs but not in orally sodium acetate-exposed 
controls and might have been a manifestation of mild intoxica­
tion. If this were the case, the pigs adapted, became normal, 
and remained normal despite higher blood lead burdens later 
in the experiment. 
The significance of the clinical signs observed in i.p. 
lead acetate-exposed pigs is clouded by the fact that i.p. 
injections of lead acetate caused a fibrinous to 
granulomatous peritonitis. Most of the signs observed could 
be attributed to chronic peritonitis with adhesions. Lateral 
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nystagmus and rhythmic jerking of the head and forelimbs in 
1 pig prior to death may have been neurological manifestations 
of lead intoxication but could also have been caused by 
electrolyte and/or acid-base imbalances resulting from 
intestinal obstruction. 
It appears that the alterations of mean blood hemoglobin 
concentrations, hematocrit percentages, MCHCs, and MCHs 
detected in experiment 1 are related to lead dosage and to 
blood lead concentrations. These values were significantly 
decreased in i.p. lead acetate-exposed groups, which had the 
highest blood lead concentrations, but were not significantly 
decreased in orally lead acetate-exposed groups, which had 
blood lead concentrations uniformly lower than those of i.p. 
lead acetate-exposed groups. Furthermore, mean blood hemo­
globin concentrations and hematocrit percentages fell below 
accepted normal limits and were significantly decreased only 
in surviving pigs from groups 8 (8 mg/kg lead acetate i.p.) 
and 9 (16 mg/kg lead acetate i.p.). These same pigs had the 
highest blood lead concentrations of any in the experiment. 
Lowered blood hemoglobin concentrations were also reported in 
lead-poisoned pigs by Link and Pensinger (1966). 
The significant decrease in mean MCV which occurred in 
group 8 (8 mg/kg lead acetate i.p.) may be related to lead 
treatment,but since a significant decrease in MCV did not 
occur in group 9 (16 mg/kg lead acetate i.p.), the 
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relationship of this alteration to lead dosage and blood lead 
concentration is not clearly established. 
There are many reports concerning the influence of lead 
on red blood cells. Possible lead-induced alterations of 
erythrocytes are; depression of heme synthesis, alterations 
of osmotic fragility, and inducement of basophilic stippling. 
It has been suggested that lead interferes with the 
activities of delta-aminolevulinic acid (ALA) synthetase 
(Goldberg et al., 1956), delta-aminolevulinic acid (ALA) 
dehydratase (Gibson et al., 1955), and heme synthetase 
(Goldberg et al., 1956). All of these enzymes catalyze 
reactions in the normal scheme of heme synthesis as noted in 
Figure 5. 
The current investigation revealed that blood ALAD 
activity in the pig is rapidly and drastically reduced by 
lead exposure. Gibson et al. (1955) demonstrated vitro 
inhibition of ALAD activity by lead, and lead-induced 
inhibition of ALAD activity vivo has subsequently been 
reported in humans (Nakao et al., 1568), cattle (Green et al., 
1973), rats (Millar et al., 1970), and hamsters (Mankus, 
1975). Gibson and Goldberg (1970) concluded that since 
glutathione could partially reverse lead-induced ALAD 
inhibition, the mechanism of such inhibition was probably 
through inactivation of the enzyme's sulfhydryl groups. 
121 
Active glycine- -Active succinate 
ALA synthetase* 
Delta-aminolevulinic acid 
ALA dehydratase* 
Porphobilinogen 
PEG deaminase 
Poly-pyrryl methane 
Isomerase 
Uroporphyrinogen III 
UPG decarboxylase 
Coproporphyrinogen III 
CPG oxidase 
CPG decarboxylase 
Protoporphyrinogen IX 
I y 
Protoporphyrin IX 
Fe++ Heme synthetase* 
Heme 
Figure 5. Schematic outline of heme synthesis (Griggs, 1964). 
Asterisks indicate enzymes most markedly inhibited 
by lead. 
Although lead clearly inhibits enzymes involved in cata­
lyzing heme synthesis, the ultimate effect of this inhibition 
on blood hemoglobin concentrations and hematocrit percentages 
is not clear. Sakurai et al. (1974) found no changes in 
hematocrits, red blood cell counts, or blood hemoglobin 
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concentrations in chronically lead-poisoned humans with blood 
lead concentrations up to 50 ug/dl, and Mankus (1975) detected 
only minor decreases in blood hemoglobin concentrations and 
hematocrit percentages in lead-exposed hamsters with marked 
decreases in blood ALAD activity. Haeger-Aronsen et al. 
(1971) estimated that before significant lead-induced impair­
ment of heme synthesis could occur, blood ALAD activity would 
have to fall to 1/3 of normal. 
In the present research, it was apparent that blood ALAD 
activities may remain below 30% of their original levels for 
nearly 12 weeks without significant detectable decreases in 
hemoglobin synthesis resulting. Bush et al. (1955) found the 
average potential life-span of swine erythrocytes to be 
86 - 11.5 days. This means that almost all erythrocytes would 
have been replaced during the 90 day period of the experiment, 
and, yet, mean blood hemoglobin concentrations and MCHCs 
remained within normal limits in groups exposed to lead 
acetate orally (groups in which blood ALAD had fallen to 
approximately 30% or less of original levels after 1 week of 
lead exposure). 
Although measured laboratory values did not clearly 
demonstrate a more profound inhibition of ALAD activity in 
i.p. than in orally lead acetate-exposed groups, the fact 
that significant reductions in blood hemoglobin concentrations, 
MCHCs, and MCHs were detected in i.p. lead acetate-exposed 
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groups infers that lead-sensitive enzymes of the heme syn­
thesis pathway were more markedly inhibited in these groups. 
The gradual fall of blood ALAD activities in sodium 
acetate-exposed groups may have been caused by very low-level 
lead exposure via contact with washings from adjacent pens of 
lead-exposed pigs or by a gradual natural fall in activity as 
pigs became older and erythrogenesis became less intense. 
Niyo (1975) reported that blood ALAD activities of young pigs 
rose until they reached 3-4 weeks of age and then fell 
gradually. 
Lead-induced changes in erythrocyte osmotic fragility 
were not detected in experiment 1 and probably played no part 
in changes of erythrocyte values. Harris and Greenberg 
(1954) suggested that such changes were due to shrunken 
erythrocytes, resulting from lead-induced potassium loss, 
having more capacity to swell before lysis. Erythrocytes of 
both lead acetate-exposed and sodium acetate-control pigs 
were more resistant to osmotic changes than has been pre­
viously reported in either baby or 7-month-old pigs (Hudson, 
1955) , 
The fact that basophilic stippling of erythrocytes was 
found in lead acetate-exposed but not in sodium acetate-
control pigs indicates that the phenomenon was related to 
lead acetate exposure. This was an extremely rare finding in 
experiment 1. Link and Pensinger (1966) found basophilic 
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stippling in erythrocytes of lead-poisoned pigs only after 
they became moribund, but in the present study, basophilic 
stippling was observed in erythrocytes of lead acetate-exposed 
pigs with no clinical signs. 
Jensen et al. (1965) demonstrated, in ultrastructural 
studies, that basophilic stippling consisted of ribosomal 
aggregates. These workers suggested that the aggregates 
probably formed as a blood smear was dried and that slow 
drying predisposed to stippling. Furthermore, it was felt 
that rather than being caused by direct ribosomal alterations, 
basophilic stippling may be a manifestation of less obvious 
chemical alterations of other cellular constituents. 
Since many of the significant alterations in mean total 
leukocyte and differential counts observed in this investiga­
tion did not occur consistently in groups exposed to highest 
lead levels, these alterations are probably not related to 
the exposure. One exception is group 9 (16 mg/kg lead 
acetate i.p.) where leukocytosis with absolute neutrophilia 
and a left shift were detected. Considering the extensive 
peritonitis caused by i.p. lead acetate injections, these 
findings are less surprising than is the fact that similar 
changes were not noted in other i.p. lead acetate-exposed 
groups. It is apparent that inflammation was severe enough 
to cause detectable effects on circulating white blood cells 
only in group 9. 
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Reports concerning the effect of lead exposure on 
leukocytes are rare. Bell et al. (1925) found a tendency 
toward leukocytosis with relative lymphocytosis and 
eosinophilia in human cancer patients treated therapeutically 
with colloidal lead. Sharma (1971) reported significant 
increases in band neutrophil and monocyte counts and signifi­
cant decreases in eosinophil counts in lead-exposed sheep. 
Significant increases in mean absolute band neutrophil and 
eosinophil counts were detected in groups 2 (16 mg/kg lead 
acetate orally) and 7 (4 mg/kg lead acetate i.p.), 
respectively, but not in most other groups with higher mean 
blood lead levels. The significance of these findings is, 
therefore, questionable. 
It must be concluded that except for direct irritation, 
the lead-exposure levels in this study did not significantly 
affect total leukocyte or differential counts. 
A significantly lower mean plasma protein:fibrinogen 
ratio was found only in group 9 (16 mg/kg lead acetate i.p.). 
This indicates that there was an increased plasma concentra­
tion of fibrinogen (Schalm, 1970) which was probably a 
response to inflammation of the peritoneal cavity (Schalm 
et al., 1970). Such a finding correlates well with the 
previously mentioned leukocyte alterations in this group. 
The only serum protein alterations which appear to be 
related to lead exposure in the present study are decreases 
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in serum albumin concentrations and in albumin:globulin ratios 
and increases in serum gamma globulin concentrations. It is 
possible that mild lead-induced liver injury inhibited 
albumin synthesis or that decreased feed intake, which was 
not noted clinically, caused decreased serum albumin 
concentrations. The finding of significant increases in mean 
serum gamma globulin concentrations in orally lead acetate-
exposed group 4 and i.p. lead acetate-exposed groups 7, 8, and 
9 are not in agreement with results reported by Hemphill 
(1973) in lead nitrate-exposed mice. It must be recognized 
that 2 pigs in group 4 had chronic pleuritis and pericarditis, 
and that many pigs in groups 7, 8, and 9 experienced 
peritonitis. These inflammatory changes were not observed in 
sodium acetate-control pigs, and, therefore, pigs in control 
groups were not antigenically stimulated to the same extent as 
were pigs in the groups with increased serum gamma globulin 
concentrations. 
Decreased A/G ratios were a result of decreased serum 
albumin concentrations coupled with increased serum gamma 
globulin concentrations in groups 4, 7, 8, and 9. 
A significant decrease in mean serum alpha2 globulin 
concentration was noted in group 3 (32 mg/kg lead acetate 
orally), but a significant increase in this same fraction was 
detected in groups 6 (2 mg/kg lead acetate i.p.) and 9 
(16 mg/kg lead acetate i.p.). While significant increases in 
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mean serum beta^ globulin concentrations occurred in groups 3 
(32 mg/kg lead acetate orally) and 8 (8 mg/kg lead acetate 
i.p.), significant alterations did not occur in groups 4 
(64 mg/kg lead acetate orally) or 9 (16 mg/kg lead acetate 
i.p.), both of which had higher mean blood lead concentrations 
than the former groups. Although significant decreases in 
mean serum betag globulin concentration occurred in groups 3 
(32 mg/kg lead acetate orally) and 4 (64 mg/kg lead acetate 
orally), such decreases did not occur in any i.p. lead acetate-
exposed groups. In all of these cases, a definite association 
between the occurrence of the alteration in protein 
concentration and either lead exposure level or blood lead 
concentration is not clearly established. The relationship of 
such alterations to lead exposure is, therefore, questionable. 
In lead-poisoned pigs, Link and Pensinger (1966) found 
highest tissue lead concentrations to be in the femur followed 
by liver, kidney, muscle, and brain, in that order. The 
current trial confirmed that highest tissue lead concentrations 
are found in bone. High lead cjoncentrations were also found 
in liver and kidney, but in certain groups, spleen, lung, bone 
marrow, or lymph node exceeded the latter organs in lead 
concentration. 
Because of its intimate contact with bone, it is not 
surprising that high lead concentrations were found in the 
bone marrow, and such a finding indicates that large amounts 
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of lead are present at the main site of erythrogenesis and 
that there is ample opportunity for a lead-mediated effect on 
this process. 
High lead concentrations in the spleen or lung are more 
difficult to explain. Lead is rapidly associated with 
erythrocytes following absorption (Barltrop and Smith, 1971), 
and normal destruction of erythrocytes takes place in the 
spleen. It seems that such erythrocyte destruction would 
result in lead being deposited in the spleen. The cause of 
high lung lead concentrations might be the result of 
accidental entrance of orally administered lead acetate 
solutions into the lungs; however, lung lead concentrations 
were also elevated in i.p. lead acetate-exposed pigs. The 
reason for high lung lead concentrations remains a mystery. 
High concentrations of lead found in lymph nodes of i.p. 
lead acetate-exposed pigs can be explained by the fact that 
some of the lymph nodes used for analysis drained areas where 
lead acetate was injected. Of more importance is the fact 
that low lead concenLraLions were detected in lymph nodes of 
pigs exposed to lead acetate orally. This suggests that if 
lead could affect antibody synthesis in lymphoid tissues other 
than the spleen, it would have to be active at a low 
concentration. 
This investigation confirmed that little lead is 
concentrated in skeletal muscle or brain. 
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Link and Pensinger (1966) reported that macroscopic 
lesions of lead-poisoned pigs included thickening of the 
mucosa of the stomach and intestines, a few petechiae on the 
heart, and congestion of the liver. These changes were not 
found in the current work. 
The pleural and pericardial adhesions noted in pigs from 
group 4 (64 mg/kg lead acetate orally) were possibly due to a 
serositis of infectious etiology. No cultures were performed 
to verify this. The macroscopic lesions observed in i.p. 
lead acetate-exposed groups were clearly caused by a direct 
irritant action of lead acetate solutions. Such an effect 
has previously been described (Truscott, 1970). 
Hsu et al. (1973) reported abundant intranuclear 
inclusion bodies in liver cord cells and renal tubular 
epithelial cells of pigs exposed to lead acetate orally for 
up to 13 weeks. Such inclusions were found in a few pigs in 
the present research. Goyer et al. (1970b) suggested that the 
intranuclear inclusion bodies observed in lead-poisoning 
consisted of a lead-protein complex. Ultrastructurally, such 
inclusions had a dense central core and a fibrillar outer 
zone. These workers theorized that such inclusions served as 
a depot for intracellular lead. Goyer et al. (1970a) stated 
that concentration of lead in intranuclear inclusions might 
be a defense mechanism which reduces lead concentrations in 
lead-sensitive organelles such as mitochondria. 
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It is apparent that lead acetate can incite a 
granulomatous reaction and that cells ingesting lead acetate 
may carry the substance to lymph nodes. The granulomatous 
masses in the abdominal cavity and the granulomatous foci in 
lymph nodes of i.p. lead acetate-exposed pigs contained 
amorphous material which was partially mineralized. This 
material probably represents deposits of lead salts. Selye 
et al. (1962) reported that lead acetate can induce 
calcinosis. Whether the mineralization observed in this 
experiment was caused by a specific effect of lead acetate or 
was due to a non-specific reaction to tissue injury, is not 
clear. 
The slight interstitial thickening observed in lungs of 
pigs exposed to lead acetate orally might have been caused by 
inhalation of lead acetate solutions during the process of 
administration. 
Link and Pensinger (1966) found degeneration of renal 
tubules in lead-exposed pigs, but such a change was not 
detected in experiment 1. 
Experiments 2 and 3 
The significantly higher mortality rate observed in lead 
chloride-exposed pigs challenged with S_. choleraesuis var. 
Kunzendorf in experiment 3 paralleled observations of 
Hemphill (1973) in lead nitrate-exposed mice challenged with 
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S. typhimurium. Mankus (1975), however, found no decrease in 
resistance to S. typhimurium in lead chloride-exposed 
hamsters. Furthermore, decreased resistance to S. 
choleraesuis var. Kunzendorf was not detected in lead acetate-
exposed pigs in experiment 2. 
Lead exposure levels in experiments 2 and 3 were adequate 
to produce significant elevations of blood lead concentrations 
without causing overt toxicosis. It must be noted that 
reduced appetites occurring in group B (2 weeks lead chloride) 
of experiment 3 during the lead-exposure period might have 
been due to mild toxicosis. At the time of challenge, blood 
lead concentrations of lead-exposed pigs were approximately 
twice as high in experiment 3 as in experiment 2. Liver and 
kidney lead concentrations were also higher in experiment 3. 
If lead exposure played a role in the increased mortality 
rates of experiment 3, the fact that such a phenomenon did not 
occur in experiment 2 might be explained by lower lead 
concentrations in blood and other tissues of lead-exposed pigs 
in this experiment and, therefore, less load-induced reduction 
of resistance. 
In both experiments, lead concentrations in blood and 
other tissues of lead-exposed pigs were adequate to cause a 
profound biological effect as demonstrated by marked 
reductions of blood ALAD activity. Such reductions in 
activity probably result from lead-induced inactivation of 
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the enzyme's free sulfhydryl groups. It might be inferred 
that lead levels in these experiments should also have been 
adequate to interfere with sulfhydryl groups of antibodies. 
Lead-exposed pigs did not appear to be more severely ill 
than control pigs in either experiment 2 or 3. Although 
clinical signs were similar in both experiments, there were 
some qualitative and/or quantitative variations. Cyanosis 
was observed only in experiment 2 while diarrhea and 
dehydration were more consistently evident and more severe in 
experiment 3. Cyanosis is more commonly observed in the 
acute septicemic form of salmonellosis while diarrhea is more 
common in the enteric form of the disease (Barnes and 
Sorensen, 1975). The obvious conclusion is that organisms 
inoculated i.p. in experiment 2 had more of a tendency to 
cause septicemia while those inoculated intragastrically 
tended to cause enteric disease. While the latter inference 
is probably valid, culture results reveal that septicemia was 
more common in experiment 3 than in experiment 2. 
The significance of increased mortaliLy rates observed 
in lead chloride-exposed pigs in experiment 3 is somewhat 
diminished by the fact that decreases of blood hemoglobin 
concentrations, MCHCs, and MCHs occurred in these groups. 
Such decreases may have been manifestations of decreased 
hemoglobin synthesis resulting from a toxic effect of lead 
or may have been due to some intrinsic abnormality of 
133 
hemoglobin synthesis and/or erythrocyte destruction which was 
more evident in lead chloride-exposed groups. If the former 
theory is true, it might be invalid to classify the pigs as 
subclinically intoxicated. The role, if any, played by 
abnormalities in hemoglobin synthesis and/or erythrocyte 
destruction in decreasing resistance of lead-exposed pigs to 
Salmonella is not clear. 
Although significant changes in total leukocyte and dif­
ferential counts following Salmonella challenge in experiment 
3 were limited to reductions of the total leukocyte count in 
group C (1 week lead chloride), and total lymphocyte counts 
in groups B (2 weeks lead chloride) and C, important 
differences in leukocyte kinetics were noted by 5-7 days 
post-challenge. Total leukocyte and segmented neutrophil 
counts of groups A, B, and C rose during the first 2-4 days 
after challenge but had fallen by 5 days post-challenge. 
These counts decreased more drastically and stayed lower in 
groups B (2 weeks lead chloride) and C (1 week lead chloride) 
than in group A (sodium chloride-control). Total band 
neutrophil counts of group A rose sooner than those of groups 
B and C following challenge but were below counts of the 
former groups after 17 days post-challenge. 
Following i.v. administration of live, virulent 
S. choleraesuis var. Kunzendorf organisms or purified endo­
toxin from these organisms to pigs, Sherman (1972) detected 
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a leukopenia followed by a leukocytosis. The leukopenic phase 
was characterized by a decrease in absolute segmented 
neutrophil and lymphocyte counts. The phase of increasing 
leukocyte counts was characterized by a marked increase in 
absolute immature neutrophil counts. All changes were more 
marked in pigs which received purified endotoxin. 
An explanation for endotoxin-induced changes of 
differential counts was given by Athens et al. (19 61) who 
discovered that radiolabeled neutrophils moved from the 
circulating granulocyte pool (CGP) of the blood to the 
marginal granulocyte pool (MGP) following administration of 
endotoxin and that during this time granulocytopenia occurred. 
These workers noted that such events were followed by a phase 
of increasing granulocyte numbers in both the CPG and MGP 
caused by an influx of cells from the bone marrow pool. 
The leukocyte changes in experiment 3 were compatible 
with the previously described endotoxin-induced changes. The 
fact that total leukocyte and segmented neutrophil counts fell 
more drastically and remained lower and that band neutrophil 
counts were higher in lead chloride-exposed pigs than in 
sodium chloride-exposed controls seems to indicate a more 
profound effect of endotoxin in the former lead chloride-
exposed pigs. 
Since a large number of previous studies have demon­
strated that lead acetate can induce increased susceptibility 
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to endotoxin and since leukocyte alterations in experiment 3 
indicate that lead chloride-exposed pigs may have been more 
profoundly affected by endotoxin than were sodium chloride-
exposed controls, it is tempting to explain the increased 
mortality of lead chloride-exposed pigs on the basis of a 
lead chloride-induced endotoxin hypersensitivity. It must be 
noted, however, that the previously mentioned alterations 
could also be caused by increased amounts of endotoxin 
entering the bloodstream of lead chloride-exposed pigs as a 
result of lead-induced immunosuppression. Such 
immunosuppression might have allowed more rapid multiplication 
of bacteria which, in turn, produced increased endotoxin. 
Significantly lower serum alpha globulin concentrations 
in lead-exposed groups prior to Salmonella challenge in 
experiment 3 and following Salmonella challenge in experiments 
2 and 3 parallel observations by Hemphill (1973) in lead-
exposed mice, Hoffman (1974) in lead-exposed sheep, and 
Soliman et al. (1970) in lead-exposed humans. In both 
experiments 2 and 3, scrum alpha globulin (alpha^ globulin in 
experiment 2) concentrations rose following Salmonella 
challenge, but the magnitude of this rise was greater in 
control pigs than in lead-exposed pigs. Soliman et al. (1970) 
attributed lower serum alpha^ and alphag globulin concentra­
tions to lead-induced urinary protein loss. Since urine 
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proteins were not measured in experiments 2 and 3, this 
explanation can neither be accepted nor refuted. 
Of greater importance than the significantly lower serum 
alpha globulin concentrations is the fact that despite 
increased mortality of lead chloride-exposed pigs in 
experiment 3, no significant decreases in serum gamma globulin 
concentrations were detected. This finding casts doubt on the 
importance of decreased humoral immunity in causing the 
reduced resistance to Salmonella challenge. This doubt is 
strengthened by the fact that significant decreases in either 
flagellar or somatic agglutinin titers of lead chloride-
exposed pigs were not detected in experiment 3. 
It must be emphasized that despite the fact that lead-
exposure levels in experiments 2 and 3 caused a marked 
biological effect (decreased ALAD activity), there is no 
evidence that such exposure caused an alteration of humoral 
immunity as measured by serum agglutinin titers or serum beta 
and gamma globulin concentrations. 
It is possible that a decreased cellular immune response 
caused lowered resistance to Salmonella in experiment 3. 
Collins (1974) concluded that while specific humoral factors 
probably make an important contribution during the early 
stages of the immune response to Salmonella, the organisms are 
protected from the actions of circulating serum factors once 
they become established in the lymphoreticular tissues of the 
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host. This reviewer contended that the host is able to 
eliminate organisms from the tissues only after a cellular 
immune response is established. Mackaness (1971) felt that 
the effectors of such a response were "activated" macrophages. 
Investigations of the endotoxin-sensitizing effect of 
lead acetate indicate that this compound may impair 
phagocytosis and/or cause ultrastructural alterations in 
phagocytic cells= If such an action took place in lead 
chloride-exposed pigs in experiment 3, a reduction in cellular 
immune response and, therefore, a decreased resistance to 
Salmonella would have resulted. 
The role of other lead-induced abnormalities such as 
hepatocyte injury cannot be ruled-out as playing a part in 
the decreased resistance of lead chloride-exposed pigs in 
experiment 3. Hepatic function tests were not performed 
during this trial and, therefore, the possibility of lead-
induced hepatic injury cannot be evaluated. 
There was no indication that lead-exposure potentiated 
tiis bprfciciu. oj. Oi y an j-uni-wughout the body. In experiment 3, 
organisms were isolated from most tissues cultured from both 
lead and sodium chloride-exposed pigs. In experiment 2, 
Salmonella was actually isolated from more sodium acetate-
exposed pigs and from more tissues of sodium acetate-exposed 
pigs than from lead acetate-exposed pigs. The fact that 
organisms were more widespread in experiment 3 is probably a 
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function of the route of inoculation. Organisms inoculated 
i.p. in experiment 2 were probably quickly phagocytized by 
peritoneal macrophages and other R-E tissues of the body which 
resulted in a relatively small number of organisms surviving 
and multiplying. In experiment 3, organisms inoculated into 
the G-I tract had an excellent environment in which to 
multiply and then invade the rest of the body. 
The fact that macroscopic lesions of spleens and 
intestines of lead chloride-exposed pigs were more severe than 
those of sodium chloride-exposed controls in experiment 3 is 
probably a manifestation of more severe illness in these pigs. 
The observation that intestinal lesions in lead chloride-
exposed pigs were more severe than those of sodium chloride-
exposed controls may indicate that bacteria were allowed to 
multiply more freely in the intestinal tract of the former. 
It must be remembered, however, that such observations are 
very crude measurements. 
Microscopic lesions in experiments 2 and 3 were those 
expected in salmonellosis. 
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SUMMARY 
The effects of subclinical levels of lead exposure on 
the resistance of swine to Salmonella choleraesuis var. 
Kunzendorf were studied in 2 separate experiments (experiments 
2 and 3). Before such studies could be performed, however, it 
was necessary to identify levels of lead exposure which would 
cause clinical and subclinical toxicosis in the pig. 
Experiment 1 was performed for this purpose. 
Experiment 1 
Thirty pigs were divided into 10 groups of 3 pigs per 
group. Four groups received lead acetate orally at 4 
different dosages, and 4 groups received lead acetate 
intraperitoneally (i.p.) at 4 different dosages. Two groups 
served as oral- and i.p.-control groups, and each pig in 
these groups received a different level of sodium acetate. 
Lead or sodium acetate was administered 6 days per week for 
13 weeks (90 days). 
It was demonstrated that pigs are extremely tolerant of 
lead. Blood lead concentrations were above 100 ug/dl in 
several pigs and reached 14,300 ug/dl in 1 pig, but these 
pigs did not die of lead toxicosis. Only mild clinical signs 
of toxicosis (gauntness and rough coats) were detected in 
orally lead acetate-exposed pigs. In pigs which received 
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lead acetate i.p., signs of lead toxicosis, if they occurred, 
were masked by signs resulting from lead acetate-induced 
peritonitis. 
Significant decreases in blood hemoglobin concentrations, 
mean corpuscular hemoglobin concentrations (MCHCs), and/or 
mean corpuscular hemoglobins (MCHs) occurred in several i.p. 
lead acetate-exposed groups and were probably the result of a 
lead-induced reduction of blood ALAD activities. Basophilic 
stippling was observed in erythrocytes of a few lead 
acetate-exposed pigs but not in those of sodium acetate-
exposed controls. 
The only alterations of total leukocyte or leukocyte 
differential counts related to lead exposure occurred in 
response to peritonitis induced by i.p. injections of lead 
acetate solutions. 
Decreases in serum albumin concentrations and increases 
in serum gamma globulin concentrations appeared to be the 
only serum protein alterations related to lead exposure. 
Serum gamma globulin concentrations did not decrease in any 
lead acetate-exposed groups. Decreased albumin concentrations 
may have resulted from subclinical lead-induced liver injury 
or from decreased feed intake. Increased gamma globulin 
concentrations probably occurred as a result of antigenic 
stimulation caused by i.p. injections of irritating lead 
acetate solutions. 
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As expected, high lead concentrations were detected in 
bone, liver, and kidney, but high concentrations also occurred 
in spleen, lung, and bone marrow of various groups. Lymph 
nodes of orally lead acetate-exposed pigs had low lead 
concentrations, and if lead were to significantly interfere 
with antibody synthesis at this site, it would have to do so 
at very low concentrations. 
Peritonitis, which was centered at injection sites, was 
evident macroscopically in most i.p. lead acetate-exposed 
pigs. 
Microscopic lesions associated with lead acetate-
exposure were acid-fast intranuclear inclusion bodies found 
in livers and/or kidneys of a small number of orally- or 
i.p.-exposed pigs,and granulomatous peritonitis and 
lymphadenitis associated with lead acetate deposits in 
i.p.-exposed pigs. 
Experiments 2 and 3 
In experiment 2, 36 pigs were divided into 2 groups of 
18 pigs each. One group was fed a ration containing 500 ppm 
lead acetate while the second was fed a ration containing 
sodium acetate. After the first week of lead exposure and at 
weekly intervals thereafter, 6 pigs from each group were 
challenged i.p. with live S. choleraesuis var. Kunzendorf 
organisms. 
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In experiment 3, 24 pigs were divided into 3 groups of 8 
pigs each. Two groups were fed a ration containing 3,000 ppm 
lead chloride for 1 and 2 weeks, respectively, and 1 group 
was fed a ration containing sodium chloride for 2 weeks. At 
the end of the lead or sodium chloride-exposure period, all 
pigs were challenged orally with live S. choleraesuis var. 
Kunzendorf organisms. 
Lead chloride-exposed pigs had significantly higher 
mortality rates than did sodium chloride-exposed controls in 
experiment 3. Only 1 pig died during experiment 2. Clinical 
signs of lead-exposed pigs did not appear to be more severe 
than those of control pigs in either experiment. 
In experiment 3, pigs exposed to lead chloride for 2 
weeks had reduced appetites near the end of the lead-exposure 
period, and both lead chloride-exposed groups had significant 
decreases in blood hemoglobin concentrations, MCHCs, and MCKs 
as compared to the sodium-chloride-control group. These 
findings could have resulted from mild lead toxicosis, and it 
might be invalid to classify the pigs as subclinically 
intoxicated. 
Alterations in leukocyte kinetics following Salmonella 
challenge in experiment 3 seem to indicate that lead chloride-
exposed pigs were being more intensely affected by endotoxin. 
This may have resulted from greater production of endotoxin 
in these pigs due to lead-induced suppression of the immune 
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response to Salmonella or from a lead induced hypersensitivity 
to endotoxin. 
Macroscopic lesions of lead chloride-exposed pigs were 
more severe than those of sodium chloride-controls in 
experiment 3. This was probably a manifestation of more 
severe illness in these pigs. 
Lead-exposed pigs in both experiments had significantly 
lower serum alpha globulin concentrations, but the cause and 
significance of this alteration are not clear. 
Despite the fact that lead exposure in experiments 2 and 
3 caused a marked biological effect (decreased blood ALAD 
activity), there was no evidence that such exposure caused an 
alteration of humoral immunity as measured by serum 
agglutinin titers or serum beta and gamma globulin concentra­
tions. It is, therefore, doubtful that suppression of 
humoral immunity caused the decreased resistance of lead 
chloride-exposed pigs in experiment 3. 
In light of reports that lead acetate may impair 
phagocytosis and that protective immunity against Salmonella 
infection is probably cellular in nature, an alteration in 
cellular immunity might be considered as a cause of lead-
induced reduction of resistance to Salmonella infection. The 
responsiveness of the cellular immune system was not studied 
in these experiments. 
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Table 36. Experiment 1—Mean blood lead concentrations 
(ug/dl) of groups exposed to lead or sodium 
acetate orally. 
Group 
Week 1 2 3 4 5 
(control) 
0^ 5 4 8 6 11 
1 28 33 31 38 7 
2 28 32 34 50 9 
3 39 46 48 68 13 
4 30 37 34 58 8 
5 38 44 50 82 12 
6 41 35 52 71 11 
7 25 28 38 53 7 
8 44 46 60 86 15 
9 38 38 63 69 13 
10 44 39 79 91 6 
11 43 35 80 105 10 
12 40 36 61 79 8 
13 57 46 77 164 8 
^Prior to lead or sodium acetate exposure. 
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Table 37. Experiment 1—Mean blood lead concentrations 
(ug/dl) of groups exposed to lead or sodium 
acetate i.p. 
Group 
Week 6 7 8^ 9^ 10 
(control) 
6 5 5 5 9 
1 30 33 35 35 8 
2 30 36 44 42 10 
3 39 51 58 208 11 
4 43 55 56 146 14 
5 56 76 89 59 17 
6 47 61 57 122 11 
7 68 88 83 185 9 
8 90 124 133 395 24 
9 59 79 93 599 13 
10 79 92 110 710 12 
11 110 156 38 2,800 9 
12 79 S3 110 5,800 10 
13 101 136 150 14,300 14 
^Values for weeks 4 and 5 are means from 2 pigs, and 
values for weeks 6-13 are from 1 pig only. 
'^Prior to lead or sodium acetate exposure. 
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Table 38. Experiment 1—Mean blood ALAD activities of groups 
exposed to lead or sodium acetate orally. 
Group 
Week 12 3 4 5 
(control) 
0^ 219.4 176.1 218.9 185.9 197.7 
1 67.5 45.0 52.8 37.5 209.2 
2 31.6 19.4 20.4 13.5 175.4 
3 20.4 13.2 12.4 7.6 161.5 
4 19.1 13.9 11.5 10.2 156.8 
5 12.1 8.9 9.8 7.7 109.6 
6 15.0 13.2 11.7 9.0 153.4 
7 7.8 6.5 5.4 4.7 107.1 
8 5.3 4.4 3.3 3.3 123.6 
9 4.8 4.1 2.8 2.8 111.1 
10 4.5 3.3 3.0 3.2 85.3 
11 2.7 1.8 1.2 1.1 88.9 
12 3-5 3.2 5.2 2.6 75.4 
13 4.1 2.9 4.3 3.3 76.9 
^Prior to lead or sodium acetate exposure. 
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Table 39. Experiment 1—Mean blood ALAD activities of groups 
exposed to lead or sodium acetate i.p. 
Group 
Week 6 7 8* 9* 10 
(control) 
0^ 216.8 219.0 270.9 196.7 242.2 
1 58.9 79.8 66.9 55.1 180.7 
2 32.4 29.8 21.2 19.2 154.1 
3 18.7 18.8 15.9 9.2 131.1 
4 16.2 13.2 19.4 12.2 94.2 
5 8.3 6.4 7.8 7.2 74.3 
6 10.6 10.1 8.1 8.3 81.3 
7 6.3 3.4 6.9 4.5 65.6 
8 4.8 3.6 5.1 6.2 67.0 
9 1.4 2.2 0.0 0.0 55.6 
10 3.1 2.2 2.2 4.5 36.7 
11 2.0 1.5 2.5 4.0 39.6 
12 1.5 1.5 2.2 8.0 30.5 
13 1.8 3.0 3.3 6.2 37.1 
^Values for weeks 4 and 5 are means from 2 pigs, and 
values for weeks 6-13 are from 1 pig only. 
^Prior to lead or sodium acetate exposure. 
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Table 40. Experiment 1—Mean blood hemoglobin concentrations 
(g/dl) of groups exposed to lead or sodium acetate 
orally. 
Group 
Week 1 2 3 4 5 
(control) 
0® 11.9 12.4 12.6 12.6 12.7 
1 11.9 11.8 11.4 11.8 11.8 
2 12.5 13.5 12.6 11.1 12.9 
3 12.9 13.6 13.8 11.9 13.5 
4 12.1 12.3 12.8 12.1 12.0 
5 12.1 11.9 12.1 12.1 12.6 
6 11.8 11.8 11.4 11.6 12.2 
•? il. 8 12:5 .1. 1 m O 11.5 12.3 
8 12.8 13.2 12.7 12.2 13.1 
9 12.1 12.1 12.6 11.3 12.8 
10 12.6 12.4 12.8 11.5 12.8 
11 12.4 12.6 12.8 11.3 11.1 
12 11.8 12.3 12.3 11.5 12.5 
13 12.4 12.4 10.8 12.3 12.3 
^Prior to lead or sodium acetate exposure. 
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Table 41. Experiment 1—Mean blood hemoglobin concentrations 
(g/dl) of groups exposed to lead or sodium acetate 
i.p. 
Group 
Week 6 7 8^ 9^ 10 
(control) 
0^ 12.3 12.4 10.8 13.1 11.9 
1 11.1 11.4 10.8 11.0 11.9 
2 11.4 12.1 10.9 11.2 13.2 
3 11.6 12.1 11.2 11.7 13.4 
4 10.9 12.0 10.2 10.2 12.8 
5 10.2 10.8 11.2 10.6 12.6 
6 11.1 11.1 9.8 8.9 11.9 
7 10.7 11.1 10.1 8.3 11.7 
8 11.8 12.0 10.4 8.0 13.1 
9 11.9 11.8 11.1 7.4 12.0 
10 11.0 10.4 9.8 6.4 12.5 
11 11.2 11.7 8.6 7.4 12.4 
12 11.2 10.9 8.9 7.7 12.9 
13 10.9 10.9 8.6 8.3 12.6 
^Values for weeks 4 and 5 are means from 2 pigs, and 
values for weeks 6-13 are from 1 pig only. 
^Prior to lead or sodium acetate exposure. 
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Table 42. Experiment 1—Mean hematocrit percentages of 
groups exposed to lead or sodium acetate orally. 
Group 
Week 1 2 3 4 5 
(control) 
0^ 38.3 39.3 39.8 40.3 33.5 
1 36.7 37.7 35.7 37.5 38.7 
2 39.8 42.7 41.0 37.0 41.0 
3 41.0 41.0 41.0 38.7 41.0 
4 37.0 36.7 39.7 36.3 37.0 
5 37.7 37.7 38.0 38.0 40.0 
6 36.3 38.3 35.7 37.3 37.3 
7 37.3 38.7 38.0 35.7 37.7 
8 41.0 39.0 39.0 38.3 41.3 
9 35.7 36.7 37.7 34.7 37.0 
10 38.7 39.0 39.0 36.3 41.0 
11 37.7 39.3 39.3 35.3 33.0 
12 34.7 37.0 36.3 35.7 36.7 
13 40.0 40.3 35.7 40.7 40.0 
^Prior to lead or sodium acetate exposure. 
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Table 43. Experiment 1—Mean hematocrit percentages of groups 
exposed to lead or sodium acetate i.p. 
Group 
Week 6 7 8* 9* 10 
(control) 
0^ 37.8 38.3 35.2 39.7 36.7 
1 35.0 36.3 33.0 37.0 37.2 
2 40.5 40.3 39.0 39.3 37.5 
3 37.8 40.0 36.7 37.0 41.0 
4 33.3 37.7 29.5 30.5 38.3 
5 30.0 32.7 32.5 35.0 38.3 
6 35.3 37.2 31.0 30.0 38.7 
1 33.7 36.7 32.5 28.0 36.0 
8 38.7 38.0 32.0 30.0 40.3 
9 38.3 37.3 34.0 25.0 34.7 
10 36.3 37.3 34.0 22.0 39.0 
11 36.3 37.7 30.0 25.0 40.3 
12 33.7 34.3 28.0 25.0 39.7 
13 37.0 36.0 30.0 28.0 40.0 
^Values for weeks 4 and 5 are means from 2 pigs, and 
values for weeks 6-13 are from 1 pig only. 
^Prior to lead or sodium acetate exposure. 
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Table 44. Experiment 1—Mean total red blood cell counts 
X 10^ (per cubic mm) of groups exposed to lead or 
sodium acetate orally. 
Group 
Week 12 3 4 5 
(control) 
0^ 7.08 7.12 7.41 7.54 8.58 
1 6.74 7.14 7.11 7.45 7.04 
2 8.43 8.83 7.30 7.45 7.14 
3 7.19 7.75 7.25 7.79 6.43 
4 7.01 7.99 6.80 7.06 8.75 
5 5.71 5.26 5.31 6.04 6.94 
6 6.29 6.95 5.88 6.80 6.50 
7 /.ûû h .  R 0 6.85 6.52 G.43 
8 6.84 6.17 6.79 6.54 7.35 
9 7.37 7.22 7.26 6.81 7.61 
10 6.84 7.30 7.06 7.15 7.92 
11 5.48 5.89 5.86 5.34 4.80 
12 7.49 7.40 7.42 7.66 7.80 
13 7.21 6.78 6.21 7.83 6.48 
^Prior to lead or sodium acetate exposure. 
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Table 45. Experiment 1—Mean total red blood cell counts 
X 10 (per cubic im) of groups exposed to lead 
or sodium acetate i.p. 
Group 
Week 6 7 8^ 9^ 10 
(control) 
0^ 7.87 7.88 7.28 8.79 7.65 
1 7.04 7.86 6,76 6.37 6.70 
2 6.70 7.29 6.71 6.59 7.68 
3 5.98 6.75 5.99 6.20 6.10 
4 5.54 6.23 6.22 5.38 6.43 
5 6.19 6.96 6.84 7.48 6.42 
6 6.06 6.17 5.31 5.27 6.03 
7 6 = 75 6,55 6.25 5.23 6.61 
8 6.84 6.35 6.41 4.84 6.84 
9 7.36 6.40 7.27 5.19 6.63 
10 6.80 6.48 6.99 4.25 7.18 
11 5.57 5.86 5.56 4.30 5.92 
12 7.45 7.04 5.93 5.32 7.28 
13 6.10 5.74 5.18 4.82 6.72 
^Values for weeks 4 and 5 are means from 2 pigs, and 
values for weeks 6-13 are from 1 pig only. 
^Prior to lead or sodium acetate exposure. 
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Table 46. Experiment 1—Mean MCVs (fl) of groups exposed to 
lead or sodium acetate orally. 
Group 
Week 1 2 3 4 5 
(control) 
0^ 54.3 55.4 53.8 53.5 47.1 
1 54.7 53.0 50.4 50.5 55.2 
2 47.5 50.8 56.2 50.1 60.3 
3 57.2 52.9 56.5 50.4 68.1 
4 56.2 46.1 58.5 51.6 42.6 
5 66.0 72.1 72.0 63.2 O
 
o
 
6 57.7 55.2 62.0 54.9 57.7 
7 53.2 57.2 55.7 54.8 60.1 
8 60.0 64.8 58.8 59.2 56.2 
9 49.0 50.9 52.5 51.0 48.5 
10 56.8 53.5 55.3 50.9 52.1 
11 68.7 66.5 67.2 67.0 68.8 
12 46 = 4 50.0 49.0 46.4 47.2 
13 55.5 59.7 58.3 52.9 61.7 
^Prior to lead or sodium acetate exposure. 
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Table 47. Experiment 1—Mean MCVs (fl) of groups exposed to 
lead or sodium acetate i.p. 
Group 
Week 6 7 8* 9* 10 
(control) 
0^ 49.4 49.0 49.7 45.9 47.8 
1 50.0 46.6 49.2 58.1 55.9 
2 60.5 55.4 58.2 59.7 48.8 
3 63.4 60.7 61.3 60.0 68.3 
4 62.9 60.7 47.5 56.8 60.4 
5 48.8 47.0 48.5 47.1 60.0 
6 58.5 60.4 58.4 56.9 64.2 
7 51.1 56.3 52.3 53.5 54.5 
8 56.7 59.8 49.9 62.0 59.0 
9 52.4 58.6 46.8 48.2 52.3 
10 53.5 57.9 48.6 51.8 55.0 
11 66.3 64.6 54.0 58.1 68.1 
12 45=7 48.9 47.2 47.0 54.4 
13 60.8 63.2 57.9 58.1 59.8 
^Values for weeks 4 and 5 are means from 2 pigs, and 
values for weeks 6-13 are from 1 pig only. 
^Prior to lead or sodium acetate exposure. 
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Table 48. Experiment 1—Mean MCHCs (g/dl) of groups exposed 
to lead or sodium acetate orally. 
Group 
Week 1 2 3 4 5 
(control) 
0^ 31.0 31.4 31.6 31.2 32.2 
1 32.4 31.3 32.1 31.4 30.4 
2 31.3 31.6 30.8 30.1 31.4 
3 31.5 33.2 33.7 30.7 31.1 
4 32.7 33.5 32.4 33.2 32.4 
5 32.0 31.6 31.9 31.9 32.0 
6 32.5 30.8 32.0 31.2 32.8 
7 31.5 32.4 31.0 32.4 32.7 
8 31.1 33.9 32.6 31.7 31.8 
9 3 4 . 0  33.2 33.4 32.6 35.0 
10 32.6 31.8 32.9 31.8 31.3 
11 32.8 31.9 32.6 32.1 33.7 
12 34.0 33 = 2 33.8 3 2 . 6  34.0 
13 31.1 30.7 30.1 30.2 30.7 
^Prior to lead or sodium acetate exposure. 
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Table 49. Experiment 1—Mean MCHCs (g/dl) of groups exposed 
to lead or sodium acetate i.p. 
Group 
Week 6 7 8* 9% 10 
(control) 
0^ 32.4 32.3 30.8 32.9 32.5 
1 31.6 31.5 32.6 29.7 32.0 
2 28.2 30.1 28.1 28.5 35.2 
3 30.7 30.2 30.5 31.5 32.6 
4 32.8 31.8 34.7 33.6 33.3 
5 34.0 32.8 34.8 30.3 32.9 
6 31.4 29.8 31.6 29.7 30.8 
7 32.1 30.2 31.2 29.6 32.4 
8 30.6 31.5 32.5 26.7 32.4 
9 31.0 31,5 32.6 29.6 34.9 
10 30.3 28.0 28.8 29.1 32.2 
11 30.8 31.0 28.7 29.6 30.7 
12 33; 2 31-6 31.8 30.8 32.4 
13 29.5 30.2 28.7 29.6 31.4 
^Values for weeks 4 and 5 are means from 2 pigs, and 
values for weeks 6-13 are from 1 pig only. 
^Prior to lead or sodium acetate exposure. 
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Table 50. Experiment 1—Mean MCHs (pg) of groups exposed to 
lead or sodium acetate orally. 
Group 
Week 1 2 3 4 5 
(control) 
0^ 16.8 17.4 17.0 16.7 15.1 
1 17.8 16.6 16.1 15.8 16.8 
2 14.8 16.0 17.3 15.1 18.7 
3 18.0 17.6 19.0 15.5 21.2 
4 18.3 15.4 19.0 17.2 13.8 
5 21.1 22.8 22.9 20.2 18.2 
5 18.8 17.0 19.8 17.1 18.9 
7 16.8 18.5 17.4 17.7 19.4 
8 18.7 21.8 19.2 18.8 17.9 
9 16.7 16.9 17.6 16.6 16.9 
10 18.5 17. 0 18.2 16.2 15.3 
11 22.6 21.2 21.9 21.6 23.2 
12 15.8 16.6 16.5 15.1 16.1 
13 17.3 18.3 17.6 16.0 18.9 
^Prior to lead or sodium acetate exposure. 
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Table 51. Experiment 1—Mean MCHs (pg) of groups exposed to 
lead or sodium acetate i.p. 
Group 
Week 6 7 8^ ga 10 
(control) 
0^ 15.9 15.8 15.3 15.1 15.6 
1 15.8 14.7 16.0 17.2 17.4 
2 17.0 16.7 16.3 17.0 17.2 
3 19.5 18.3 18.6 18.9 22.3 
4 20.7 19.3 16.5 19.1 20.2 
5 16.6 15.4 16.6 14.2 19.8 
6 18.3 18.0 18.4 16.9 19.8 
7 16.2 17.0 16.2 15.9 17.7 
8 17.4 lb. 8 16. 2 16.5 XV . J. 
9 16.2 18.5 15.3 14.2 18.2 
10 16.2 16.2 14 • 0 15.0 17.6 
11 20.4 20.0 15.5 17.2 20.9 
12 15.2 15.5 15.0 14.5 17.6 
13 18.0 19.1 16,6 17.2 18.8 
^Values for weeks 4 and 5 are means from 2 pigs, and 
values for weeks 6-13 are from 1 pig only. 
^Prior to lead or sodium acetate exposure. 
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Table 52. Experiment 1—Mean total leukocyte counts (per 
cubic mm) of groups exposed to lead or sodium 
acetate orally. 
Group 
Week 12 3 4 5 
(control) 
0^ 27,433 26,433 23,733 23,300 22,866 
1 22,600 21,067 19,600 24,567 22,567 
2 21,033 21,600 20,767 22,467 19,533 
3 21,800 17,433 22,133 22,300 15,267 
4 20,833 20,367 19,733 19,833 22,500 
5 20,300 18,367 16,700 20,800 21,967 
6 22,533 18,833 17,133 24,933 21,933 
7 22,167 18,767 20,333 20,333 16,767 
8 20,133 20,467 19,133 20,533 18,267 
9 19,933 21,700 20,667 23,300 17,833 
10 17,933 13,367 17,633 21,467 17,133 
11 12,333 10,333 11,900 11,167 11,533 
12 17,033 16,400 17,000 13,200 17/067 
13 17,267 14,400 14,367 19,000 15,733 
^Prior to lead or sodium acetate exposure. 
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Table 53. Experiment 1—Mean total leukocyte counts (per 
cubic mm) of groups exposed to lead or sodium 
acetate i.p. 
Group 
Week 6 7 8* ga 10 
(control) 
0^ 23,067 26,667 24,933 21,500 18,167 
1 20,967 22,767 22,133 19,667 24,700 
2 23,650 19,433 22,267 24,633 21,967 
3 16,367 25,367 19,267 22,933 16,867 
4 17,300 22,767 20,000 28,300 20,567 
5 21,800 20,500 23,350 24,400 22,367 
6 19,833 19,667 16,900 26,200 20,533 
n $ 16,067 21,967 18,500 26;300 21,033 
8 20,033 20,833 16,700 26,600 21,367 
9 21,433 19,967 16,800 20,600 20,833 
10 20,533 20,333 18,400 43,500 18,433 
11 15,933 19,967 15,200 28,700 16,400 
12 18,033 18,967 14,200 27,700 19,435 
13 15,467 20,067 16,800 15,000 18,500 
^Values for weeks 4 and 5 are means from 2 pigs, and 
values for weeks 6-13 are from 1 pig only. 
^Prior to lead or sodium acetate exposure. 
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Table 54. Experiment 1—Mean total segmented neutrophil 
counts (per cubic mm) of groups exposed to lead 
or sodium acetate orally. 
Group 
Week 1 2 3 4 5 
(control) 
0^ 5,331 10,119 7,961 8,737 8,175 
1 7,221 7,536 5,244 8,121 8,375 
2 5,250 8,003 5,128 7,844 7,104 
3 5,049 4,804 4,956 6,645 4,989 
4 5,923 7,835 5,401 5,839 11,074 
5 6,902 7,620 3,575 6,558 9,845 
6 4,956 5,528 4,273 8,122 9,020 
y 5, 3 4 7  5,762 5-9 01 5; Î/M 4.867 
8 6,482 6,845 4,034 3,632 5,934 
9 4,281 5,639 4,236 7,108 5,327 
10 5,537 4,552 4,831 6,743 6,055 
11 2,495 2,767 2,851 1,904 4,153 
12 4,987 3,737 4,560 5,517 5,028 
13 3,215 2,603 2,167 3,627 3,352 
^Prior to lead or sodium acetate exposure. 
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Table 55. Experiment 1—Mean total segmented neutrophil 
counts (per cubic mm) of groups exposed to lead 
or sodium acetate i.p. 
Group 
Week 6 7 8* 9* 10 
(control) 
0^ 6,090 10,503 10,067 6,640 7,728 
1 6,250 9,155 8,029 5,419 9,182 
2 8,128 7,585 7,313 9,240 8,052 
3 4 , 8 2 8  12,274 6,893 6,581 3,902 
4 5,571 7,673 7,616 12,768 6,786 
5 8,213 8,083 9,020 7,086 6,706 
6 4,309 4,771 7,605 7,086 5,393 
7 3,628 6,756 6,529 7,627 5,923 
8 5,341 8,441 6,513 14,896 4,522 
9 6,865 5,703 3,192 7,622 4,560 
10 5,417 5,823 6,808 22,185 5,190 
11 3,828 5,215 4,712 12,341 3,883 
12 3.737 5,227 4,260 11,357 4,991 
13 2,615 4,458 6,384 8,250 4,152 
Values for weeks 4 and 5 are means from 2 pigs, and 
values for weeks 6-13 are from 1 pig only. 
^Prior to lead or sodium acetate exposure. 
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Table 56. Experiment 1—Mean total band neutrophil counts 
(per cubic mm) of groups exposed to lead or sodium 
acetate orally. 
Group 
Week 12 3 4 
(control) 
0^ 620 2,687 483 881 1,733 
1 1,053 2,485 865 1,829 2,107 
2 354 776 209 674 751 
3 940 1,806 1,074 385 655 
4 1,028 2,675 884 559 1,350 
5 953 1,885 723 1,059 1,368 
6 594 1,105 674 1,428 1,187 
7 581 1 .11/ 1 .052 734 
8 638 3,574 751 1,243 445 
9 1,194 3,552 911 694 780 
10 163 440 477 239 106 
11 263 802 374 378 500 
12 576 1,711 351 797 1,337 
13 658 1,919 1,324 891 791 
^Prior to lead or sodium acetate exposure. 
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Table 57. Experiment 1—Mean total band neutrophil counts 
(per cubic mm) of groups exposed to lead or sodium 
acetate i.p. 
Group 
Week 6 7 8* 9% 10 
(control) 
0^ 1,236 1,268 1,259 1,918 625 
1 2,830 2,288 1,847 3,661 2,169 
2 818 595 1,594 1,701 355 
3 925 2,580 912 4,251 1,245 
4 1,495 905 2,608 3,462 2,330 
5 719 2,920 2,292 9,312 2,999 
6 1,320 1,762 1,521 8,646 2,080 
7 1 ; /98 1.950 1,672 7,101 2,028 
8 654 1,488 1,670 1,596 1,374 
9 1,024 1,264 2,352 5,974 2,401 
10 689 941 1,656 6,090 3,817 
11 450 974 912 3,731 908 
12 881 989 852 5,817 1,436 
13 642 1,540 1,848 2,250 1,516 
^Values for weeks 4 and 5 are means from 2 pigs, and 
values for weeks 6-13 are from 1 pig only. 
^Prior to lead or sodium acetate exposure. 
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Table 58. Experiment 1—Mean total lymphocyte counts (per 
cubic mm) of groups exposed to lead or sodium 
acetate orally. 
Group 
Week 1 2 3 4 5 
(control) 
0^ 19,005 12,277 14,015 12,833 11,783 
1 12,862 9,376 12,119 12,274 10,773 
2 14,799 11,736 13,916 12,416 10,702 
3 15,183 9,668 15,025 14,568 8,594 
4 12,306 8,394 12,190 11,291 8,790 
5 11,459 8,272 11,058 11,785 9,586 
6 15,949 10,892 11,082 14,007 11,207 
7 15.669 9.785 12,320 12,662 10,076 
8 11,890 7,910 12,441 14,445 11,045 
9 13,667 9,020 13,872 14,058 11,037 
10 11,515 7,718 11,495 12,749 10,532 
11 9,139 6,510 8,083 8,264 6,659 
12 10,823 9,876 11,365 12,090 10,056 
13 12,684 9,056 10,325 13,277 10,983 
^Prior to lead or sodium acetate exposure. 
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Table 59. Experiment 1—Mean total lymphocyte counts (per 
cubic mm) of groups exposed to lead or sodium 
acetate i.p. 
Group 
Week 6 7 8% 9* 10 
(control) 
0^ 9,759 12,768 12,743 11,738 8,656 
1 9,722 9,455 10,437 9,186 12,366 
2 12,581 10,407 12,194 12,393 12,373 
3 10,173 9,275 10,497 11,255 10,381 
4 9,771 12,770 8,992 10,870 9,679 
5 11,260 8,811 10,839 7,628 11,840 
6 13,000 11,103 7,098 9,432 11,862 
n iO,326 10."Qû 9.205 11157 2 11,702 
8 11,950 8,526 7,181 9,310 13,954 
9 12,379 10,704 10,584 6,798 12,823 
10 12,717 11,734 8 , 6 4 8  14,355 11,773 
11 11,044 12,650 8,360 11,480 11,033 
12 12,337 11,243 8,236 10,526 12,424 
13 11,986 11,912 7,392 3,750 11,679 
^Values for weeks 4 and 5 are means from 2 pigs, and 
values for weeks 6-13 are from 1 pig only. 
^Prior to lead or sodium acetate exposure. 
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Table 60. Experiment 1—Mean total eosinophil counts (per 
cubic mm) of groups exposed to lead or sodium 
acetate orally. 
Group 
Week 12 3 4 5 
(control) 
0^ 780 769 186 373 287 
1 295 486 838 321 485 
2 417 306 944 648 411 
3 134 427 672 280 268 
4 678 871 570 797 363 
5 209 290 727 503 340 
6 768 1,178 795 1,031 327 
7 430 641 322 676 o o o V w 
8 691 1,271 1,438 879 433 
9 507 920 816 1,062 538 
10 501 347 388 1,128 199 
11 312 213 383 452 29 
12 429 517 374 604 423 
13 541 538 312 1,022 415 
^Prior to lead or sodium acetate exposure. 
180 
Table 61. Experiment 1—Mean total eosinophil counts (per 
cubic mm) of groups exposed to lead or sodium 
acetate i.p. 
Group 
Week 6 7 8^ 9^ 10 
(control) 
0^ 162 775 311 225 224 
1 709 583 414 536 661 
2 879 293 378 350 599 
3 167 152 116 65 397 
4 231 807 200 400 206 
5 932 304 129 260 379 
6 729 1,158 676 0 869 
715 j ; QS3 440 0 825 
8 1,235 1,524 167 0 915 
9 791 1,788 336 0 782 
10 1,124 1,529 736 870 567 
11 568 921 912 861 260 
12 956 1,069 710 0 450 
13 390 1,682 504 450 1,096 
^Values for weeks 4 and 5 are means from 2 pigs, and 
values for weeks 6-13 are from 1 pig only. 
^Prior to lead or sodium acetate exposure. 
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Table 62. Experiment 1—Mean total monocyte counts (per cubic 
mm) of groups exposed to lead or sodium acetate 
orally. 
Group 
Week 1 2 3 4 5 
(control) 
0^ 1,425 582 710 373 810 
1 1,013 929 359 1,700 771 
2 142 640 514 752 566 
3 377 664 354 421 639 
4 765 536 613 1,148 859 
5 557 300 450 643 736 
6 267 130 271 345 193 
7 7 0 527 553 193 
8 274 666 470 335 399 
9 285 217 620 377 102 
10 109 223 318 441 65 
11 38 41 165 125 192 
12 153 509 295 61 169 
13 112 237 119 124 192 
^Prior to lead or sodium acetate exposure. 
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Table 63. Experiment 1—Mean total monocyte counts (per 
cubic mm) of groups exposed to lead or sodium 
acetate i.p. 
Group 
Week 6 7 8* 9^ 10 
(control) 
0^ 1,273 955 554 979 644 
1 1,306 1,086 1,184 800 239 
2 1,008 434 723 864 524 
3 227 905 741 653 712 
4 164 612 488 799 1,567 
5 393 268 1,070 114 365 
6 474 798 0 262 329 
7 100 43? 0 0 404 
8 601 712 835 798 602 
9 295 432 336 206 59 
10 234 184 552 0 324 
11 43 0 304 0 118 
12 68 121 142 Û 63 
13 165 270 672 300 56 
^Values for weeks 4 and 5 are means from 2 pigs, and 
values for weeks 6-13 are from 1 pig only. 
^Prior to lead or sodium acetate exposure. 
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Table 64. Experiment 1—Mean total basophil counts (per cubic 
mm) of groups exposed to lead or sodium acetate 
orally. 
Group 
Week 1 2 3 4 5 
(control) 
0^ 272 0 186 102 289 
1 157 255 175 321 55 
2 70 139 55 133 0 
3 117 65 53 0 122 
4 134 56 0 56 64 
5 209 0 167 151 92 
6 0 0 38 0 0 
7 70 0 0 62 59 
8 159 200 0 0 0 
9 0 151 212 0 50 
10 108 87 126 167 175 
11 85 0 45 43 0 
12 65 49 54 131 53 
13 55 47 119 59 0 
^Prior to lead or sodium acetate exposure. 
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Table 65. Experiment 1—Mean total basophil counts (per 
cubic mm) of groups exposed to lead or sodium 
acetate i.p. 
Group 
Week 6 7 8^ 9^ 10 
(control) 
0^ 0 297 0 0 41 
1 149 199 222 0 83 
2 0 120 65 85 142 
3 46 181 107 129 229 
4 69 0 96 0 0 
5 283 114 0 0 78 
6 0 74 0 0 0 
7 0 0 0 0 151 
8 252 143 334 0 0 
9 79 76 0 0 208 
10 352 122 0 0 198 
11 0 207 0 287 199 
12 54 318 0 0 59 
13 598 204 0 0 0 
Values for weeks 4 and 5 are means from 2 pigs, and 
values for weeks 6-13 are from 1 pig only. 
^Prior to lead or sodium acetate exposure. 
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Table 65. Experiment 1—Mean plasma protein;fibrinogen ratios 
of groups exposed to lead or sodium acetate orally. 
Group 
Week 1 2 3 4 5 
(control) 
0^ 20 22 21 34 20 
1 15 20 18 22 19 
2 25 21 28 33 20 
3 30 25 2 4  44 16 
4 43 41 34 40 16 
5 42 29 31 29 22 
6 29 25 23 40 28 
7 28 31 27 27 29 
8 19 29 27 25 24 
9 39 30 26 39 44 
10 33 60 37 39 31 
11 64 59 60 63 56 
12 52 72 40 37 66 
13 20 27 22 29 35 
^Prior to lead or sodium acetate exposure. 
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Table 67. Experiment 1—Mean plasma protein: fibrinogen 
ratios of groups exposed to lead or sodium 
acetate i.p. 
Group 
Week 6 7 8^ 9^ 10 
(control) 
o" 20 20 21 32 29 
1 14 18 21 16 17 
2 18 13 31 31 64 
3 31 25 40 30 39 
4 19 21 35 19 19 
5 17 23 15 23 28 
6 35 26 66 10 26 
7 37 31 42 21 24 
8 18 45 34 20 38 
9 39 56 38 32 28 
10 30 45 27 31 58 
11 40 70 71 34 29 
12 54 54 65 22 72 
13 39 56 72 18 20 
^Values for weeks 4 and 5 are means from 2 pigs, and 
values for weeks 6-13 are from 1 pig only. 
^Prior to lead or sodium acetate exposure. 
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Table 68. Experiment 1—Mean total serum protein concentra­
tions (g/dl) of groups exposed to lead or sodium 
acetate orally. 
Group 
Week 12 3 4 5 
(control) 
0^ 6.0 5.9 6.0 6.3 6.3 
1 6.1 6.0 5.5 5.8 5.9 
2 6.3 6.5 6.1 6.3 6.2 
3 6.6 6.7 6.4 6.4 6.6 
5 6.2 6.7 5.9 6.4 6.3 
7 6.1 6.8 5.9 6.0 6.2 
8 7.1 6.2 5.9 6.2 6.4 
n V C 1 5.6 6 -1 6: 3 f>. 5 
10 6.4 7.1 5.9 6.2 6.9 
11 6.3 7.0 5.9 6.2 6.6 
12 6.1 7.1 5.9 6.1 6.5 
13 6.2 6.7 5.8 6.4 6.5 
^Prior to lead or sodium acetate exposure. 
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Table 69. Experiment 1—Mean total serum protein concentra­
tions (g/dl) of groups exposed to lead or sodium 
acetate i.p. 
Group 
Week 6 7 8^ 9^ 10 
(control) 
0^ 6.5 6.3 6. 2 6.3 6.3 
1 6.1 6.3 5. 0 6.3 6.1 
2 6.8 6.6 6.5 6.0 6.3 
3 6.4 6. 6 6.6 6.3 6.7 
5 6.0 6.3 6.4 6.2 6.6 
7 6.2 6.3 — — — 5.9 6.1 
8 6.2 6.6 6.7 5.7 6.8 
9 6.3 6.6 7 = 3 6-1 6.3 
10 6.4 6.7 7.7 6.0 6.7 
11 6.5 6.9 7.0 6.6 7.1 
12 6.3 6.5 6.4 6.3 7.1 
13 6.2 6.6 7.1 7.0 6.4 
^alue for week 5 is a mean from 2 pigs, and values 
for weeks 7-13 are from 1 pig only. 
^Prior to lead or sodium acetate exposure. 
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Table 70. Experiment 1—Mean serum albumin concentrations 
(g/dl) of groups exposed to lead or sodium acetate 
orally. 
Group 
Week 1 2 3 4 5 
(control) 
0^ 2.31 2.15 2.38 2.36 2.47 
1 2.56 2.66 2. 36 2.35 2.23 
2 2.67 2.66 2.40 2.16 2.49 
3 2.53 2.73 2.43 2.11 2.54 
5 2.52 2.63 2.32 2.29 2.68 
7 2.53 3.20 2.44 2.28 2.78 
8 2.90 3.06 2.38 2.56 2.58 
2.51 2.81 2.32 2 = 20 2.74 
10 2.81 3.36 2.51 2.47 3.00 
11 2.85 3.15 2.08 2.12 2.90 
12 2.70 2.78 2.36 2.37 2.79 
13 2.60 3.01 2.24 2.35 2.69 
^Prior to lead or sodium acetate exposure. 
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Table 71. Experiment 1—Mean serum albumin concentrations 
(g/dl) of groups exposed to lead or sodium 
acetate i.p. 
Group 
Week 6 7 8^ 9^ 10 
(control) 
0^ 2.56 2.26 2.09 2.38 2.41 
1 2.21 2.29 1.97 2.22 2. 35 
2 2.64 2.19 2.36 1.98 2.51 
3 2.52 2.27 2.12 1.95 2.62 
5 2.21 1.93 1.85 1.90 2.56 
7 2.33 2.00 —  — —  —  1.66 2.37 
8 2.26 1.97 2.26 1.65 3.15 
Q 2. 55 2.10 2.11 1.77 2.45 
10 3.06 2.53 2.62 1.76 2.97 
11 2.56 2.29 1.95 1.70 2.90 
12 2.12 2.42 1.96 1.58 2.81 
13 2.42 2.38 2.31 2.12 2.46 
^Value for week 5 is a mean from 2 pigs, and values 
for weeks 7-13 are from 1 pig only. 
^Prior to lead or sodium acetate exposure. 
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Table 72. Experiment 1—Mean serum alpha^ globulin concentra­
tions (g/dl) of groups exposed to lead or sodium 
acetate orally. 
Group 
Week 12 3 4 5 
(control) 
0^ 0.30 0.29 0.22 0.28 0.26 
1 0.20 0.18 0.13 0.17 0.38 
2 0.18 0.26 0.28 0.25 0.28 
3 0.32 0.35 0.29 0.25 0.31 
5 0.23 0.19 0.18 0.22 0.14 
7 0.33 0.19 0.17 0.32 0.23 
8 0.46 0.18 0.15 0.12 0.28 
O G. 2*1 0.2 0 0= 31 0. 7 â 0.21 
10 0.30 0.22 0.24 0.23 0.28 
11 0.18 0.27 0.26 0.29 0.22 
12 0.19 0.27 0.22 0.24 0.16 
13 0.26 0.22 0.09 0.26 0.30 
^Prior to lead or sodium acetate exposure. 
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Table 73. Experiment 1—Mean serum alpha^^ globulin concentra­
tions (g/dl) of groups exposed to lead or sodium 
acetate i.p. 
Group 
Week 6 7 8^ 9^ 10 
(control) 
0^ 0.28 0.32 0.32 0.26 0.29 
1 0.21 0.27 0.29 0.26 0.21 
2 0.18 0.24 0.29 0.24 0.22 
3 0.22 0.25 0.27 0.28 0.20 
5 0.19 0.18 0.33 0.20 0.18 
7 0.24 0.26 — — — — 0.26 0.39 
8 0.26 0.30 0.22 0.20 0.17 
Q 0.28 0, / 7 0.33 0 • 34 0.19 
10 0.18 0.24 0.15 0.12 0.28 
11 0.23 0.33 0.19 0.13 0.33 
12 0.25 0.19 0.36 0.13 0.24 
13 0.18 0.21 0.29 0.31 0.24 
^Value for week 5 is a mean from 2 pigs, and values for 
weeks 7-13 are from 1 pig only. 
^Prior to lead or sodium acetate exposure. 
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Table 74. Experiment 1—Mean serum alpha2 globulin concentra­
tions (g/dl) of groups exposed to lead or sodium 
acetate orally. 
Group 
Week 1 2 3 4 5 
(control) 
0^ 1.11 1.21 1.16 1.35 1.25 
1 1.08 1.10 0.91 1.16 0.96 
2 1.01 1.10 0.97 1.24 1.02 
3 1.08 1.14 1.04 1.09 1.22 
5 0.91 1.24 0.82 1.06 1.07 
7 0.82 1.02 0.82 0.91 0.95 
8 0.88 0.83 0.66 0.95 0.97 
9 0.94 1.06 0.84 1.04 1 = 00 
10 0.94 1.08 0.77 0.90 1.01 
11 1.04 1.08 0.89 0.98 1.10 
12 0.99 1.28 0.83 0.92 1.14 
13 0.94 1.00 0.97 1.03 0.97 
^Prior to lead or sodium acetate exposure. 
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Table 75. Experiment 1—Mean serum alphag globulin concentra­
tions (g/dl) of groups exposed to lead or sodium 
acetate i.p. 
Group 
Week 6 7 8^ 9^ 10 
(control) 
0^ 1.19 1.16 1.24 1.30 1.14 
1 1.23 1.26 1.20 1.33 1.05 
2 1.29 1.26 1.02 1.22 0.99 
3 1.24 1.37 1.26 1.52 1.11 
5 1.20 1.14 0.94 1.08 1.06 
7 0.93 0.94 — — — — 1.14 0.92 
8 0.98 0.91 0.93 1.02 0.90 
5 1.02 1.04 1.05 1-51 0 • 96 
10 0.98 0.91 1.30 1.12 0.87 
11 1.10 0.97 1.26 1.40 1.12 
12 1.13 0.87 0.98 1.28 1.25 
13 1.03 1.00 0.45 1.36 0.99 
^Value for week 5 is a mean from 2 pigs, and values for 
weeks 7-13 are from 1 pig only. 
^Prior to lead or sodium acetate exposure. 
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Table 76. Experiment 1—Mean serum beta, globulin concentra­
tions (g/dl) of groups exposed to lead or sodium 
acetate orally. 
Group 
Week 12 3 4 5 
(control) 
0^ 0.30 0.30 0.25 0.18 0.29 
1 0.29 0.29 0.30 0.20 0.27 
2 0.34 0.31 0.34 0.31 0.32 
3 0.28 0.31 0.26 0.22 0.34 
5 0.40 0.34 0.47 0.28 0.27 
7 0.37 0.32 0.37 0.34 0.32 
8 0.58 0.31 0.65 0.30 0.39 
9 0.23 0.35 0.42 0.31 0,30 
10 0.35 0.37 0.32 0.35 0.35 
11 0.30 0.35 0.51 0.29 0.25 
12 0.31 0.32 0.40 0.39 0.27 
13 0.32 0.30 0.36 0.34 0.31 
^Prior to lead or sodium acetate exposure. 
196 
Table 77. Experiment 1—Mean serum beta, globulin concentra­
tions (g/dl) of groups exposed to lead or sodium 
acetate i.p. 
Group 
Week 6 7 8* 9* 10 
(control) 
0^ 0,34 0.29 0.37 0.29 0.41 
1 0.33 0.28 0.29 0.46 0.40 
2 0.38 0.41 0.34 0.37 0.37 
3 0.28 0.33 0.38 0.26 0.36 
5 0.35 0.38 0.48 0.42 0.40 
7 0.39 0.43 • 0.44 0.35 
8 0.45 0.42 0.53 0.46 0.38 
9 n. 4 8 0.37 0.73 0.42 0.36 
10 0.37 0.54 0.52 0.55 0.35 
11 0.35 0.37 0.44 0.43 0.41 
12 0.46 0.43 0.60 0.57 0.44 
13 0.34 0.34 0.77 0.46 0.38 
^Value for week 5 is a mean from 2 pigs, and values for 
weeks 7-13 are from 1 pig only. 
^Prior to lead or sodium acetate exposure. 
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Table 78. Experiment 1—Mean serum beta? globulin concentra­
tions (g/dl) of groups exposed to lead or sodium 
acetate orally. 
Group 
Week 1 2 3 4 5 
(control) 
0^ 0.89 0.91 0.80 0.84 0.83 
1 0.86 0.90 0.74 0.71 1.05 
2 0.85 0.82 0.76 0.84 0.89 
3 0.98 0.88 0.91 0.80 0.89 
5 0.89 1.01 0.77 0.87 1.00 
7 0.79 0.89 0.79 0.87 0.82 
8 0.88 0.82 0.77 0.86 0.83 
r> y 0 2° 0. BG 0.98 0,58 1 • 17 
10 0.97 1.06 0.77 0.79 1.00 
11 1.04 0.79 1.06 0.92 1.31 
12 1.08 1.44 1.05 1.14 1.21 
13 1.02 1.05 0.98 0.88 1.07 
^Prior to lead or sodium acetate exposure. 
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Table 79. Experiment 1—Mean serum beta2 globulin concentra 
tions (g/dl) of groups exposed to lead or sodium 
acetate i.p. 
Group 
Week 6 7 8* 9* 10 
(control) 
0^ 0.91 0.83 0.88 0.88 0.88 
1 0.86 0.86 0.93 0.89 0.80 
2 0.96 0.92 0.87 0.85 0.83 
3 0.84 0.85 0.94 0.85 0.82 
5 0.87 0.94 0.94 0.70 0.98 
7 0.88 0.81 — — — — 0.83 0.88 
8 0.84 0.95 0.87 0.72 0.80 
9 0.93 0.84 1 • 19 0.99 1.09 
10 0.79 0.79 1.12 1.00 0.99 
11 0.93 0.94 1.04 0.79 1.21 
12 1.02 1.05 0.89 1.12 1.28 
13 0.90 0.87 1.26 0.82 1.14 
^alue for week 5 is a mean from 2 pigs, and values for 
weeks 7-13 are from 1 pig only. 
^Prior to lead or sodium acetate exposure. 
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Table 80. Experiment 1—Mean serum gamma globulin concentra 
tions (g/dl) of groups exposed to lead or sodium 
acetate orally. 
Group 
Week 1 2 3 4 5 
(control) 
0^ 1.12 1.00 1.19 1.29 1.18 
1 1.10 0.83 1.09 1.24 0.95 
2 1.25 1.34 1.35 1.50 1.16 
3 1.36 1.24 1.50 1.89 1.30 
5 1.28 1.29 1.37 1.68 1.17 
7 1.29 1.14 1.27 1.24 1.14 
8 1.44 1.02 1.29 1.36 1.37 
3 1 n o X • ^  u 1.32 1.20 1.48 1.06 
10 1,00 1.01 1.27 1.48 1.23 
11 0.87 1.38 1.12 1.52 0.79 
12 0.80 1.01 1.07 1.00 0.92 
13 1.05 1.08 1.16 1.53 1.12 
^Prior to lead or sodium acetate exposure. 
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Table 81. Experiment 1—Mean serum gamma globulin concentra­
tions (g/dl) of groups exposed to lead or sodium 
acetate i.p. 
Group 
Week 6 7 8* 9a 10 
(control) 
0^ 1.17 1.40 1.26 1.15 1.16 
1 1.23 1.34 1.12 1.18 1.32 
2 1.31 1.54 1.42 1.33 1.35 
3 1.27 1.55 1.62 1.44 1.58 
5 1.21 1.69 1.81 1.90 1.39 
7 1.39 1.89 — — — — 1.56 1.24 
8 1.41 2.03 1.88 1.65 1.36 
Û 1.28 1.97 1.89 1.07 1=26 
10 1.02 1.66 1.98 1.46 1.21 
11 1.37 2.04 2.11 2.15 1.15 
12 1.18 1.51 1.61 1.62 1.12 
13 1.31 1.81 2.02 1.93 1.14 
^Value for week 5 is a mean from 2 pigs, and values for 
weeks 7-13 are from 1 pig only. 
^Prior to lead or sodium acetate exposure. 
201 
Table 82. Experiment 1—Mean serum albumin;globulin ratios 
of groups exposed to lead or sodium acetate orally. 
Group 
Week 1 2 3 4 5 
(control) 
0^ 0.63 0.61 0.66 0.52 0.65 
1 0.74 0.81 0.74 0.67 0.63 
2 0.74 0.70 0.65 0.53 0.68 
3 0.64 0.70 0.61 0.50 0.63 
5 0.68 0.65 0.65 0.57 0.74 
7 0.71 0.90 0.71 0.62 0.81 
8 0.68 0.96 0.68 0.72 0.68 
9 0.70 0.74 0.62 0.55 0.74 
10 0.80 0.94 0.74 0.69 0.78 
11 0.83 0.81 0.54 0.58 0.79 
12 0.80 0.64 0.67 0.64 0.76 
13 0.73 0.76 0.65 0.59 0.72 
^Prior to lead or sodium acetate exposure. 
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Table 83= Experiment 1—Mean serum albumin;globulin ratios 
of groups exposed to lead or sodium acetate i.p. 
Group 
Week 6 7 8* 9* 10 
(control) 
0^ 0.66 0.58 0.51 0.61 0.62 
1 0.58 0.57 0.52 0.55 0.63 
2 0.64 0.50 0.57 0.49 0.67 
3 0.66 0.52 0.48 0.45 0.65 
5 0.60 0.44 0.42 0.44 0.64 
7 0.62 0.47 0.39 0.64 
8 0.58 0.43 0.51 0.41 0.86 
9 0.59 0.47 0.41 0.41 0.63 
10 0.92 0.61 0.52 0.41 0.80 
11 0.65 0.50 0.38 0.35 0.69 
12 0.55 0.60 0.44 0.34 0.66 
13 0.65 0.59 0.48 0.43 0.64 
^alue for week 5 is a mean from 2 pigs, and values for 
weeks 7-13 are from 1 pig only. 
^Prior to lead or sodium acetate exposure. 
1 
3 
5 
8 
10 
12 
15 
17 
19 
21 
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Experiment 2—Mean body temperatures ( C) during 
the lead or sodium acetate-exposure period prior 
to Salmonella challenge. 
Group A 
(lead-exposed) 
Group B 
(control) 
Rep 1 Rep 2 Rep 3 Rep 1 Rep 2 Rep 3 
39.8 39-9 39.9 39.8 39.4 39.7 
40.0 40.0 39.9 39.9 39.9 39.6 
39.4 39.9 39.3 39.1 39.5 39.3 
39.1 39.4 39.3 39.4 39.4 39.3 
39.6 39.4 39.4 39.4 
39.4 39.7 39.6 39.4 
—  39.5 39.5 39.1 39.0 
: ^ • — 39.4 —  —  — —  39 = 0 
— — 
—  39.2 —  —  — —  38.7 
— mm mm mm f>w «M »» 39.0 mm » — = —. — — —. 39.2 
39.6 39.7 39.5 39.6 39.5 39.3 
1 
2 
3 
4 
5 
6 
7 
8 
y 
10 
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Experiment 2—Mean body temperatures ( C) following 
Salmonella challenge. 
Group A 
(lead-exposed) 
Group B 
(control) 
Rep 1 Rep 2 Rep 3 Rep 1 Rep 2 Rep 3 
39.9 39.9 40.3 39. 9 40.0 40.1 
39.6 39.8 39.1 39.9 39.8 39.4 
40.8 41.0 41.0 40.6 41.3 41.3 
40.5 40.9 40.6 40.4 41.5 40.5 
41.0 40.9 40.8 41.0 40.8 40.4 
40.3 40.6 40.2 40.9 40.9 40.1 
40.3 40.4 39.8 40.5 40.9 39.6 
39.5 40.1 40.0 40.0 40.6 40.2 
39.7 39.5 39. 8 33.8 A r\ 1 TKJ • M 39.5 
40.0 39.4 39.5 40.0 39.7 39.3 
40.2 40.2 40.1 40.3 40.6 40.0 
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Table 86. Experiment 2—Mean blood lead concentrations 
(ug/dl) during lead or sodium acetate exposure 
and following Salmonella challenge. 
Group A Group B 
(lead-exposed) (control) 
Day Rep 1 Rep 2 Rep 3 Rep 1 Rep 2 Rep ; 
Exposure 
0 4 5 4 9 5 6 
2 36 41 34 3 4 4 
4 39 38 35 1 1 2 
8 42 40 29 1 2 2 
15 42 37 - 5 2 
21 48 - - 2 
Post-challenge 
2 29 25 25 11 5 7 
S 17 16 18 3 3 2 
33 34 32 4 3 3 
^Day 0 omitted in calculating means. 
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Table 87. Experiment 2—Mean blood ALAD activities during 
lead or sodium acetate exposure and following 
Salmonella challenge. 
Group A Group B 
(lead-exposed) (control) 
Day Rep 1 Rep 2 Rep 3 Rep 1 Rep 2 Rep 3 
Exposure 
0 228.9 221.0 219.7 214.5 222.9 209.7 
2 56.2 55.0 48.6 208.2 223.2 194.2 
4 37.9 41.0 39.5 210.3 234.2 203.0 
8 59.8 59.0 58.2 246.2 252.6 226.6 
15 38.8 35.2 227.3 196.9 
21 14.5 152.3 
Post-challenge 
2 69.7 42.8 16.7 216.2 220.7 131.7 
9 35.4 25.3 16.0 126.2 180.8 129.6 
51.8 43.6 32.7 201.4 223.1 176.3 
^Day 0 omitted in calculating means. 
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Table 88. Experiment 2—Mean hematocrit percentages during 
lead or sodium acetate exposure and following 
Salmonella challenge. 
Group A 
(lead-exposed) 
Group B 
(control) 
Day Rep 1 Rep 2 Rep 3 Rep 1 Rep 2 Rep 3 
Exposure 
0 33 34 32 34 35 33 
8 33 33 32 31 32 32 
15 35 34 33 32 
21 — 33 33 
33 34 33 31 32 32 
Post-challenge 
2 34 33 32 31 32 33 
4 28 33 32 2 8  31 32 
9 26 2 9  30 25 28 29 
X 29 32 31 28 30 31 
^Day 0 omitted in calculating means. 
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Table 89. Experiment 2—Mean total leukocyte counts (per 
cubic mm) during lead or sodium acetate exposure 
and following Salmonella challenge. 
Group A Group B 
(lead-exposed) (control) 
Days Rep 1 Rep 2 Rep 3 Rep 1 Rep 2 Rep 3 
Exposure 
0 15,917 15,250 17,650 13,967 17,117 19,717 
8 16,033 17,000 18,417 19,783 18,633 22,033 
15 17,633 19,900 19,283 22,650 
21 20,267 ————— 22,550 
3^ 16,033 17,316 19,528 19,783 18,958 22,411 
Post-
CJidllfciiKje 
2 27,033 20,167 28,033 33,017 25,783 27,000 
4 22,817 16,200 21,650 20,767 19,300 17,917 
9 20,633 16,967 22,100 18,883 19,240 21,317 
X 23,434 17,778 23,928 24,222 21,441 22,078 
^Day 0 omitted in calculating means. 
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Table 90. Experiment 2—Mean total segmented neutrophil 
counts (per cubic mm) during lead or sodium 
acetate exposure and following Salmonella challenge. 
Group A Group B 
(lead-exposed) (control) 
Day Rep 1 Rep 2 Rep 3 Rep 1 Rep 2 Rep 3 
Exposure 
0 5,220 5,614 7,016 5,182 6,158 8,068 
8 4,032 4,464 4,065 7,117 6,098 8,487 
15 6,638 4,800 7,210 9,275 
21 — — — — — — — 6,114 — — — — — — — — 7,775 
4,03? 5 551 4,993 7,117 6,654 8,512 
Post-challenae 
2 9,558 2,179 14,265 11,434 4,024 10,772 
4 5,711 3,220 6,329 3,355 3,992 3,203 
9 5,781 5,527 7,001 5,831 5,459 7,609 
X 7,017 3,642 9,198 6,873 4,492 7,195 
^Day 0 omitted in calculating means. 
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Table 91. Experiment 2—Mean total band neutrophil counts 
(per cubic mm) during lead or sodium acetate 
exposure and following Salmonella challenge. 
Group A Group B 
(lead-exposed) (control) 
Day Rep 1 Rep 2 Rep 3 Rep 1 Rep 2 Rep 3 
Exposure 
0 27 27 161 140 105 57 
8 210 27 281 89 160 110 
15 — —  —  288 848 — 916 790 
21 — 1,783 1,836 
X* 210 158 971 89 538 912 
Post-challenge 
2 8,394 10,354 5,589 9,498 13,353 10,412 
4 8,181 5,080 5,066 7,238 6,446 5,809 
9 4,317 3,516 7,532 5,215 5,895 9,564 
X 6,964 6,317 6,396 7,317 8,565 8,595 
^Day 0 omitted in calculating means. 
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Table 92. Experiment 2—Mean total lymphocyte counts (per 
cubic mm) during lead or sodium acetate exposure 
and following Salmonella challenge. 
Group A Group B 
(lead-exposure) (control) 
Day Rep 1 Rep 2 Rep 3 Rep 1 Rep 2 Rep 3 
Exposure 
0 10,136 9,223 10,087 8,221 10,402 11,340 
8 11,423 12,222 13,102 12,266 11,826 13,112 
15 10,329 13,547 10,510 12,106 
21 — — — — — —  — — 11,832 — — — — — —  — — — — — —  12,697 
11,423 11,276 12,827 12,266 11,168 12,638 
Post-
Cl i â x Ic ily c 
2 8 , 3 9 2  7 , 6 0 3  8,180 11,290 8,075 5,778 
4 8.638 7,479 8 , 7 9 7  9,735 8,196 8,834 
9 9 , 9 8 5  7,555 7,219 7,405 7,469 3,937 
9 f 005 7,546 3,065 9,477 7.-913 6,183 
^Day 0 omitted in calculating means. 
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Table 93. Experiment 2—Mean total eosinophil counts (per 
cubic mm) during lead or sodium acetate exposure 
and following Salmonella challenge. 
Exposure 
0 390 248 243 323 364 94 
8 267 215 590 186 370 179 
15 — 342 705 — 584 479 
21 508 —— 335 
267 278 601 186 477 331 
Post-challenge 
2 173 30 0 164 330 0 
4 167 337 458 314 546 71 
9 346 370 348 393 454 207 
X 229 246 403 290 443 93 
^Day 0 omitted in calculating means. 
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Table 94. Experiment 2—Mean total monocyte counts (per 
cubic mm) during lead or sodium acetate exposure 
and following Salmonella challenge. 
Group A Group B 
(lead-exposed) (control) 
Day Rep 1 Rep 2 Rep 3 Rep 1 Rep 2 Rep 3 
Exposure 
0 143 138 143 125 87 231 
8 102 272 443 124 120 146 
15 37 0 — 28 0 
21 29 — — 0 
102 154 157 124 74 49 
Post-challenge 
2 516 0 0 631 0 38 
4 154 85 0 125 65 0 
9 43 0 0 0 0 0 
X 238 28 0 252 22 13 
^Day 0 omitted in calculating means. 
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Table 95. Experiment 2—Mean plasma protein:fibrinogen ratios 
during lead or sodium acetate exposure and 
following Salmonella challenge. 
Group A Group B 
(lead-exposed) (control) 
Day Rep 1 Rep 2 Rep 3 Rep 1 Rep 2 Rep 3 
Exposure 
0 20 16 16 16 18 15 
8 24 26 26 29 22 24 
15 22 25 — — 18 21 
21 27 — — 21 
24 24 26 29 20 22 
Post-challenge 
2 15 11 14 11 11 12 
4 11 42 14 10 52 16 
9 13 15 14 11 17 15 
X 13 23 14 11 27 14 
^Day 0 omitted in calculating means. 
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Table 96. Experiment 2—Mean total servmi protein concentra­
tions (g/dl) during lead or sodium acetate 
exposure and following Salmonella challenge. 
Exposure 
0 5.5 6.0 5.8 5.4 5.7 5.8 
2 5.6 6.2 6.0 5.6 6.2 6.0 
4 6.1 6.1 6.0 5.5 5.8 6.0 
8 6.4 6.5 6.4 5.9 6.2 6.1 
15 6.6 6.5 6.3 6.4 
21 6.4 6.4 
G.G C.4 6.3 5.7 5.1 6.2 
Post-challenge 
2 6.2 7.2 6.8 6.1 6.9 7.0 
4 6.2 7.3 6.9 6.4 6.9 7.0 
7 6.3 6.8 7.1 6.8 6.5 7.2 
9 6.7 6.6 6.8 6.6 6.9 7.1 
X 6.4 7.0 6.9 6.5 6.8 7.1 
^Day 0 omitted in calculating means. 
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Table 97. Experiment 2—Mean serum albumin concentrations 
(g/dl) during lead or sodium acetate exposure and 
following Salmonella challenge. 
Group A Group B 
(lead-exposed) (control) 
Day Rep 1 Rep 2 Rep 3 Rep 1 Rep 2 Rep 3 
Exposure 
0 2.02 2.24 2.17 2.06 2.10 2.11 
2 2.05 2.24 2.16 2.15 2.25 2.18 
4 2.26 2.26 2.17 2.07 2.12 2.20 
8 2.27 2.34 2.28 2.13 2.17 2.06 
15 2.51 2.24 2.22 2.13 
21 2.18 ———— 2.21 
X"* 2.19 2.34 2.21 2.11 2.19 2.16 
Post-challenge 
2 2.09 2.23 2.13 1.88 2.09 2.09 
4 1.96 2.20 2.00 1.87 1.98 1.99 
7 1.87 2.10 1.99 1.87 1.90 2.03 
9 2.01 1.96 1.90 1.94 2.07 1.96 
X 1.98 2.12 2.00 1.89 2.01 2.02 
^Day 0 omitted in calculating means. 
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Table 98. Experiment 2—Mean serum alpha, globulin concentra­
tions (g/dl) during lead or sodium acetate exposure 
and following Salmonella challenge. 
Group A Group B 
(lead-exposed) (control) 
Day Rep 1 Rep 2 Rep 3 Rep 1 Rep 2 Rep 3 
Exposure 
0 0.30 0.36 0 = 35 0.34 0.37 0.38 
2 0.31 0.34 0.40 0.31 0.36 0.37 
4 0.32 0.29 0.38 0.31 0.30 0.37 
8 0.33 0.34 0.36 0.31 0.30 0.37 
15 0.28 0.37 — —  — —  0.32 0.40 
21 0.34 —  —  — —  —  —  —  —  0.35 
rrâ 
A  A 3 1 0.37 0.31 0-32 0.37 
Post-challenge 
2 0.29 0.37 0.35 0.41 0.36 0.41 
4 0.30 0.37 0.38 0.37 0.30 0.39 
7 0.29 0 9 30 0.35 0.31 0.22 0.39 
9 0.24 0.27 0.40 0.30 0.27 0.35 
X 0.28 0.33 0.37 0.35 0.29 0.38 
^Day 0 omitted in calculating means. 
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Table 99. Experiment 2—Mean serum alpha2 globulin concentra­
tions (g/dl) during lead or sodium acetate exposure 
and following Salmonella challenge. 
Group A Group B 
(lead-exposed) (control) 
Day Rep 1 Rep 2 Rep 3 Rep 1 Rep 2 Rep 3 
Exposure 
0 1.19 1.23 1.21 
2 1.21 1.30 1.22 
4 1.28 1.24 1.19 
8 1.35 1.31 1.21 
15 —  —  — —  1.13 1.10 
21 — = ». — M •«« M 1.20 
1.28 1.24 1 1 n 
Post-challenge 
2 1.44 1.66 1.47 
4 1.55 1.73 1.66 
7 1.64 1.6 3 1.75 
9 1.69 1.61 1. 4 9  
X 1. 58 1.66 1.59 
^Day 0 omitted in calculating means. 
1.08 1.16 1.16 
1.15 1.28 1.20 
1.12 1.17 1.20 
1.23 1.21 1.26 
—  — — —  1.16 1.19 
—  —  —  1.14 
1.21 
1.36 1.63 1.56 
1.70 1.80 1.74 
1.90 1.77 1.75 
1.81 1.76 1.55 
1.69 1.74 1.65 
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Table 100. Experiment 2—Mean serum beta^ globulin concentra­
tions (g/dl) during lead or sodium acetate 
exposure and following Salmonella challenge. 
Group A Group B 
(lead-exposed) (control) 
Day Rep 1 Rep 2 Rep 3 Rep 1 Rep 2 Rep 3 
Exposure 
0 0 . 4 2  0 . 4 6  0 = 43 0,42 0.40 0.42 
2 0.43 0.47 0.45 0.38 0.46 0.42 
4 0.48 0.45 0.49 0.38 0.44 0.40 
8 0.46 0.49 0.57 0.42 0.48 0.50 
15 —  0.43 0.52 —  —  —  —  0.43 0.49 
21 — —  — —  —  — — —  0.55 —  —  — —  —  — —  —  0.44 
wO. 
A  
r\ A /T U • 1 u 0.45 C 52 n  Q O  0.45 0.45 
Post-challenge 
2 0.51 0.60 0.64 0.53 0.54 0.62 
4 0.55 0.74 0.71 0.65 0.70 0.70 
7 0.58 0.60 0.70 0.90 0 • 66 0.70 
9 0 . 6 8  0.58 0.72 0.65 0.68 0.82 
X 0.58 0.63 0.69 0.66 0.64 0.71 
^Day 0 omitted in calculating means. 
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Table 101. Experiment 2—Mean serum beta2 globulin concentra­
tions (g/dl) during lead or sodium acetate 
exposure and following Salmonella challenge. 
Group A Group B 
(lead-exposed) (control) 
Day Rep 1 Rep 2 Rep 3 Rep 1 Rep 2 Rep 3 
Exposure 
0 0.84 0. 86 0.86 0.75 0.80 0.92 
2 0.85 0.86 0.94 0.71 0.85 0.92 
4  0.87 0.89 0.88 0.76 0.80 0.87 
8 0.97 0.93 0.90 0.79 0.82 0.87 
15 — 0.96 0.98 —  —  — —  0.91 0.91 
21 —  —  — —  0.94 "" 0.98 
0.50 C. 91 0.93 0.75 0.91 
Post-challenge 
2 0.81 0.98 0.95 0.86 0.92 0.99 
4 0.84 0.92 0.91 0.78 0.81 0.90 
7 0.83 0.76 0.87 0.78 0 = 72 0.87 
9 0.82 0.76 0. 83 0.77 0.76 0.83 
X 0.82 0.86 0.89 0.80 0.76 0.90 
^Day 0 omitted in calculating means. 
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Table 102. Experiment 2—Mean serum gamma globulin concentra­
tions (g/dl) during lead or sodium acetate 
exposure and following Salmonella challenge. 
Group A Group B 
(lead-exposed) (control) 
Day Rep 1 Rep 2 Rep 3 Rep 1 Rep 2 Rep 3 
Exposure 
0 0 . 7 5  0 . 8 6  0 . 7 8  0.77 0.90 0.79 
2 0.78 0.92 0.84 0.87 0.99 0.86 
4 0.86 0.97 0.88 0.87 1.02 0.99 
8 1.02 1.12 1.08 0.99 1.17 1.05 
15 —  —  — —  1 . 2 8  1.25 —  1.27 1.31 
21 —  — — —  — — — —  1.23 — — — —  1.29 
77a A .  A  0  r v  w  •  U  V  1 07 1. OS 0.91 1.11 1.10 
Post-challenge 
2 1.10 1.34 1.22 1.09 1.35 1.30 
4 1 . 0 2  1.36 1.26 1.06 1.31 1.25 
7 1.14 1.40 1  39 1.00 1.31 1.43 
9 1.28 1.44 1. 48 1.17 1.40 1.56 
X 1.14 1.38 1.34 1.08 1.34 1.39 
^Day 0 omitted in calculating means. 
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Table 103. Experiment 2—Mean serum albumin:globulin ratios 
during lead or sodium acetate exposure and 
following Salmonella challenge. 
Group A Group B 
(lead-exposed) (control) 
Day Rep 1 Rep 2 Rep 3 Rep 1 Rep 2 Rep 3 
Exposure 
0 0.58 0.60 0.60 0.62 0,58 0.57 
2 0.57 0.58 0.56 0.64 0.57 0.58 
4 0,59 0.59 0.57 0.60 0.57 0.58 
8 0.55 0.56 0.55 0.57 0.54 0.51 
15 0.61 0.53 0.54 0.50 
21 ——— 0.51 0.53 
0.57 0.58 0.54 0.60 0.5S 0.54 
Post-challenge 
2 0.50 0.45 0.46 0.44 0.44 0.43 
4 0.46 0.43 0.41 0.42 0.40 0.40 
7 0.36 0.44 0.40 0.34 0.41 0.40 
9 0.43 0.42 0.39 0.41 0.43 0.38 
X 0.44 0.44 0.42 0.40 0.42 0.40 
^Day 0 omitted in calculating means. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
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Experiment 3—Mean body temperatures ( C) during 
the lead or sodium chloride-exposure period prior 
to Salmonella challenge (day 15). 
Group 
A B C 
(control) 
39.2 39.1 39.0 
39.1 39.6 39.3 
39.2 38.9 39.6 
39.4 39.3 39.5 
39.5 39.4 39.7 
39.5 39.3 40.0 
39.5 39.8 39.4 
39.7 39.8 39.8 
39.9 39.8 39.7 
39.8 39.8 39.6 
39.7 39.6 39.1 
39.8 39.4 39.1 
39.7 39.3 39=2 
40.2 39.3 39.1 
39.7 39.3 38.8 
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Table 105. Experiment 3—Mean body temperatures (°C) 
following Salmonella challenge (day 15). 
Group 
Day A B C 
(control) 
16 39.7 39.1 38.7 
17 39.9 39.3 38.7 
18 40.6 41.1 40.7 
19 40.4 40.9 41.1 
20 39.8 40.2 40.3 
21 40.1 40.1 40.7 
22 39.8 40.4 40.0 
23 40.2 41.2 40.2 
24 40.1 40.9 oo n 
25 39.3 41.2 39.8 
26 39.6 39.5 40.0 
27 39.3 40.0 39.9 
28 38.9 —  — —  —  39.9 
29 39.6 39.0 
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Table 106. Experiment 3—Mean blood lead concentrations 
(ug/dl) during lead or sodium chloride exposure 
and following Salmonella challenge (day 15). 
Group 
Day A 
(control) 
B C 
1 2^ 2^ 
6 3 98 — — 
8 12 118 9^ 
13 3 107 92 
15 1 97 86 
21 5 26 24 
^Prior to lead or sodium chloride exposure. 
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Table 107. Experiment 3—Mean blood ALAD activities during 
lead or sodium chloride exposure and following 
Salmonella challenge (day 15). 
Group 
Day A 
(control) 
B C 
1 109.8^ 112.8* No collection 
6 129.9 20.2 No collection 
8 124.2 16.4 127.1* 
13 136.4 14.9 23.9 
15 135.6 17.1 25.7 
21 97.2 9.0 14.2 
^Prior to lead or sodium chloride exposure. 
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Table 108. Experiment 3—Mean blood hemoglobin concentrations 
(g/dl) during lead or sodium chloride exposure and 
following Salmonella challenge (day 15). 
Group 
Day A 
(control) 
B C 
Lead Expos. 
1 10-6^ 
rd 
C
O
 o
 
1—1 
10.3^ 
6 9.2 9.5 00
 
00
 
8 8.3 8.3 8.4 
13 8.7 8.1 
00 
15 8.0 7.7 7.3 
Post-Inoc. 
17 G.5 CO
 
? .  y  
18 7.9 7 . 8  7 . 3  
20 8 . 3  7.8 6.8 
22 8.4 6 . 8  7,2 
24 8.3 6.9 7.1 
^Prior to lead or sodium chloride exposure. 
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Table 109. Experiment 3—Mean hematocrit percentages during 
lead or sodium chloride exposure and following 
Salmonella challenge (day 15). 
Day-
Group 
A 
(control) 
B C 
Lead Expos. 
1 33^ 34^ 33^ 
6 29 31 29^ 
8 27 29 27 
13 28 28 26 
15 27 26 26 
Post-Inoc. 
17 27 28 27 
18 27 29 26 
20 29 27 24 
22 29 25 26 
2 4  30 25 26 
^Prior to lead or sodium chloride exposure. 
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Table 110. Experiment 3—Mean total red blood cell counts 
X 10^ (per cubic mm) during lead or sodium 
chloride exposure and following Salmonella 
challenge (day 15). 
Group 
Day A B C 
(control) 
Exposure 
1 4.8^ 5.1* 5.2* 
6 5.6 6.0 6.0* 
8 5.0 4.8 5.0 
13 4.6 5.4 4.8 
15 4.8 4.9 4.7 
Post-challenge 
17 5.4 5.8 5.6 
18 4.3 5.2 5.1 
20 5.2 5.1 4.6 
22 5.3 4.6 4.8 
24 5.5 4.8 4.8 
*Prior to lead or sodium chloride exposure. 
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Table 111. Experiment 3—Mean MCVs (fl) during lead or sodium 
chloride exposure and following Salmonella 
challenge (day 15). 
Group 
Day A B C 
(control) 
Exposure 
1 68.5^ 66.8^ 63.5* 
6 51.4 51.5 48.0^ 
8 55.5 61.3 54.8 
13 61.4 51.5 55.8 
15 58.0 53.7 54.5 
Post-challenge 
17 50.7 50.0 49.0 
18 63.0 55.5 51.1 
20 55.5 53.2 53.1 
22 54.9 55.2 53.7 
24 53.9 53.5 53.6 
^Prior to lead or sodium chloride exposure. 
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Table 112. Experiment 3—Mean MCHCs (g/dl) during lead or 
sodium chloride exposure and following Salmonella 
challenge (day 15). 
Group 
Day A B C 
(control) 
Exposure 
1 32.1^ 31.8^ 31.4^ 
6 32.2 30.5 30.8^ 
8 30.9 28.5 30.6 
13 30.8 29.4 29.6 
15 30.2 29.4 28.2 
Post-challenge 
17 30.8 30.0 23.1 
18 29.3 27.4 28.2 
20 29.2 28.5 28.3 
22 28.6 27.1 27.9 
24 28.1 27.7 27.3 
^Prior to lead or sodium chloride exposure. 
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Table 113. Experiment 3—Mean MCHs (pg) during lead or sodium 
chloride exposure and following Salmonella 
challenge (day 15). 
Group 
Day A B C 
(control) 
Exposure 
1 22.1^ 21,2^ 19.6^ 
6 16.6 15.7 14.5 
8 16.9 17.2 16.6 
13 18.7 15.0 16.4 
15 17.0 15.7 15.5 
Post-challenge 
17 15.7 14.4 14.2 
18 18.4 15.2 14.3 
20 16.0 15.1 15.0 
22 15.6 14.8 15.0 
24 15.0 14.2 14.6 
^Prior to lead or sodium chloride exposure. 
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Table 114. Experiment 3—Mean total leukocyte counts (per 
cubic mm) during lead or sodium chloride exposure 
and following Salmonella challenge (day 15). 
Group 
Day A B C 
(control) 
Exposure 
1 17,750^ 16,500^ 17,825^ 
6 20,300 22,575 21,876^ 
8 16,025 18,288 17,175 
13 20,375 24,125 22,288 
15 21,838 21,688 17,925 
Post-challenge 
17 30,062 /A;APR 24,588 
18 24,800 30,612 24,438 
20 21,738 17,557 13,062 
22 30,033 20,100 18,243 
24 36,280 21,467 24,533 
^Prior to lead or sodium chloride exposure. 
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Table 115. Experiment 3—Mean total segmented neutrophil 
counts (per cubic mm) during le^d or sodium 
chloride exposure and following Salmonella 
challenge (day 15). 
Day 
Group 
A 
(control) 
B C 
Exposure 
1 9,757^ 10,712" 8,069^ 
6 11,472 12,876 12,675^ 
8 8,315 9,514 9,550 
13 11,332 11,363 11,738 
15 12,407 11,097 9,833 
Post-challenge 
17 15,681 14,310 10,270 
18 5,644 10,776 9,704 
20 4,272 1,138 878 
22 8,390 1,825 2,192 
24 14,093 1,498 4,989 
^Prior to lead or sodium chloride exposure. 
235 
Table 116. Experiment 3—Mean total band neutrophil counts 
(per cubic mm) during lead or sodium chloride 
exposure and following Salmonella challenge 
(day 15). 
Group 
Day ABC 
(control) 
Exposure 
1 1,003" 1,291^ W28* 
6 836 571 751^ 
8 425 1,212 454 
13 445 0 192 
15 232 27 0 
Post-challenge 
17 4,105 623 286 
18 10,602 13,992 8,050 
20 8,679 9,810 6,407 
22 8,383 13,320 9,110 
24 8,871 14,623 13,070 
^Prior to lead or sodium chloride exposure. 
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Table 117. Experiment 3—Mean total lymphocyte counts (per 
cubic mm) during lead or sodium chloride exposure 
and following Salmonella challenge (day 15). 
Group 
Day ABC 
(control) 
Exposure 
1 6,335^ 4,337* 8,639* 
6 7,702 8,025 7,855* 
8 7,399 7,119 6,785 
13 8,422 12,518 10,140 
15 8,951 10,132 7,915 
Post-challenge 
17 10,070 11,212 13,428 
18 8,173 5,510 6,519 
20 8,253 6,552 5,627 
22 12,451 4,895 6,674 
24 12,914 4,838 6,315 
*Prior to lead or sodium chloride exposure. 
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Table 118. Experiment 3—Mean total eosinophil counts (per 
cubic mm) during lead or sodium chloride exposure 
and following Salmonella challenge (day 15) . 
Group 
Day A 
(control) 
B C 
Exposure 
1 281^ 55^ 112^ 
6 264 746 197^ 
8 250 333 296 
13 175 243 153 
15 248 431 176 
Post-challenge 
17 282 Ann -3 U V 4SI 
18 122 0 18 
20 206 0 134 
22 456 0 177 
24 340 0 87 
^Prior to lead or sodium chloride exposure. 
Table 119. Experiment 3—Mean total monocyte counts (per 
cubic mm) during lead or sodium chloride exposure 
and following Salmonella challenge (day 15). 
Group 
Day A 
(control) 
B C 
Exposure 
1 329^ 84^ 196^ 
6 0 197 269^ 
8 14 131 77 
13 0 0 0 
15 0 0 0 
Post-challenge 
1 n 4 -1S 25 C 28 
18 258 0 168 
20 286 78 0 
22 352 120 89 
24 63 449 73 
^Prior to lead or sodium chloride exposure. 
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Table 120. Experiment 3—Mean plasma protein:fibrinogen 
ratios during lead or sodium chloride exposure 
and following Salmonella challenge (day 15). 
Group 
Day A B C 
(control) 
Exposure 
1 40.3^ 47.0^ 38.6^ 
6 28.8 28.1 28.5^ 
8 27.3 39.2 19.5 
13 26.0 32.3 30.0 
15 18.4 39.5 35.3 
Post-challenge 
17 20:0 38:7 41:6 
18 16.9 34.7 33.9 
20 28.4 28.0 21.0 
22 17.1 14.0 10.0 
24 22.8 14.9 15.7 
^Prior to lead or sodium chloride exposure. 
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Table 121. Experiment 3—Mean total serum protein concentra­
tions (g/dl) during lead or sodium chloride 
exposure and following Salmonella challenge 
(day 15). 
Group 
Day A B 
(control) 
Exposure 
6 4.4 4.6 4.4 
13 4.8 4.2 4.4 
Post-challenge 
17 5.5 5.2 5.2 
20 5.3 4.8 4.6 
22 5.2 4.6 4.4 
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Table 122. Experiment 3—Mean serum albumin concentrations 
(g/dl) during lead or sodium chloride exposure 
and following Salmonella challenge (day 15). 
Group 
Day A B 
(control) 
Exposure 
6 1.42 1.60 1.46 
13 1.44 1.38 1.46 
Post-challenge 
17 1.61 1.74 1.78 
20 1.34 1.35 1.42 
22 1.39 1.28 1.16 
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Table 123. Experiment 3—Mean serum alpha globulin concentra­
tions (g/dl) during lead or sodium chloride 
exposure and following Salmonella challenge 
(day 15). 
Group 
Day A B 
(control) 
Exposure 
6 1.60 1.55 1.62 
13 1.68 1.28 1.45 
Post-challenge 
17 2.05 1.58 1.58 
20 2.24 1.63 1.57 
22 2.03 1.65 1.65 
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Table 124. Experiment 3—Mean serum beta globulin concentra­
tions (g/dl) during lead or sodium chloride 
exposure and following Salmonella challenge 
(day 15). 
Group 
Day A B 
(control) 
Exposure 
6 0.70 0.79 0.76 
13 0.83 0.73 0.76 
Post-challenge 
17 0.88 0.89 0.82 
20 0.84 0.82 0.81 
22 0.87 0.77 0.74 
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Table 125. Experiment 3—Mean serum gamma globulin concentra­
tions (g/dl) during lead or sodium chloride 
exposure and following Salmonella challenge 
(day 15) . 
Group 
Day A B C 
(control) 
Exposure 
6 0.66 0.68 0.62 
13 0.86 0.78 0.78 
Post-challenge 
17 
20 
0.95 
0.85 
0.90 
0.97 
0.92 
0 . 8 6  
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Table 126. Experiment 3—Mean albumin;globulin ratios during 
lead or sodium chloride exposure and following 
Salmonella challenge (day 15). 
Day A 
(control) 
Group 
B 
Exposure 
6 
13 
0.48 
0.43 
0.53 
0.49 
0.49 
0.49 
Post-challenge 
17 
20 
22 
0.41 
0.34 
0.37 
0.51 
0.40 
0.38 
0.54 
0.44 
0.37 
